<!DOCTYPE html><html  lang="en" data-capo=""><head><meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<title>Frontiers | Identification of Eight Spliceogenic Variants in BRCA2 Exon 16 by Minigene Assays</title>
<link rel="stylesheet" href="/ap-2024/_nuxt/entry.CWBB-NGm.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/vue-core.B-WA3Vg5.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/explainer.CMppEa5M.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleDetails.B93eTAmx.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleLayoutHeader.CKWUz2Al.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/AnnouncementCard.Db7nmstV.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/FloatingButtons.xuP8gC33.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleEvent.D0PaxIW7.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/SimilarArticles.BMee4Fk4.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleTemplateBanner.CXmOJ7NH.css">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/v1IBIWh4.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/B674Mi_H.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BXedFy5e.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/eQMj-Fph.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Y8NTh2i4.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUyL5Z_3.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/m8mdd2tc.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DHv8pTSw.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BHPWSuhB.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/x5HZk7Le.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CNJXQ6ZR.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dss5ciUI.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Do5q9QoL.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BhVAcJSK.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/y69VltF1.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Bw-bWKkJ.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/sQBxgu5L.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/D5YKKJGW.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CSLdjdGS.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUN89Jk2.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CCeQzihV.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DVDwh0-U.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dw4ta0fP.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CYv-CzHi.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/U-mJlaMn.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/NhyIC1F3.js">
<link rel="prefetch" as="style" crossorigin href="/ap-2024/_nuxt/ArticleHubLayout.q6CU8_bN.css">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/CKQJuUlk.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/D3plh7Cs.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/GWtHKqLR.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/DS3EY-DL.js">
<meta name="theme-color" content="#0C4DED">
<meta name="mobile-web-app-capable" content="yes">
<meta name="apple-mobile-web-app-capable" content="yes">
<script type="text/javascript" data-hid="4cd079c">window.NREUM||(NREUM={});NREUM.info = {"agent":"","beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"598a124f17","applicationID":"586843029","agentToken":null,"applicationTime":3.180637,"transactionName":"MQcDMkECCkNSW0YMWghNLwlBDgVcWkJXAWAUC04MXBYWXlJUQUpSAwwEEloAFx9SSkYMVgoHEkkZTAJXVlZXSwdWU1lIA1NVCAsXVBBZCg==","queueTime":0,"ttGuid":"e042cd235bdb1002"}; (window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},feature_flags:["soft_nav"],distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"594460232",accountID:"230385",trustKey:"230385",xpid:"VgUHUl5WGwYIUllWBAEFXw==",licenseKey:"598a124f17",applicationID:"586843029",browserID:"594460232"};;/*! For license information please see nr-loader-spa-1.303.0.min.js.LICENSE.txt */
(()=>{var e,t,r={384:(e,t,r)=>{"use strict";r.d(t,{NT:()=>s,US:()=>d,Zm:()=>a,bQ:()=>u,dV:()=>c,pV:()=>l});var n=r(6154),i=r(1863),o=r(1910);const s={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return n.gm.NREUM||(n.gm.NREUM={}),void 0===n.gm.newrelic&&(n.gm.newrelic=n.gm.NREUM),n.gm.NREUM}function c(){let e=a();return e.o||(e.o={ST:n.gm.setTimeout,SI:n.gm.setImmediate||n.gm.setInterval,CT:n.gm.clearTimeout,XHR:n.gm.XMLHttpRequest,REQ:n.gm.Request,EV:n.gm.Event,PR:n.gm.Promise,MO:n.gm.MutationObserver,FETCH:n.gm.fetch,WS:n.gm.WebSocket},(0,o.i)(...Object.values(e.o))),e}function u(e,t){let r=a();r.initializedAgents??={},t.initializedAt={ms:(0,i.t)(),date:new Date},r.initializedAgents[e]=t}function d(e,t){a()[e]=t}function l(){return function(){let e=a();const t=e.info||{};e.info={beacon:s.beacon,errorBeacon:s.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),c(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},782:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewTiming},860:(e,t,r)=>{"use strict";r.d(t,{$J:()=>d,K7:()=>c,P3:()=>u,XX:()=>i,Yy:()=>a,df:()=>o,qY:()=>n,v4:()=>s});const n="events",i="jserrors",o="browser/blobs",s="rum",a="browser/logs",c={ajax:"ajax",genericEvents:"generic_events",jserrors:i,logging:"logging",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",softNav:"soft_navigations",spa:"spa"},u={[c.pageViewEvent]:1,[c.pageViewTiming]:2,[c.metrics]:3,[c.jserrors]:4,[c.spa]:5,[c.ajax]:6,[c.sessionTrace]:7,[c.softNav]:8,[c.sessionReplay]:9,[c.logging]:10,[c.genericEvents]:11},d={[c.pageViewEvent]:s,[c.pageViewTiming]:n,[c.ajax]:n,[c.spa]:n,[c.softNav]:n,[c.metrics]:i,[c.jserrors]:i,[c.sessionTrace]:o,[c.sessionReplay]:o,[c.logging]:a,[c.genericEvents]:"ins"}},944:(e,t,r)=>{"use strict";r.d(t,{R:()=>i});var n=r(3241);function i(e,t){"function"==typeof console.debug&&(console.debug("New Relic Warning: https://github.com/newrelic/newrelic-browser-agent/blob/main/docs/warning-codes.md#".concat(e),t),(0,n.W)({agentIdentifier:null,drained:null,type:"data",name:"warn",feature:"warn",data:{code:e,secondary:t}}))}},993:(e,t,r)=>{"use strict";r.d(t,{A$:()=>o,ET:()=>s,TZ:()=>a,p_:()=>i});var n=r(860);const i={ERROR:"ERROR",WARN:"WARN",INFO:"INFO",DEBUG:"DEBUG",TRACE:"TRACE"},o={OFF:0,ERROR:1,WARN:2,INFO:3,DEBUG:4,TRACE:5},s="log",a=n.K7.logging},1687:(e,t,r)=>{"use strict";r.d(t,{Ak:()=>u,Ze:()=>f,x3:()=>d});var n=r(3241),i=r(7836),o=r(3606),s=r(860),a=r(2646);const c={};function u(e,t){const r={staged:!1,priority:s.P3[t]||0};l(e),c[e].get(t)||c[e].set(t,r)}function d(e,t){e&&c[e]&&(c[e].get(t)&&c[e].delete(t),p(e,t,!1),c[e].size&&h(e))}function l(e){if(!e)throw new Error("agentIdentifier required");c[e]||(c[e]=new Map)}function f(e="",t="feature",r=!1){if(l(e),!e||!c[e].get(t)||r)return p(e,t);c[e].get(t).staged=!0,h(e)}function h(e){const t=Array.from(c[e]);t.every(([e,t])=>t.staged)&&(t.sort((e,t)=>e[1].priority-t[1].priority),t.forEach(([t])=>{c[e].delete(t),p(e,t)}))}function p(e,t,r=!0){const s=e?i.ee.get(e):i.ee,c=o.i.handlers;if(!s.aborted&&s.backlog&&c){if((0,n.W)({agentIdentifier:e,type:"lifecycle",name:"drain",feature:t}),r){const e=s.backlog[t],r=c[t];if(r){for(let t=0;e&&t<e.length;++t)g(e[t],r);Object.entries(r).forEach(([e,t])=>{Object.values(t||{}).forEach(t=>{t[0]?.on&&t[0]?.context()instanceof a.y&&t[0].on(e,t[1])})})}}s.isolatedBacklog||delete c[t],s.backlog[t]=null,s.emit("drain-"+t,[])}}function g(e,t){var r=e[1];Object.values(t[r]||{}).forEach(t=>{var r=e[0];if(t[0]===r){var n=t[1],i=e[3],o=e[2];n.apply(i,o)}})}},1741:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(944),i=r(4261);class o{#e(e,...t){if(this[e]!==o.prototype[e])return this[e](...t);(0,n.R)(35,e)}addPageAction(e,t){return this.#e(i.hG,e,t)}register(e){return this.#e(i.eY,e)}recordCustomEvent(e,t){return this.#e(i.fF,e,t)}setPageViewName(e,t){return this.#e(i.Fw,e,t)}setCustomAttribute(e,t,r){return this.#e(i.cD,e,t,r)}noticeError(e,t){return this.#e(i.o5,e,t)}setUserId(e){return this.#e(i.Dl,e)}setApplicationVersion(e){return this.#e(i.nb,e)}setErrorHandler(e){return this.#e(i.bt,e)}addRelease(e,t){return this.#e(i.k6,e,t)}log(e,t){return this.#e(i.$9,e,t)}start(){return this.#e(i.d3)}finished(e){return this.#e(i.BL,e)}recordReplay(){return this.#e(i.CH)}pauseReplay(){return this.#e(i.Tb)}addToTrace(e){return this.#e(i.U2,e)}setCurrentRouteName(e){return this.#e(i.PA,e)}interaction(e){return this.#e(i.dT,e)}wrapLogger(e,t,r){return this.#e(i.Wb,e,t,r)}measure(e,t){return this.#e(i.V1,e,t)}consent(e){return this.#e(i.Pv,e)}}},1863:(e,t,r)=>{"use strict";function n(){return Math.floor(performance.now())}r.d(t,{t:()=>n})},1910:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(944);const i=new Map;function o(...e){return e.every(e=>{if(i.has(e))return i.get(e);const t="function"==typeof e&&e.toString().includes("[native code]");return t||(0,n.R)(64,e?.name||e?.toString()),i.set(e,t),t})}},2555:(e,t,r)=>{"use strict";r.d(t,{D:()=>a,f:()=>s});var n=r(384),i=r(8122);const o={beacon:n.NT.beacon,errorBeacon:n.NT.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0};function s(e){try{return!!e.licenseKey&&!!e.errorBeacon&&!!e.applicationID}catch(e){return!1}}const a=e=>(0,i.a)(e,o)},2614:(e,t,r)=>{"use strict";r.d(t,{BB:()=>s,H3:()=>n,g:()=>u,iL:()=>c,tS:()=>a,uh:()=>i,wk:()=>o});const n="NRBA",i="SESSION",o=144e5,s=18e5,a={STARTED:"session-started",PAUSE:"session-pause",RESET:"session-reset",RESUME:"session-resume",UPDATE:"session-update"},c={SAME_TAB:"same-tab",CROSS_TAB:"cross-tab"},u={OFF:0,FULL:1,ERROR:2}},2646:(e,t,r)=>{"use strict";r.d(t,{y:()=>n});class n{constructor(e){this.contextId=e}}},2843:(e,t,r)=>{"use strict";r.d(t,{u:()=>i});var n=r(3878);function i(e,t=!1,r,i){(0,n.DD)("visibilitychange",function(){if(t)return void("hidden"===document.visibilityState&&e());e(document.visibilityState)},r,i)}},3241:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(6154);const i="newrelic";function o(e={}){try{n.gm.dispatchEvent(new CustomEvent(i,{detail:e}))}catch(e){}}},3304:(e,t,r)=>{"use strict";r.d(t,{A:()=>o});var n=r(7836);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())??""}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}return""}}},3333:(e,t,r)=>{"use strict";r.d(t,{$v:()=>d,TZ:()=>n,Xh:()=>c,Zp:()=>i,kd:()=>u,mq:()=>a,nf:()=>s,qN:()=>o});const n=r(860).K7.genericEvents,i=["auxclick","click","copy","keydown","paste","scrollend"],o=["focus","blur"],s=4,a=1e3,c=2e3,u=["PageAction","UserAction","BrowserPerformance"],d={RESOURCES:"experimental.resources",REGISTER:"register"}},3434:(e,t,r)=>{"use strict";r.d(t,{Jt:()=>o,YM:()=>u});var n=r(7836),i=r(5607);const o="nr@original:".concat(i.W),s=50;var a=Object.prototype.hasOwnProperty,c=!1;function u(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");const s="-"===n.charAt(0);for(let a=0;a<t.length;a++){const c=t[a],u=e[c];l(u)||(e[c]=r(u,s?c+n:n,i,c,o))}},r.flag=o,r;function r(t,r,n,c,u){return l(t)?t:(r||(r=""),nrWrapper[o]=t,function(e,t,r){if(Object.defineProperty&&Object.keys)try{return Object.keys(e).forEach(function(r){Object.defineProperty(t,r,{get:function(){return e[r]},set:function(t){return e[r]=t,t}})}),t}catch(e){d([e],r)}for(var n in e)a.call(e,n)&&(t[n]=e[n])}(t,nrWrapper,e),nrWrapper);function nrWrapper(){var o,a,l,f;let h;try{a=this,o=[...arguments],l="function"==typeof n?n(o,a):n||{}}catch(t){d([t,"",[o,a,c],l],e)}i(r+"start",[o,a,c],l,u);const p=performance.now();let g;try{return f=t.apply(a,o),g=performance.now(),f}catch(e){throw g=performance.now(),i(r+"err",[o,a,e],l,u),h=e,h}finally{const e=g-p,t={start:p,end:g,duration:e,isLongTask:e>=s,methodName:c,thrownError:h};t.isLongTask&&i("long-task",[t,a],l,u),i(r+"end",[o,a,f],l,u)}}}function i(r,n,i,o){if(!c||t){var s=c;c=!0;try{e.emit(r,n,i,t,o)}catch(t){d([t,r,n,i],e)}c=s}}}function d(e,t){t||(t=n.ee);try{t.emit("internal-error",e)}catch(e){}}function l(e){return!(e&&"function"==typeof e&&e.apply&&!e[o])}},3606:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(9908);o.on=s;var i=o.handlers={};function o(e,t,r,o){s(o||n.d,i,e,t,r)}function s(e,t,r,i,o){o||(o="feature"),e||(e=n.d);var s=t[o]=t[o]||{};(s[r]=s[r]||[]).push([e,i])}},3738:(e,t,r)=>{"use strict";r.d(t,{He:()=>i,Kp:()=>a,Lc:()=>u,Rz:()=>d,TZ:()=>n,bD:()=>o,d3:()=>s,jx:()=>l,sl:()=>f,uP:()=>c});const n=r(860).K7.sessionTrace,i="bstResource",o="resource",s="-start",a="-end",c="fn"+s,u="fn"+a,d="pushState",l=1e3,f=3e4},3785:(e,t,r)=>{"use strict";r.d(t,{R:()=>c,b:()=>u});var n=r(9908),i=r(1863),o=r(860),s=r(8154),a=r(993);function c(e,t,r={},c=a.p_.INFO,u,d=(0,i.t)()){(0,n.p)(s.xV,["API/logging/".concat(c.toLowerCase(),"/called")],void 0,o.K7.metrics,e),(0,n.p)(a.ET,[d,t,r,c,u],void 0,o.K7.logging,e)}function u(e){return"string"==typeof e&&Object.values(a.p_).some(t=>t===e.toUpperCase().trim())}},3878:(e,t,r)=>{"use strict";function n(e,t){return{capture:e,passive:!1,signal:t}}function i(e,t,r=!1,i){window.addEventListener(e,t,n(r,i))}function o(e,t,r=!1,i){document.addEventListener(e,t,n(r,i))}r.d(t,{DD:()=>o,jT:()=>n,sp:()=>i})},3962:(e,t,r)=>{"use strict";r.d(t,{AM:()=>s,O2:()=>l,OV:()=>o,Qu:()=>f,TZ:()=>c,ih:()=>h,pP:()=>a,t1:()=>d,tC:()=>i,wD:()=>u});var n=r(860);const i=["click","keydown","submit"],o="popstate",s="api",a="initialPageLoad",c=n.K7.softNav,u=5e3,d=500,l={INITIAL_PAGE_LOAD:"",ROUTE_CHANGE:1,UNSPECIFIED:2},f={INTERACTION:1,AJAX:2,CUSTOM_END:3,CUSTOM_TRACER:4},h={IP:"in progress",PF:"pending finish",FIN:"finished",CAN:"cancelled"}},4234:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(7836),i=r(1687);class o{constructor(e,t){this.agentIdentifier=e,this.ee=n.ee.get(e),this.featureName=t,this.blocked=!1}deregisterDrain(){(0,i.x3)(this.agentIdentifier,this.featureName)}}},4261:(e,t,r)=>{"use strict";r.d(t,{$9:()=>d,BL:()=>c,CH:()=>p,Dl:()=>R,Fw:()=>w,PA:()=>v,Pl:()=>n,Pv:()=>A,Tb:()=>f,U2:()=>s,V1:()=>E,Wb:()=>T,bt:()=>y,cD:()=>b,d3:()=>x,dT:()=>u,eY:()=>g,fF:()=>h,hG:()=>o,hw:()=>i,k6:()=>a,nb:()=>m,o5:()=>l});const n="api-",i=n+"ixn-",o="addPageAction",s="addToTrace",a="addRelease",c="finished",u="interaction",d="log",l="noticeError",f="pauseReplay",h="recordCustomEvent",p="recordReplay",g="register",m="setApplicationVersion",v="setCurrentRouteName",b="setCustomAttribute",y="setErrorHandler",w="setPageViewName",R="setUserId",x="start",T="wrapLogger",E="measure",A="consent"},4387:(e,t,r)=>{"use strict";function n(e={}){return!(!e.id||!e.name)}function i(e){return"string"==typeof e&&e.trim().length<501||"number"==typeof e}function o(e,t){if(2!==t?.harvestEndpointVersion)return{};const r=t.agentRef.runtime.appMetadata.agents[0].entityGuid;return n(e)?{"mfe.id":e.id,"mfe.name":e.name,eventSource:e.eventSource,"parent.id":e.parent?.id||r}:{"entity.guid":r,appId:t.agentRef.info.applicationID}}r.d(t,{Ux:()=>o,c7:()=>n,yo:()=>i})},5205:(e,t,r)=>{"use strict";r.d(t,{j:()=>_});var n=r(384),i=r(1741);var o=r(2555),s=r(3333);const a=e=>{if(!e||"string"!=typeof e)return!1;try{document.createDocumentFragment().querySelector(e)}catch{return!1}return!0};var c=r(2614),u=r(944),d=r(8122);const l="[data-nr-mask]",f=e=>(0,d.a)(e,(()=>{const e={feature_flags:[],experimental:{allow_registered_children:!1,resources:!1},mask_selector:"*",block_selector:"[data-nr-block]",mask_input_options:{color:!1,date:!1,"datetime-local":!1,email:!1,month:!1,number:!1,range:!1,search:!1,tel:!1,text:!1,time:!1,url:!1,week:!1,textarea:!1,select:!1,password:!0}};return{ajax:{deny_list:void 0,block_internal:!0,enabled:!0,autoStart:!0},api:{get allow_registered_children(){return e.feature_flags.includes(s.$v.REGISTER)||e.experimental.allow_registered_children},set allow_registered_children(t){e.experimental.allow_registered_children=t},duplicate_registered_data:!1},browser_consent_mode:{enabled:!1},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},get feature_flags(){return e.feature_flags},set feature_flags(t){e.feature_flags=t},generic_events:{enabled:!0,autoStart:!0},harvest:{interval:30},jserrors:{enabled:!0,autoStart:!0},logging:{enabled:!0,autoStart:!0},metrics:{enabled:!0,autoStart:!0},obfuscate:void 0,page_action:{enabled:!0},page_view_event:{enabled:!0,autoStart:!0},page_view_timing:{enabled:!0,autoStart:!0},performance:{capture_marks:!1,capture_measures:!1,capture_detail:!0,resources:{get enabled(){return e.feature_flags.includes(s.$v.RESOURCES)||e.experimental.resources},set enabled(t){e.experimental.resources=t},asset_types:[],first_party_domains:[],ignore_newrelic:!0}},privacy:{cookies_enabled:!0},proxy:{assets:void 0,beacon:void 0},session:{expiresMs:c.wk,inactiveMs:c.BB},session_replay:{autoStart:!0,enabled:!1,preload:!1,sampling_rate:10,error_sampling_rate:100,collect_fonts:!1,inline_images:!1,fix_stylesheets:!0,mask_all_inputs:!0,get mask_text_selector(){return e.mask_selector},set mask_text_selector(t){a(t)?e.mask_selector="".concat(t,",").concat(l):""===t||null===t?e.mask_selector=l:(0,u.R)(5,t)},get block_class(){return"nr-block"},get ignore_class(){return"nr-ignore"},get mask_text_class(){return"nr-mask"},get block_selector(){return e.block_selector},set block_selector(t){a(t)?e.block_selector+=",".concat(t):""!==t&&(0,u.R)(6,t)},get mask_input_options(){return e.mask_input_options},set mask_input_options(t){t&&"object"==typeof t?e.mask_input_options={...t,password:!0}:(0,u.R)(7,t)}},session_trace:{enabled:!0,autoStart:!0},soft_navigations:{enabled:!0,autoStart:!0},spa:{enabled:!0,autoStart:!0},ssl:void 0,user_actions:{enabled:!0,elementAttributes:["id","className","tagName","type"]}}})());var h=r(6154),p=r(9324);let g=0;const m={buildEnv:p.F3,distMethod:p.Xs,version:p.xv,originTime:h.WN},v={consented:!1},b={appMetadata:{},get consented(){return this.session?.state?.consent||v.consented},set consented(e){v.consented=e},customTransaction:void 0,denyList:void 0,disabled:!1,harvester:void 0,isolatedBacklog:!1,isRecording:!1,loaderType:void 0,maxBytes:3e4,obfuscator:void 0,onerror:void 0,ptid:void 0,releaseIds:{},session:void 0,timeKeeper:void 0,registeredEntities:[],jsAttributesMetadata:{bytes:0},get harvestCount(){return++g}},y=e=>{const t=(0,d.a)(e,b),r=Object.keys(m).reduce((e,t)=>(e[t]={value:m[t],writable:!1,configurable:!0,enumerable:!0},e),{});return Object.defineProperties(t,r)};var w=r(5701);const R=e=>{const t=e.startsWith("http");e+="/",r.p=t?e:"https://"+e};var x=r(7836),T=r(3241);const E={accountID:void 0,trustKey:void 0,agentID:void 0,licenseKey:void 0,applicationID:void 0,xpid:void 0},A=e=>(0,d.a)(e,E),S=new Set;function _(e,t={},r,s){let{init:a,info:c,loader_config:u,runtime:d={},exposed:l=!0}=t;if(!c){const e=(0,n.pV)();a=e.init,c=e.info,u=e.loader_config}e.init=f(a||{}),e.loader_config=A(u||{}),c.jsAttributes??={},h.bv&&(c.jsAttributes.isWorker=!0),e.info=(0,o.D)(c);const p=e.init,g=[c.beacon,c.errorBeacon];S.has(e.agentIdentifier)||(p.proxy.assets&&(R(p.proxy.assets),g.push(p.proxy.assets)),p.proxy.beacon&&g.push(p.proxy.beacon),e.beacons=[...g],function(e){const t=(0,n.pV)();Object.getOwnPropertyNames(i.W.prototype).forEach(r=>{const n=i.W.prototype[r];if("function"!=typeof n||"constructor"===n)return;let o=t[r];e[r]&&!1!==e.exposed&&"micro-agent"!==e.runtime?.loaderType&&(t[r]=(...t)=>{const n=e[r](...t);return o?o(...t):n})})}(e),(0,n.US)("activatedFeatures",w.B),e.runSoftNavOverSpa&&=!0===p.soft_navigations.enabled&&p.feature_flags.includes("soft_nav")),d.denyList=[...p.ajax.deny_list||[],...p.ajax.block_internal?g:[]],d.ptid=e.agentIdentifier,d.loaderType=r,e.runtime=y(d),S.has(e.agentIdentifier)||(e.ee=x.ee.get(e.agentIdentifier),e.exposed=l,(0,T.W)({agentIdentifier:e.agentIdentifier,drained:!!w.B?.[e.agentIdentifier],type:"lifecycle",name:"initialize",feature:void 0,data:e.config})),S.add(e.agentIdentifier)}},5270:(e,t,r)=>{"use strict";r.d(t,{Aw:()=>s,SR:()=>o,rF:()=>a});var n=r(384),i=r(7767);function o(e){return!!(0,n.dV)().o.MO&&(0,i.V)(e)&&!0===e?.session_trace.enabled}function s(e){return!0===e?.session_replay.preload&&o(e)}function a(e,t){try{if("string"==typeof t?.type){if("password"===t.type.toLowerCase())return"*".repeat(e?.length||0);if(void 0!==t?.dataset?.nrUnmask||t?.classList?.contains("nr-unmask"))return e}}catch(e){}return"string"==typeof e?e.replace(/[\S]/g,"*"):"*".repeat(e?.length||0)}},5289:(e,t,r)=>{"use strict";r.d(t,{GG:()=>o,Qr:()=>a,sB:()=>s});var n=r(3878);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.sp)("load",e,t)}function s(e){if(i())return e();(0,n.DD)("DOMContentLoaded",e)}function a(e){if(i())return e();(0,n.sp)("popstate",e)}},5607:(e,t,r)=>{"use strict";r.d(t,{W:()=>n});const n=(0,r(9566).bz)()},5701:(e,t,r)=>{"use strict";r.d(t,{B:()=>o,t:()=>s});var n=r(3241);const i=new Set,o={};function s(e,t){const r=t.agentIdentifier;o[r]??={},e&&"object"==typeof e&&(i.has(r)||(t.ee.emit("rumresp",[e]),o[r]=e,i.add(r),(0,n.W)({agentIdentifier:r,loaded:!0,drained:!0,type:"lifecycle",name:"load",feature:void 0,data:e})))}},6154:(e,t,r)=>{"use strict";r.d(t,{A4:()=>a,OF:()=>d,RI:()=>i,WN:()=>h,bv:()=>o,gm:()=>s,lR:()=>f,m:()=>u,mw:()=>c,sb:()=>l});var n=r(1863);const i="undefined"!=typeof window&&!!window.document,o="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),s=i?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a="complete"===s?.document?.readyState,c=Boolean("hidden"===s?.document?.visibilityState),u=""+s?.location,d=/iPad|iPhone|iPod/.test(s.navigator?.userAgent),l=d&&"undefined"==typeof SharedWorker,f=(()=>{const e=s.navigator?.userAgent?.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),h=Date.now()-(0,n.t)()},6344:(e,t,r)=>{"use strict";r.d(t,{BB:()=>d,Qb:()=>l,TZ:()=>i,Ug:()=>s,Vh:()=>o,_s:()=>a,bc:()=>u,yP:()=>c});var n=r(2614);const i=r(860).K7.sessionReplay,o="errorDuringReplay",s=.12,a={DomContentLoaded:0,Load:1,FullSnapshot:2,IncrementalSnapshot:3,Meta:4,Custom:5},c={[n.g.ERROR]:15e3,[n.g.FULL]:3e5,[n.g.OFF]:0},u={RESET:{message:"Session was reset",sm:"Reset"},IMPORT:{message:"Recorder failed to import",sm:"Import"},TOO_MANY:{message:"429: Too Many Requests",sm:"Too-Many"},TOO_BIG:{message:"Payload was too large",sm:"Too-Big"},CROSS_TAB:{message:"Session Entity was set to OFF on another tab",sm:"Cross-Tab"},ENTITLEMENTS:{message:"Session Replay is not allowed and will not be started",sm:"Entitlement"}},d=5e3,l={API:"api",RESUME:"resume",SWITCH_TO_FULL:"switchToFull",INITIALIZE:"initialize",PRELOAD:"preload"}},6389:(e,t,r)=>{"use strict";function n(e,t=500,r={}){const n=r?.leading||!1;let i;return(...r)=>{n&&void 0===i&&(e.apply(this,r),i=setTimeout(()=>{i=clearTimeout(i)},t)),n||(clearTimeout(i),i=setTimeout(()=>{e.apply(this,r)},t))}}function i(e){let t=!1;return(...r)=>{t||(t=!0,e.apply(this,r))}}r.d(t,{J:()=>i,s:()=>n})},6630:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewEvent},6774:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.jserrors},7295:(e,t,r)=>{"use strict";r.d(t,{Xv:()=>s,gX:()=>i,iW:()=>o});var n=[];function i(e){if(!e||o(e))return!1;if(0===n.length)return!0;for(var t=0;t<n.length;t++){var r=n[t];if("*"===r.hostname)return!1;if(a(r.hostname,e.hostname)&&c(r.pathname,e.pathname))return!1}return!0}function o(e){return void 0===e.hostname}function s(e){if(n=[],e&&e.length)for(var t=0;t<e.length;t++){let r=e[t];if(!r)continue;0===r.indexOf("http://")?r=r.substring(7):0===r.indexOf("https://")&&(r=r.substring(8));const i=r.indexOf("/");let o,s;i>0?(o=r.substring(0,i),s=r.substring(i)):(o=r,s="");let[a]=o.split(":");n.push({hostname:a,pathname:s})}}function a(e,t){return!(e.length>t.length)&&t.indexOf(e)===t.length-e.length}function c(e,t){return 0===e.indexOf("/")&&(e=e.substring(1)),0===t.indexOf("/")&&(t=t.substring(1)),""===e||e===t}},7378:(e,t,r)=>{"use strict";r.d(t,{$p:()=>x,BR:()=>b,Kp:()=>R,L3:()=>y,Lc:()=>c,NC:()=>o,SG:()=>d,TZ:()=>i,U6:()=>p,UT:()=>m,d3:()=>w,dT:()=>f,e5:()=>E,gx:()=>v,l9:()=>l,oW:()=>h,op:()=>g,rw:()=>u,tH:()=>A,uP:()=>a,wW:()=>T,xq:()=>s});var n=r(384);const i=r(860).K7.spa,o=["click","submit","keypress","keydown","keyup","change"],s=999,a="fn-start",c="fn-end",u="cb-start",d="api-ixn-",l="remaining",f="interaction",h="spaNode",p="jsonpNode",g="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=(0,n.dV)().o.ST,w="-start",R="-end",x="-body",T="cb"+R,E="jsTime",A="fetch"},7485:(e,t,r)=>{"use strict";r.d(t,{D:()=>i});var n=r(6154);function i(e){if(0===(e||"").indexOf("data:"))return{protocol:"data"};try{const t=new URL(e,location.href),r={port:t.port,hostname:t.hostname,pathname:t.pathname,search:t.search,protocol:t.protocol.slice(0,t.protocol.indexOf(":")),sameOrigin:t.protocol===n.gm?.location?.protocol&&t.host===n.gm?.location?.host};return r.port&&""!==r.port||("http:"===t.protocol&&(r.port="80"),"https:"===t.protocol&&(r.port="443")),r.pathname&&""!==r.pathname?r.pathname.startsWith("/")||(r.pathname="/".concat(r.pathname)):r.pathname="/",r}catch(e){return{}}}},7699:(e,t,r)=>{"use strict";r.d(t,{It:()=>o,KC:()=>a,No:()=>i,qh:()=>s});var n=r(860);const i=16e3,o=1e6,s="SESSION_ERROR",a={[n.K7.logging]:!0,[n.K7.genericEvents]:!1,[n.K7.jserrors]:!1,[n.K7.ajax]:!1}},7767:(e,t,r)=>{"use strict";r.d(t,{V:()=>i});var n=r(6154);const i=e=>n.RI&&!0===e?.privacy.cookies_enabled},7836:(e,t,r)=>{"use strict";r.d(t,{P:()=>a,ee:()=>c});var n=r(384),i=r(8990),o=r(2646),s=r(5607);const a="nr@context:".concat(s.W),c=function e(t,r){var n={},s={},d={},l=!1;try{l=16===r.length&&u.initializedAgents?.[r]?.runtime.isolatedBacklog}catch(e){}var f={on:p,addEventListener:p,removeEventListener:function(e,t){var r=n[e];if(!r)return;for(var i=0;i<r.length;i++)r[i]===t&&r.splice(i,1)},emit:function(e,r,n,i,o){!1!==o&&(o=!0);if(c.aborted&&!i)return;t&&o&&t.emit(e,r,n);var a=h(n);g(e).forEach(e=>{e.apply(a,r)});var u=v()[s[e]];u&&u.push([f,e,r,a]);return a},get:m,listeners:g,context:h,buffer:function(e,t){const r=v();if(t=t||"feature",f.aborted)return;Object.entries(e||{}).forEach(([e,n])=>{s[n]=t,t in r||(r[t]=[])})},abort:function(){f._aborted=!0,Object.keys(f.backlog).forEach(e=>{delete f.backlog[e]})},isBuffering:function(e){return!!v()[s[e]]},debugId:r,backlog:l?{}:t&&"object"==typeof t.backlog?t.backlog:{},isolatedBacklog:l};return Object.defineProperty(f,"aborted",{get:()=>{let e=f._aborted||!1;return e||(t&&(e=t.aborted),e)}}),f;function h(e){return e&&e instanceof o.y?e:e?(0,i.I)(e,a,()=>new o.y(a)):new o.y(a)}function p(e,t){n[e]=g(e).concat(t)}function g(e){return n[e]||[]}function m(t){return d[t]=d[t]||e(f,t)}function v(){return f.backlog}}(void 0,"globalEE"),u=(0,n.Zm)();u.ee||(u.ee=c)},8122:(e,t,r)=>{"use strict";r.d(t,{a:()=>i});var n=r(944);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.R)(3);if(!t||"object"!=typeof t)return(0,n.R)(4);const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let s in o)if(void 0!==e[s])try{if(null===e[s]){r[s]=null;continue}Array.isArray(e[s])&&Array.isArray(t[s])?r[s]=Array.from(new Set([...e[s],...t[s]])):"object"==typeof e[s]&&"object"==typeof t[s]?r[s]=i(e[s],t[s]):r[s]=e[s]}catch(e){r[s]||(0,n.R)(1,e)}return r}catch(e){(0,n.R)(2,e)}}},8139:(e,t,r)=>{"use strict";r.d(t,{u:()=>f});var n=r(7836),i=r(3434),o=r(8990),s=r(6154);const a={},c=s.gm.XMLHttpRequest,u="addEventListener",d="removeEventListener",l="nr@wrapped:".concat(n.P);function f(e){var t=function(e){return(e||n.ee).get("events")}(e);if(a[t.debugId]++)return t;a[t.debugId]=1;var r=(0,i.YM)(t,!0);function f(e){r.inPlace(e,[u,d],"-",p)}function p(e,t){return e[1]}return"getPrototypeOf"in Object&&(s.RI&&h(document,f),c&&h(c.prototype,f),h(s.gm,f)),t.on(u+"-start",function(e,t){var n=e[1];if(null!==n&&("function"==typeof n||"object"==typeof n)&&"newrelic"!==e[0]){var i=(0,o.I)(n,l,function(){var e={object:function(){if("function"!=typeof n.handleEvent)return;return n.handleEvent.apply(n,arguments)},function:n}[typeof n];return e?r(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=e[1]=i}}),t.on(d+"-start",function(e){e[1]=this.wrapped||e[1]}),t}function h(e,t,...r){let n=e;for(;"object"==typeof n&&!Object.prototype.hasOwnProperty.call(n,u);)n=Object.getPrototypeOf(n);n&&t(n,...r)}},8154:(e,t,r)=>{"use strict";r.d(t,{z_:()=>o,XG:()=>a,TZ:()=>n,rs:()=>i,xV:()=>s});r(6154),r(9566),r(384);const n=r(860).K7.metrics,i="sm",o="cm",s="storeSupportabilityMetrics",a="storeEventMetrics"},8374:(e,t,r)=>{r.nc=(()=>{try{return document?.currentScript?.nonce}catch(e){}return""})()},8990:(e,t,r)=>{"use strict";r.d(t,{I:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},9300:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.ajax},9324:(e,t,r)=>{"use strict";r.d(t,{AJ:()=>s,F3:()=>i,Xs:()=>o,Yq:()=>a,xv:()=>n});const n="1.303.0",i="PROD",o="CDN",s="@newrelic/rrweb",a="1.0.1"},9566:(e,t,r)=>{"use strict";r.d(t,{LA:()=>a,ZF:()=>c,bz:()=>s,el:()=>u});var n=r(6154);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function s(){const e=n.gm?.crypto||n.gm?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(30))),i.split("").map(e=>"x"===e?o(t,r++).toString(16):"y"===e?(3&o()|8).toString(16):e).join("")}function a(e){const t=n.gm?.crypto||n.gm?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(e)));const s=[];for(var a=0;a<e;a++)s.push(o(r,i++).toString(16));return s.join("")}function c(){return a(16)}function u(){return a(32)}},9908:(e,t,r)=>{"use strict";r.d(t,{d:()=>n,p:()=>i});var n=r(7836).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce((t,r)=>(i.f[r](e,t),t),[])),i.u=e=>({212:"nr-spa-compressor",249:"nr-spa-recorder",478:"nr-spa"}[e]+"-1.303.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA-1.303.0.PROD:",i.l=(r,n,o,s)=>{if(e[r])e[r].push(n);else{var a,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d<u.length;d++){var l=u[d];if(l.getAttribute("src")==r||l.getAttribute("data-webpack")==t+o){a=l;break}}if(!a){c=!0;var f={478:"sha512-Q1pLqcoiNmLHv0rtq3wFkJBA3kofBdRJl0ExDl0mTuAoCBd0qe/1J0XWrDlQKuNlUryL6aZfVkAMPLmoikWIoQ==",249:"sha512-695ZzudsxlMtHKnpDNvkMlJd3tdMtY03IQKVCw9SX12tjUC+f7Nrx5tnWO72Vg9RFf6DSY6wVmM3cEkRM12kkQ==",212:"sha512-18Gx1wIBsppcn0AnKFhwgw4IciNgFxiw3J74W393Ape+wtg4hlg7t6SBKsIE/Dk/tfl2yltgcgBFvYRs283AFg=="};(a=document.createElement("script")).charset="utf-8",i.nc&&a.setAttribute("nonce",i.nc),a.setAttribute("data-webpack",t+o),a.src=r,0!==a.src.indexOf(window.location.origin+"/")&&(a.crossOrigin="anonymous"),f[s]&&(a.integrity=f[s])}e[r]=[n];var h=(t,n)=>{a.onerror=a.onload=null,clearTimeout(p);var i=e[r];if(delete e[r],a.parentNode&&a.parentNode.removeChild(a),i&&i.forEach(e=>e(n)),t)return t(n)},p=setTimeout(h.bind(null,void 0,{type:"timeout",target:a}),12e4);a.onerror=h.bind(null,a.onerror),a.onload=h.bind(null,a.onload),c&&document.head.appendChild(a)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.p="https://js-agent.newrelic.com/",(()=>{var e={38:0,788:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise((r,i)=>n=e[t]=[r,i]);r.push(n[2]=o);var s=i.p+i.u(t),a=new Error;i.l(s,r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),s=r&&r.target&&r.target.src;a.message="Loading chunk "+t+" failed.\n("+o+": "+s+")",a.name="ChunkLoadError",a.type=o,a.request=s,n[1](a)}},"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[s,a,c]=r,u=0;if(s.some(t=>0!==e[t])){for(n in a)i.o(a,n)&&(i.m[n]=a[n]);if(c)c(i)}for(t&&t(r);u<s.length;u++)o=s[u],i.o(e,o)&&e[o]&&e[o][0](),e[o]=0},r=self["webpackChunk:NRBA-1.303.0.PROD"]=self["webpackChunk:NRBA-1.303.0.PROD"]||[];r.forEach(t.bind(null,0)),r.push=t.bind(null,r.push.bind(r))})(),(()=>{"use strict";i(8374);var e=i(9566),t=i(1741);class r extends t.W{agentIdentifier=(0,e.LA)(16)}var n=i(860);const o=Object.values(n.K7);var s=i(5205);var a=i(9908),c=i(1863),u=i(4261),d=i(3241),l=i(944),f=i(5701),h=i(8154);function p(e,t,i,o){const s=o||i;!s||s[e]&&s[e]!==r.prototype[e]||(s[e]=function(){(0,a.p)(h.xV,["API/"+e+"/called"],void 0,n.K7.metrics,i.ee),(0,d.W)({agentIdentifier:i.agentIdentifier,drained:!!f.B?.[i.agentIdentifier],type:"data",name:"api",feature:u.Pl+e,data:{}});try{return t.apply(this,arguments)}catch(e){(0,l.R)(23,e)}})}function g(e,t,r,n,i){const o=e.info;null===r?delete o.jsAttributes[t]:o.jsAttributes[t]=r,(i||null===r)&&(0,a.p)(u.Pl+n,[(0,c.t)(),t,r],void 0,"session",e.ee)}var m=i(1687),v=i(4234),b=i(5289),y=i(6154),w=i(5270),R=i(7767),x=i(6389),T=i(7699);class E extends v.W{constructor(e,t){super(e.agentIdentifier,t),this.agentRef=e,this.abortHandler=void 0,this.featAggregate=void 0,this.loadedSuccessfully=void 0,this.onAggregateImported=new Promise(e=>{this.loadedSuccessfully=e}),this.deferred=Promise.resolve(),!1===e.init[this.featureName].autoStart?this.deferred=new Promise((t,r)=>{this.ee.on("manual-start-all",(0,x.J)(()=>{(0,m.Ak)(e.agentIdentifier,this.featureName),t()}))}):(0,m.Ak)(e.agentIdentifier,t)}importAggregator(e,t,r={}){if(this.featAggregate)return;const n=async()=>{let n;await this.deferred;try{if((0,R.V)(e.init)){const{setupAgentSession:t}=await i.e(478).then(i.bind(i,8766));n=t(e)}}catch(e){(0,l.R)(20,e),this.ee.emit("internal-error",[e]),(0,a.p)(T.qh,[e],void 0,this.featureName,this.ee)}try{if(!this.#t(this.featureName,n,e.init))return(0,m.Ze)(this.agentIdentifier,this.featureName),void this.loadedSuccessfully(!1);const{Aggregate:i}=await t();this.featAggregate=new i(e,r),e.runtime.harvester.initializedAggregates.push(this.featAggregate),this.loadedSuccessfully(!0)}catch(e){(0,l.R)(34,e),this.abortHandler?.(),(0,m.Ze)(this.agentIdentifier,this.featureName,!0),this.loadedSuccessfully(!1),this.ee&&this.ee.abort()}};y.RI?(0,b.GG)(()=>n(),!0):n()}#t(e,t,r){if(this.blocked)return!1;switch(e){case n.K7.sessionReplay:return(0,w.SR)(r)&&!!t;case n.K7.sessionTrace:return!!t;default:return!0}}}var A=i(6630),S=i(2614);class _ extends E{static featureName=A.T;constructor(e){var t;super(e,A.T),this.setupInspectionEvents(e.agentIdentifier),t=e,p(u.Fw,function(e,r){"string"==typeof e&&("/"!==e.charAt(0)&&(e="/"+e),t.runtime.customTransaction=(r||"http://custom.transaction")+e,(0,a.p)(u.Pl+u.Fw,[(0,c.t)()],void 0,void 0,t.ee))},t),this.importAggregator(e,()=>i.e(478).then(i.bind(i,1983)))}setupInspectionEvents(e){const t=(t,r)=>{t&&(0,d.W)({agentIdentifier:e,timeStamp:t.timeStamp,loaded:"complete"===t.target.readyState,type:"window",name:r,data:t.target.location+""})};(0,b.sB)(e=>{t(e,"DOMContentLoaded")}),(0,b.GG)(e=>{t(e,"load")}),(0,b.Qr)(e=>{t(e,"navigate")}),this.ee.on(S.tS.UPDATE,(t,r)=>{(0,d.W)({agentIdentifier:e,type:"lifecycle",name:"session",data:r})})}}var O=i(384);var N=i(2843),I=i(3878),P=i(782);class j extends E{static featureName=P.T;constructor(e){super(e,P.T),y.RI&&((0,N.u)(()=>(0,a.p)("docHidden",[(0,c.t)()],void 0,P.T,this.ee),!0),(0,I.sp)("pagehide",()=>(0,a.p)("winPagehide",[(0,c.t)()],void 0,P.T,this.ee)),this.importAggregator(e,()=>i.e(478).then(i.bind(i,9917))))}}class k extends E{static featureName=h.TZ;constructor(e){super(e,h.TZ),y.RI&&document.addEventListener("securitypolicyviolation",e=>{(0,a.p)(h.xV,["Generic/CSPViolation/Detected"],void 0,this.featureName,this.ee)}),this.importAggregator(e,()=>i.e(478).then(i.bind(i,6555)))}}var C=i(6774),L=i(3304);class H{constructor(e,t,r,n,i){this.name="UncaughtError",this.message="string"==typeof e?e:(0,L.A)(e),this.sourceURL=t,this.line=r,this.column=n,this.__newrelic=i}}function M(e){return U(e)?e:new H(void 0!==e?.message?e.message:e,e?.filename||e?.sourceURL,e?.lineno||e?.line,e?.colno||e?.col,e?.__newrelic,e?.cause)}function K(e){const t="Unhandled Promise Rejection: ";if(!e?.reason)return;if(U(e.reason)){try{e.reason.message.startsWith(t)||(e.reason.message=t+e.reason.message)}catch(e){}return M(e.reason)}const r=M(e.reason);return(r.message||"").startsWith(t)||(r.message=t+r.message),r}function D(e){if(e.error instanceof SyntaxError&&!/:\d+$/.test(e.error.stack?.trim())){const t=new H(e.message,e.filename,e.lineno,e.colno,e.error.__newrelic,e.cause);return t.name=SyntaxError.name,t}return U(e.error)?e.error:M(e)}function U(e){return e instanceof Error&&!!e.stack}function F(e,t,r,i,o=(0,c.t)()){"string"==typeof e&&(e=new Error(e)),(0,a.p)("err",[e,o,!1,t,r.runtime.isRecording,void 0,i],void 0,n.K7.jserrors,r.ee),(0,a.p)("uaErr",[],void 0,n.K7.genericEvents,r.ee)}var W=i(4387),B=i(993),V=i(3785);function G(e,{customAttributes:t={},level:r=B.p_.INFO}={},n,i,o=(0,c.t)()){(0,V.R)(n.ee,e,t,r,i,o)}function z(e,t,r,i,o=(0,c.t)()){(0,a.p)(u.Pl+u.hG,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function Z(e,t,r,i,o=(0,c.t)()){const{start:s,end:d,customAttributes:f}=t||{},h={customAttributes:f||{}};if("object"!=typeof h.customAttributes||"string"!=typeof e||0===e.length)return void(0,l.R)(57);const p=(e,t)=>null==e?t:"number"==typeof e?e:e instanceof PerformanceMark?e.startTime:Number.NaN;if(h.start=p(s,0),h.end=p(d,o),Number.isNaN(h.start)||Number.isNaN(h.end))(0,l.R)(57);else{if(h.duration=h.end-h.start,!(h.duration<0))return(0,a.p)(u.Pl+u.V1,[h,e,i],void 0,n.K7.genericEvents,r.ee),h;(0,l.R)(58)}}function q(e,t={},r,i,o=(0,c.t)()){(0,a.p)(u.Pl+u.fF,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function X(e){p(u.eY,function(t){return Y(e,t)},e)}function Y(e,t,r){const i={};(0,l.R)(54,"newrelic.register"),t||={},t.eventSource="MicroFrontendBrowserAgent",t.licenseKey||=e.info.licenseKey,t.blocked=!1,t.parent=r||{};let o=()=>{};const s=e.runtime.registeredEntities,u=s.find(({metadata:{target:{id:e,name:r}}})=>e===t.id);if(u)return u.metadata.target.name!==t.name&&(u.metadata.target.name=t.name),u;const d=e=>{t.blocked=!0,o=e};e.init.api.allow_registered_children||d((0,x.J)(()=>(0,l.R)(55))),(0,W.c7)(t)||d((0,x.J)(()=>(0,l.R)(48,t))),(0,W.yo)(t.id)&&(0,W.yo)(t.name)||d((0,x.J)(()=>(0,l.R)(48,t)));const f={addPageAction:(r,n={})=>m(z,[r,{...i,...n},e],t),log:(r,n={})=>m(G,[r,{...n,customAttributes:{...i,...n.customAttributes||{}}},e],t),measure:(r,n={})=>m(Z,[r,{...n,customAttributes:{...i,...n.customAttributes||{}}},e],t),noticeError:(r,n={})=>m(F,[r,{...i,...n},e],t),register:(t={})=>m(Y,[e,t],f.metadata.target),recordCustomEvent:(r,n={})=>m(q,[r,{...i,...n},e],t),setApplicationVersion:e=>g("application.version",e),setCustomAttribute:(e,t)=>g(e,t),setUserId:e=>g("enduser.id",e),metadata:{customAttributes:i,target:t}},p=()=>(t.blocked&&o(),t.blocked);p()||s.push(f);const g=(e,t)=>{p()||(i[e]=t)},m=(t,r,i)=>{if(p())return;const o=(0,c.t)();(0,a.p)(h.xV,["API/register/".concat(t.name,"/called")],void 0,n.K7.metrics,e.ee);try{return e.init.api.duplicate_registered_data&&"register"!==t.name&&t(...r,void 0,o),t(...r,i,o)}catch(e){(0,l.R)(50,e)}};return f}class J extends E{static featureName=C.T;constructor(e){var t;super(e,C.T),t=e,p(u.o5,(e,r)=>F(e,r,t),t),function(e){p(u.bt,function(t){e.runtime.onerror=t},e)}(e),function(e){let t=0;p(u.k6,function(e,r){++t>10||(this.runtime.releaseIds[e.slice(-200)]=(""+r).slice(-200))},e)}(e),X(e);try{this.removeOnAbort=new AbortController}catch(e){}this.ee.on("internal-error",(t,r)=>{this.abortHandler&&(0,a.p)("ierr",[M(t),(0,c.t)(),!0,{},e.runtime.isRecording,r],void 0,this.featureName,this.ee)}),y.gm.addEventListener("unhandledrejection",t=>{this.abortHandler&&(0,a.p)("err",[K(t),(0,c.t)(),!1,{unhandledPromiseRejection:1},e.runtime.isRecording],void 0,this.featureName,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),y.gm.addEventListener("error",t=>{this.abortHandler&&(0,a.p)("err",[D(t),(0,c.t)(),!1,{},e.runtime.isRecording],void 0,this.featureName,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,()=>i.e(478).then(i.bind(i,2176)))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var Q=i(8990);let ee=1;function te(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===y.gm?0:(0,Q.I)(e,"nr@id",function(){return ee++})}function re(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,L.A)(e).length}catch(e){return}}}var ne=i(8139),ie=i(7836),oe=i(3434);const se={},ae=["open","send"];function ce(e){var t=e||ie.ee;const r=function(e){return(e||ie.ee).get("xhr")}(t);if(void 0===y.gm.XMLHttpRequest)return r;if(se[r.debugId]++)return r;se[r.debugId]=1,(0,ne.u)(t);var n=(0,oe.YM)(r),i=y.gm.XMLHttpRequest,o=y.gm.MutationObserver,s=y.gm.Promise,a=y.gm.setInterval,c="readystatechange",u=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],d=[],f=y.gm.XMLHttpRequest=function(e){const t=new i(e),o=r.context(t);try{r.emit("new-xhr",[t],o),t.addEventListener(c,(s=o,function(){var e=this;e.readyState>3&&!s.resolved&&(s.resolved=!0,r.emit("xhr-resolved",[],e)),n.inPlace(e,u,"fn-",b)}),(0,I.jT)(!1))}catch(e){(0,l.R)(15,e);try{r.emit("internal-error",[e])}catch(e){}}var s;return t};function h(e,t){n.inPlace(t,["onreadystatechange"],"fn-",b)}if(function(e,t){for(var r in e)t[r]=e[r]}(i,f),f.prototype=i.prototype,n.inPlace(f.prototype,ae,"-xhr-",b),r.on("send-xhr-start",function(e,t){h(e,t),function(e){d.push(e),o&&(p?p.then(v):a?a(v):(g=-g,m.data=g))}(t)}),r.on("open-xhr-start",h),o){var p=s&&s.resolve();if(!a&&!s){var g=1,m=document.createTextNode(g);new o(v).observe(m,{characterData:!0})}}else t.on("fn-end",function(e){e[0]&&e[0].type===c||v()});function v(){for(var e=0;e<d.length;e++)h(0,d[e]);d.length&&(d=[])}function b(e,t){return t}return r}var ue="fetch-",de=ue+"body-",le=["arrayBuffer","blob","json","text","formData"],fe=y.gm.Request,he=y.gm.Response,pe="prototype";const ge={};function me(e){const t=function(e){return(e||ie.ee).get("fetch")}(e);if(!(fe&&he&&y.gm.fetch))return t;if(ge[t.debugId]++)return t;function r(e,r,n){var i=e[r];"function"==typeof i&&(e[r]=function(){var e,r=[...arguments],o={};t.emit(n+"before-start",[r],o),o[ie.P]&&o[ie.P].dt&&(e=o[ie.P].dt);var s=i.apply(this,r);return t.emit(n+"start",[r,e],s),s.then(function(e){return t.emit(n+"end",[null,e],s),e},function(e){throw t.emit(n+"end",[e],s),e})})}return ge[t.debugId]=1,le.forEach(e=>{r(fe[pe],e,de),r(he[pe],e,de)}),r(y.gm,"fetch",ue),t.on(ue+"end",function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(ue+"done",[null,r],n)}else t.emit(ue+"done",[e],n)}),t}var ve=i(7485);class be{constructor(e){this.agentRef=e}generateTracePayload(t){const r=this.agentRef.loader_config;if(!this.shouldGenerateTrace(t)||!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var s=(0,e.ZF)(),a=(0,e.el)(),c=Date.now(),u={spanId:s,traceId:a,timestamp:c};return(t.sameOrigin||this.isAllowedOrigin(t)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(s,a),u.traceContextStateHeader=this.generateTraceContextStateHeader(s,c,n,i,o)),(t.sameOrigin&&!this.excludeNewrelicHeader()||!t.sameOrigin&&this.isAllowedOrigin(t)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(s,a,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof y.gm?.btoa))return null;var s={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(s.d.tk=o),btoa((0,L.A)(s))}shouldGenerateTrace(e){return this.agentRef.init?.distributed_tracing?.enabled&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var t=!1;const r=this.agentRef.init?.distributed_tracing;if(e.sameOrigin)t=!0;else if(r?.allowed_origins instanceof Array)for(var n=0;n<r.allowed_origins.length;n++){var i=(0,ve.D)(r.allowed_origins[n]);if(e.hostname===i.hostname&&e.protocol===i.protocol&&e.port===i.port){t=!0;break}}return t}excludeNewrelicHeader(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.exclude_newrelic_header}useNewrelicHeaderForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!1!==e.cors_use_newrelic_header}useTraceContextHeadersForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.cors_use_tracecontext_headers}}var ye=i(9300),we=i(7295);function Re(e){return"string"==typeof e?e:e instanceof(0,O.dV)().o.REQ?e.url:y.gm?.URL&&e instanceof URL?e.href:void 0}var xe=["load","error","abort","timeout"],Te=xe.length,Ee=(0,O.dV)().o.REQ,Ae=(0,O.dV)().o.XHR;const Se="X-NewRelic-App-Data";class _e extends E{static featureName=ye.T;constructor(e){super(e,ye.T),this.dt=new be(e),this.handler=(e,t,r,n)=>(0,a.p)(e,t,r,n,this.ee);try{const e={xmlhttprequest:"xhr",fetch:"fetch",beacon:"beacon"};y.gm?.performance?.getEntriesByType("resource").forEach(t=>{if(t.initiatorType in e&&0!==t.responseStatus){const r={status:t.responseStatus},i={rxSize:t.transferSize,duration:Math.floor(t.duration),cbTime:0};Oe(r,t.name),this.handler("xhr",[r,i,t.startTime,t.responseEnd,e[t.initiatorType]],void 0,n.K7.ajax)}})}catch(e){}me(this.ee),ce(this.ee),function(e,t,r,i){function o(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},t.latestLongtaskEnd=0,e.addEventListener("load",function(r){A(t,e)},(0,I.jT)(!1)),y.lR||e.addEventListener("progress",function(e){t.lastSize=e.loaded},(0,I.jT)(!1))}function s(e){this.params={method:e[0]},Oe(this,e[1]),this.metrics={}}function u(t,r){e.loader_config.xpid&&this.sameOrigin&&r.setRequestHeader("X-NewRelic-ID",e.loader_config.xpid);var n=i.generateTracePayload(this.parsedOrigin);if(n){var o=!1;n.newrelicHeader&&(r.setRequestHeader("newrelic",n.newrelicHeader),o=!0),n.traceContextParentHeader&&(r.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&r.setRequestHeader("tracestate",n.traceContextStateHeader),o=!0),o&&(this.dt=n)}}function d(e,r){var n=this.metrics,i=e[0],o=this;if(n&&i){var s=re(i);s&&(n.txSize=s)}this.startTime=(0,c.t)(),this.body=i,this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof r.onload)&&"function"==typeof o.end)&&o.end(r)}catch(e){try{t.emit("internal-error",[e])}catch(e){}}};for(var a=0;a<Te;a++)r.addEventListener(xe[a],this.listener,(0,I.jT)(!1))}function l(e,t,r){this.cbTime+=e,t?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof r.onload||"function"!=typeof this.end||this.end(r)}function f(e,t){var r=""+te(e)+!!t;this.xhrGuids&&!this.xhrGuids[r]&&(this.xhrGuids[r]=!0,this.totalCbs+=1)}function p(e,t){var r=""+te(e)+!!t;this.xhrGuids&&this.xhrGuids[r]&&(delete this.xhrGuids[r],this.totalCbs-=1)}function g(){this.endTime=(0,c.t)()}function m(e,r){r instanceof Ae&&"load"===e[0]&&t.emit("xhr-load-added",[e[1],e[2]],r)}function v(e,r){r instanceof Ae&&"load"===e[0]&&t.emit("xhr-load-removed",[e[1],e[2]],r)}function b(e,t,r){t instanceof Ae&&("onload"===r&&(this.onload=!0),("load"===(e[0]&&e[0].type)||this.onload)&&(this.xhrCbStart=(0,c.t)()))}function w(e,r){this.xhrCbStart&&t.emit("xhr-cb-time",[(0,c.t)()-this.xhrCbStart,this.onload,r],r)}function R(e){var t,r=e[1]||{};if("string"==typeof e[0]?0===(t=e[0]).length&&y.RI&&(t=""+y.gm.location.href):e[0]&&e[0].url?t=e[0].url:y.gm?.URL&&e[0]&&e[0]instanceof URL?t=e[0].href:"function"==typeof e[0].toString&&(t=e[0].toString()),"string"==typeof t&&0!==t.length){t&&(this.parsedOrigin=(0,ve.D)(t),this.sameOrigin=this.parsedOrigin.sameOrigin);var n=i.generateTracePayload(this.parsedOrigin);if(n&&(n.newrelicHeader||n.traceContextParentHeader))if(e[0]&&e[0].headers)a(e[0].headers,n)&&(this.dt=n);else{var o={};for(var s in r)o[s]=r[s];o.headers=new Headers(r.headers||{}),a(o.headers,n)&&(this.dt=n),e.length>1?e[1]=o:e.push(o)}}function a(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,c.t)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r=this.opts||{},n=this.target;Oe(this,Re(n));var i=(""+(n&&n instanceof Ee&&n.method||r.method||"GET")).toUpperCase();this.params.method=i,this.body=r.body,this.txSize=re(r.body)||0}function T(e,t){if(this.endTime=(0,c.t)(),this.params||(this.params={}),(0,we.iW)(this.params))return;let i;this.params.status=t?t.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(i=+this.rxSize);const o={txSize:this.txSize,rxSize:i,duration:(0,c.t)()-this.startTime};r("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,n.K7.ajax)}function E(e){const t=this.params,i=this.metrics;if(!this.ended){this.ended=!0;for(let t=0;t<Te;t++)e.removeEventListener(xe[t],this.listener,!1);t.aborted||(0,we.iW)(t)||(i.duration=(0,c.t)()-this.startTime,this.loadCaptureCalled||4!==e.readyState?null==t.status&&(t.status=0):A(this,e),i.cbTime=this.cbTime,r("xhr",[t,i,this.startTime,this.endTime,"xhr"],this,n.K7.ajax))}}function A(e,r){e.params.status=r.status;var i=function(e,t){var r=e.responseType;return"json"===r&&null!==t?t:"arraybuffer"===r||"blob"===r||"json"===r?re(e.response):"text"===r||""===r||void 0===r?re(e.responseText):void 0}(r,e.lastSize);if(i&&(e.metrics.rxSize=i),e.sameOrigin&&r.getAllResponseHeaders().indexOf(Se)>=0){var o=r.getResponseHeader(Se);o&&((0,a.p)(h.rs,["Ajax/CrossApplicationTracing/Header/Seen"],void 0,n.K7.metrics,t),e.params.cat=o.split(", ").pop())}e.loadCaptureCalled=!0}t.on("new-xhr",o),t.on("open-xhr-start",s),t.on("open-xhr-end",u),t.on("send-xhr-start",d),t.on("xhr-cb-time",l),t.on("xhr-load-added",f),t.on("xhr-load-removed",p),t.on("xhr-resolved",g),t.on("addEventListener-end",m),t.on("removeEventListener-end",v),t.on("fn-end",w),t.on("fetch-before-start",R),t.on("fetch-start",x),t.on("fn-start",b),t.on("fetch-done",T)}(e,this.ee,this.handler,this.dt),this.importAggregator(e,()=>i.e(478).then(i.bind(i,3845)))}}function Oe(e,t){var r=(0,ve.D)(t),n=e.params||e;n.hostname=r.hostname,n.port=r.port,n.protocol=r.protocol,n.host=r.hostname+":"+r.port,n.pathname=r.pathname,e.parsedOrigin=r,e.sameOrigin=r.sameOrigin}const Ne={},Ie=["pushState","replaceState"];function Pe(e){const t=function(e){return(e||ie.ee).get("history")}(e);return!y.RI||Ne[t.debugId]++||(Ne[t.debugId]=1,(0,oe.YM)(t).inPlace(window.history,Ie,"-")),t}var je=i(3738);function ke(e){p(u.BL,function(t=Date.now()){const r=t-y.WN;r<0&&(0,l.R)(62,t),(0,a.p)(h.XG,[u.BL,{time:r}],void 0,n.K7.metrics,e.ee),e.addToTrace({name:u.BL,start:t,origin:"nr"}),(0,a.p)(u.Pl+u.hG,[r,u.BL],void 0,n.K7.genericEvents,e.ee)},e)}const{He:Ce,bD:Le,d3:He,Kp:Me,TZ:Ke,Lc:De,uP:Ue,Rz:Fe}=je;class We extends E{static featureName=Ke;constructor(e){var t;super(e,Ke),t=e,p(u.U2,function(e){if(!(e&&"object"==typeof e&&e.name&&e.start))return;const r={n:e.name,s:e.start-y.WN,e:(e.end||e.start)-y.WN,o:e.origin||"",t:"api"};r.s<0||r.e<0||r.e<r.s?(0,l.R)(61,{start:r.s,end:r.e}):(0,a.p)("bstApi",[r],void 0,n.K7.sessionTrace,t.ee)},t),ke(e);if(!(0,R.V)(e.init))return void this.deregisterDrain();const r=this.ee;let o;Pe(r),this.eventsEE=(0,ne.u)(r),this.eventsEE.on(Ue,function(e,t){this.bstStart=(0,c.t)()}),this.eventsEE.on(De,function(e,t){(0,a.p)("bst",[e[0],t,this.bstStart,(0,c.t)()],void 0,n.K7.sessionTrace,r)}),r.on(Fe+He,function(e){this.time=(0,c.t)(),this.startPath=location.pathname+location.hash}),r.on(Fe+Me,function(e){(0,a.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,n.K7.sessionTrace,r)});try{o=new PerformanceObserver(e=>{const t=e.getEntries();(0,a.p)(Ce,[t],void 0,n.K7.sessionTrace,r)}),o.observe({type:Le,buffered:!0})}catch(e){}this.importAggregator(e,()=>i.e(478).then(i.bind(i,6974)),{resourceObserver:o})}}var Be=i(6344);class Ve extends E{static featureName=Be.TZ;#n;recorder;constructor(e){var t;let r;super(e,Be.TZ),t=e,p(u.CH,function(){(0,a.p)(u.CH,[],void 0,n.K7.sessionReplay,t.ee)},t),function(e){p(u.Tb,function(){(0,a.p)(u.Tb,[],void 0,n.K7.sessionReplay,e.ee)},e)}(e);try{r=JSON.parse(localStorage.getItem("".concat(S.H3,"_").concat(S.uh)))}catch(e){}(0,w.SR)(e.init)&&this.ee.on(u.CH,()=>this.#i()),this.#o(r)&&this.importRecorder().then(e=>{e.startRecording(Be.Qb.PRELOAD,r?.sessionReplayMode)}),this.importAggregator(this.agentRef,()=>i.e(478).then(i.bind(i,6167)),this),this.ee.on("err",e=>{this.blocked||this.agentRef.runtime.isRecording&&(this.errorNoticed=!0,(0,a.p)(Be.Vh,[e],void 0,this.featureName,this.ee))})}#o(e){return e&&(e.sessionReplayMode===S.g.FULL||e.sessionReplayMode===S.g.ERROR)||(0,w.Aw)(this.agentRef.init)}importRecorder(){return this.recorder?Promise.resolve(this.recorder):(this.#n??=Promise.all([i.e(478),i.e(249)]).then(i.bind(i,4866)).then(({Recorder:e})=>(this.recorder=new e(this),this.recorder)).catch(e=>{throw this.ee.emit("internal-error",[e]),this.blocked=!0,e}),this.#n)}#i(){this.blocked||(this.featAggregate?this.featAggregate.mode!==S.g.FULL&&this.featAggregate.initializeRecording(S.g.FULL,!0,Be.Qb.API):this.importRecorder().then(()=>{this.recorder.startRecording(Be.Qb.API,S.g.FULL)}))}}var Ge=i(3962);function ze(e){const t=e.ee.get("tracer");function r(){}p(u.dT,function(e){return(new r).get("object"==typeof e?e:{})},e);const i=r.prototype={createTracer:function(r,i){var o={},s=this,d="function"==typeof i;return(0,a.p)(h.xV,["API/createTracer/called"],void 0,n.K7.metrics,e.ee),e.runSoftNavOverSpa||(0,a.p)(u.hw+"tracer",[(0,c.t)(),r,o],s,n.K7.spa,e.ee),function(){if(t.emit((d?"":"no-")+"fn-start",[(0,c.t)(),s,d],o),d)try{return i.apply(this,arguments)}catch(e){const r="string"==typeof e?new Error(e):e;throw t.emit("fn-err",[arguments,this,r],o),r}finally{t.emit("fn-end",[(0,c.t)()],o)}}}};["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach(t=>{p.apply(this,[t,function(){return(0,a.p)(u.hw+t,[(0,c.t)(),...arguments],this,e.runSoftNavOverSpa?n.K7.softNav:n.K7.spa,e.ee),this},e,i])}),p(u.PA,function(){e.runSoftNavOverSpa?(0,a.p)(u.hw+"routeName",[performance.now(),...arguments],void 0,n.K7.softNav,e.ee):(0,a.p)(u.Pl+"routeName",[(0,c.t)(),...arguments],this,n.K7.spa,e.ee)},e)}class Ze extends E{static featureName=Ge.TZ;constructor(e){if(super(e,Ge.TZ),ze(e),!y.RI||!(0,O.dV)().o.MO)return;const t=Pe(this.ee);try{this.removeOnAbort=new AbortController}catch(e){}Ge.tC.forEach(e=>{(0,I.sp)(e,e=>{s(e)},!0,this.removeOnAbort?.signal)});const r=()=>(0,a.p)("newURL",[(0,c.t)(),""+window.location],void 0,this.featureName,this.ee);t.on("pushState-end",r),t.on("replaceState-end",r),(0,I.sp)(Ge.OV,e=>{s(e),(0,a.p)("newURL",[e.timeStamp,""+window.location],void 0,this.featureName,this.ee)},!0,this.removeOnAbort?.signal);let n=!1;const o=new((0,O.dV)().o.MO)((e,t)=>{n||(n=!0,requestAnimationFrame(()=>{(0,a.p)("newDom",[(0,c.t)()],void 0,this.featureName,this.ee),n=!1}))}),s=(0,x.s)(e=>{(0,a.p)("newUIEvent",[e],void 0,this.featureName,this.ee),o.observe(document.body,{attributes:!0,childList:!0,subtree:!0,characterData:!0})},100,{leading:!0});this.abortHandler=function(){this.removeOnAbort?.abort(),o.disconnect(),this.abortHandler=void 0},this.importAggregator(e,()=>i.e(478).then(i.bind(i,4393)),{domObserver:o})}}var qe=i(7378);const Xe={},Ye=["appendChild","insertBefore","replaceChild"];function Je(e){const t=function(e){return(e||ie.ee).get("jsonp")}(e);if(!y.RI||Xe[t.debugId])return t;Xe[t.debugId]=!0;var r=(0,oe.YM)(t),n=/[?&](?:callback|cb)=([^&#]+)/,i=/(.*)\.([^.]+)/,o=/^(\w+)(\.|$)(.*)$/;function s(e,t){if(!e)return t;const r=e.match(o),n=r[1];return s(r[3],t[n])}return r.inPlace(Node.prototype,Ye,"dom-"),t.on("dom-start",function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var o=(a=e.src,c=a.match(n),c?c[1]:null);var a,c;if(!o)return;var u=function(e){var t=e.match(i);if(t&&t.length>=3)return{key:t[2],parent:s(t[1],window)};return{key:e,parent:window}}(o);if("function"!=typeof u.parent[u.key])return;var d={};function l(){t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}function f(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",l,(0,I.jT)(!1)),e.addEventListener("error",f,(0,I.jT)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])}),t}const $e={};function Qe(e){const t=function(e){return(e||ie.ee).get("promise")}(e);if($e[t.debugId])return t;$e[t.debugId]=!0;var r=t.context,n=(0,oe.YM)(t),i=y.gm.Promise;return i&&function(){function e(r){var o=t.context(),s=n(r,"executor-",o,null,!1);const a=Reflect.construct(i,[s],e);return t.context(a).getCtx=function(){return o},a}y.gm.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return i.toString()},Object.setPrototypeOf(e,i),["all","race"].forEach(function(r){const n=i[r];e[r]=function(e){let i=!1;[...e||[]].forEach(e=>{this.resolve(e).then(s("all"===r),s(!1))});const o=n.apply(this,arguments);return o;function s(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}}),["resolve","reject"].forEach(function(r){const n=i[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}}),e.prototype=i.prototype;const o=i.prototype.then;i.prototype.then=function(...e){var i=this,s=r(i);s.promise=i,e[0]=n(e[0],"cb-",s,null,!1),e[1]=n(e[1],"cb-",s,null,!1);const a=o.apply(this,e);return s.nextPromise=a,t.emit("propagate",[i,!0],a,!1,!1),a},i.prototype.then[oe.Jt]=o,t.on("executor-start",function(e){e[0]=n(e[0],"resolve-",this,null,!1),e[1]=n(e[1],"resolve-",this,null,!1)}),t.on("executor-err",function(e,t,r){e[1](r)}),t.on("cb-end",function(e,r,n){t.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),t.on("propagate",function(e,r,n){if(!this.getCtx||r){const r=this,n=e instanceof Promise?t.context(e):null;let i;this.getCtx=function(){return i||(i=n&&n!==r?"function"==typeof n.getCtx?n.getCtx():n:r,i)}}})}(),t}const et={},tt="setTimeout",rt="setInterval",nt="clearTimeout",it="-start",ot=[tt,"setImmediate",rt,nt,"clearImmediate"];function st(e){const t=function(e){return(e||ie.ee).get("timer")}(e);if(et[t.debugId]++)return t;et[t.debugId]=1;var r=(0,oe.YM)(t);return r.inPlace(y.gm,ot.slice(0,2),tt+"-"),r.inPlace(y.gm,ot.slice(2,3),rt+"-"),r.inPlace(y.gm,ot.slice(3),nt+"-"),t.on(rt+it,function(e,t,n){e[0]=r(e[0],"fn-",null,n)}),t.on(tt+it,function(e,t,n){this.method=n,this.timerDuration=isNaN(e[1])?0:+e[1],e[0]=r(e[0],"fn-",this,n)}),t}const at={};function ct(e){const t=function(e){return(e||ie.ee).get("mutation")}(e);if(!y.RI||at[t.debugId])return t;at[t.debugId]=!0;var r=(0,oe.YM)(t),n=y.gm.MutationObserver;return n&&(window.MutationObserver=function(e){return this instanceof n?new n(r(e,"fn-")):n.apply(this,arguments)},MutationObserver.prototype=n.prototype),t}const{TZ:ut,d3:dt,Kp:lt,$p:ft,wW:ht,e5:pt,tH:gt,uP:mt,rw:vt,Lc:bt}=qe;class yt extends E{static featureName=ut;constructor(e){if(super(e,ut),ze(e),!y.RI)return;try{this.removeOnAbort=new AbortController}catch(e){}let t,r=0;const n=this.ee.get("tracer"),o=Je(this.ee),s=Qe(this.ee),u=st(this.ee),d=ce(this.ee),l=this.ee.get("events"),f=me(this.ee),h=Pe(this.ee),p=ct(this.ee);function g(e,t){h.emit("newURL",[""+window.location,t])}function m(){r++,t=window.location.hash,this[mt]=(0,c.t)()}function v(){r--,window.location.hash!==t&&g(0,!0);var e=(0,c.t)();this[pt]=~~this[pt]+e-this[mt],this[bt]=e}function b(e,t){e.on(t,function(){this[t]=(0,c.t)()})}this.ee.on(mt,m),s.on(vt,m),o.on(vt,m),this.ee.on(bt,v),s.on(ht,v),o.on(ht,v),this.ee.on("fn-err",(...t)=>{t[2]?.__newrelic?.[e.agentIdentifier]||(0,a.p)("function-err",[...t],void 0,this.featureName,this.ee)}),this.ee.buffer([mt,bt,"xhr-resolved"],this.featureName),l.buffer([mt],this.featureName),u.buffer(["setTimeout"+lt,"clearTimeout"+dt,mt],this.featureName),d.buffer([mt,"new-xhr","send-xhr"+dt],this.featureName),f.buffer([gt+dt,gt+"-done",gt+ft+dt,gt+ft+lt],this.featureName),h.buffer(["newURL"],this.featureName),p.buffer([mt],this.featureName),s.buffer(["propagate",vt,ht,"executor-err","resolve"+dt],this.featureName),n.buffer([mt,"no-"+mt],this.featureName),o.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),b(f,gt+dt),b(f,gt+"-done"),b(o,"new-jsonp"),b(o,"jsonp-end"),b(o,"cb-start"),h.on("pushState-end",g),h.on("replaceState-end",g),window.addEventListener("hashchange",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",function(){g(0,r>1)},(0,I.jT)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,()=>i.e(478).then(i.bind(i,5592)))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var wt=i(3333);class Rt extends E{static featureName=wt.TZ;constructor(e){super(e,wt.TZ);const t=[e.init.page_action.enabled,e.init.performance.capture_marks,e.init.performance.capture_measures,e.init.user_actions.enabled,e.init.performance.resources.enabled];var r;r=e,p(u.hG,(e,t)=>z(e,t,r),r),function(e){p(u.fF,(t,r)=>q(t,r,e),e)}(e),ke(e),X(e),function(e){p(u.V1,(t,r)=>Z(t,r,e),e)}(e);const o=e.init.feature_flags.includes("user_frustrations");let s;if(y.RI&&o&&(me(this.ee),ce(this.ee),s=Pe(this.ee)),y.RI){if(e.init.user_actions.enabled&&(wt.Zp.forEach(e=>(0,I.sp)(e,e=>(0,a.p)("ua",[e],void 0,this.featureName,this.ee),!0)),wt.qN.forEach(e=>{const t=(0,x.s)(e=>{(0,a.p)("ua",[e],void 0,this.featureName,this.ee)},500,{leading:!0});(0,I.sp)(e,t)}),o)){function c(t){const r=(0,ve.D)(t);return e.beacons.includes(r.hostname+":"+r.port)}function d(){s.emit("navChange")}y.gm.addEventListener("error",()=>{(0,a.p)("uaErr",[],void 0,n.K7.genericEvents,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),this.ee.on("open-xhr-start",(e,t)=>{c(e[1])||t.addEventListener("readystatechange",()=>{2===t.readyState&&(0,a.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)})}),this.ee.on("fetch-start",e=>{e.length>=1&&!c(Re(e[0]))&&(0,a.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)}),s.on("pushState-end",d),s.on("replaceState-end",d),window.addEventListener("hashchange",d,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",d,(0,I.jT)(!0,this.removeOnAbort?.signal))}if(e.init.performance.resources.enabled&&y.gm.PerformanceObserver?.supportedEntryTypes.includes("resource")){new PerformanceObserver(e=>{e.getEntries().forEach(e=>{(0,a.p)("browserPerformance.resource",[e],void 0,this.featureName,this.ee)})}).observe({type:"resource",buffered:!0})}}try{this.removeOnAbort=new AbortController}catch(l){}this.abortHandler=()=>{this.removeOnAbort?.abort(),this.abortHandler=void 0},t.some(e=>e)?this.importAggregator(e,()=>i.e(478).then(i.bind(i,8019))):this.deregisterDrain()}}var xt=i(2646);const Tt=new Map;function Et(e,t,r,n){if("object"!=typeof t||!t||"string"!=typeof r||!r||"function"!=typeof t[r])return(0,l.R)(29);const i=function(e){return(e||ie.ee).get("logger")}(e),o=(0,oe.YM)(i),s=new xt.y(ie.P);s.level=n.level,s.customAttributes=n.customAttributes;const a=t[r]?.[oe.Jt]||t[r];return Tt.set(a,s),o.inPlace(t,[r],"wrap-logger-",()=>Tt.get(a)),i}var At=i(1910);class St extends E{static featureName=B.TZ;constructor(e){var t;super(e,B.TZ),t=e,p(u.$9,(e,r)=>G(e,r,t),t),function(e){p(u.Wb,(t,r,{customAttributes:n={},level:i=B.p_.INFO}={})=>{Et(e.ee,t,r,{customAttributes:n,level:i})},e)}(e),X(e);const r=this.ee;["log","error","warn","info","debug","trace"].forEach(e=>{(0,At.i)(y.gm.console[e]),Et(r,y.gm.console,e,{level:"log"===e?"info":e})}),this.ee.on("wrap-logger-end",function([e]){const{level:t,customAttributes:n}=this;(0,V.R)(r,e,n,t)}),this.importAggregator(e,()=>i.e(478).then(i.bind(i,5288)))}}new class extends r{constructor(e){var t;(super(),y.gm)?(this.features={},(0,O.bQ)(this.agentIdentifier,this),this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(_),this.runSoftNavOverSpa=[...this.desiredFeatures].some(e=>e.featureName===n.K7.softNav),(0,s.j)(this,e,e.loaderType||"agent"),t=this,p(u.cD,function(e,r,n=!1){if("string"==typeof e){if(["string","number","boolean"].includes(typeof r)||null===r)return g(t,e,r,u.cD,n);(0,l.R)(40,typeof r)}else(0,l.R)(39,typeof e)},t),function(e){p(u.Dl,function(t){if("string"==typeof t||null===t)return g(e,"enduser.id",t,u.Dl,!0);(0,l.R)(41,typeof t)},e)}(this),function(e){p(u.nb,function(t){if("string"==typeof t||null===t)return g(e,"application.version",t,u.nb,!1);(0,l.R)(42,typeof t)},e)}(this),function(e){p(u.d3,function(){e.ee.emit("manual-start-all")},e)}(this),function(e){p(u.Pv,function(t=!0){if("boolean"==typeof t){if((0,a.p)(u.Pl+u.Pv,[t],void 0,"session",e.ee),e.runtime.consented=t,t){const t=e.features.page_view_event;t.onAggregateImported.then(e=>{const r=t.featAggregate;e&&!r.sentRum&&r.sendRum()})}}else(0,l.R)(65,typeof t)},e)}(this),this.run()):(0,l.R)(21)}get config(){return{info:this.info,init:this.init,loader_config:this.loader_config,runtime:this.runtime}}get api(){return this}run(){try{const e=function(e){const t={};return o.forEach(r=>{t[r]=!!e[r]?.enabled}),t}(this.init),t=[...this.desiredFeatures];t.sort((e,t)=>n.P3[e.featureName]-n.P3[t.featureName]),t.forEach(t=>{if(!e[t.featureName]&&t.featureName!==n.K7.pageViewEvent)return;if(this.runSoftNavOverSpa&&t.featureName===n.K7.spa)return;if(!this.runSoftNavOverSpa&&t.featureName===n.K7.softNav)return;const r=function(e){switch(e){case n.K7.ajax:return[n.K7.jserrors];case n.K7.sessionTrace:return[n.K7.ajax,n.K7.pageViewEvent];case n.K7.sessionReplay:return[n.K7.sessionTrace];case n.K7.pageViewTiming:return[n.K7.pageViewEvent];default:return[]}}(t.featureName).filter(e=>!(e in this.features));r.length>0&&(0,l.R)(36,{targetFeature:t.featureName,missingDependencies:r}),this.features[t.featureName]=new t(this)})}catch(e){(0,l.R)(22,e);for(const e in this.features)this.features[e].abortHandler?.();const t=(0,O.Zm)();delete t.initializedAgents[this.agentIdentifier]?.features,delete this.sharedAggregator;return t.ee.get(this.agentIdentifier).abort(),!1}}}({features:[_e,_,j,We,Ve,k,J,Rt,St,Ze,yt],loaderType:"spa"})})()})();</script>
<link rel="icon" type="image/png" sizes="16x16" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png">
<meta name="apple-mobile-web-app-title" content="Frontiers | Articles">
<link rel="manifest" href="/manifest.json">
<link rel="canonical" href="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/full">
<meta property="description" name="description" content="Genetic testing of BRCA1 and BRCA2 identifies a large number of variants of uncertain clinical significance (VUS) whose functional and clinical interpretatio...">
<meta property="og:title" name="title" content="Frontiers | Identification of Eight Spliceogenic Variants in BRCA2 Exon 16 by Minigene Assays">
<meta property="og:description" name="description" content="Genetic testing of BRCA1 and BRCA2 identifies a large number of variants of uncertain clinical significance (VUS) whose functional and clinical interpretatio...">
<meta name="keywords" content="breast cancer,BRCA2,DNA variants,Splicing,hybrid minigenes">
<meta property="og:site_name" name="site_name" content="Frontiers">
<meta property="og:image" name="image" content="https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g001.jpg">
<meta property="og:type" name="type" content="article">
<meta property="og:url" name="url" content="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/full">
<meta name="twitter:card" content="summary_large_image">
<meta name="citation_volume" content="9">
<meta name="citation_journal_title" content="Frontiers in Genetics">
<meta name="citation_publisher" content="Frontiers">
<meta name="citation_journal_abbrev" content="Front. Genet.">
<meta name="citation_issn" content="1664-8021">
<meta name="citation_doi" content="10.3389/fgene.2018.00188">
<meta name="citation_firstpage" content="340287">
<meta name="citation_language" content="English">
<meta name="citation_title" content="Identification of Eight Spliceogenic Variants in BRCA2 Exon 16 by Minigene Assays">
<meta name="citation_keywords" content="breast cancer; BRCA2; DNA variants; Splicing; hybrid minigenes">
<meta name="citation_abstract" content="Genetic testing of BRCA1 and BRCA2 identifies a large number of variants of uncertain clinical significance (VUS) whose functional and clinical interpretations pose a challenge for genetic counselling.  Interestingly, a relevant fraction of DNA variants can disrupt the splicing process in cancer susceptibility genes.  We have tested more than 200 variants throughout 19 BRCA2 exons mostly by minigene assays, 54% of which displayed aberrant splicing, thus confirming the utility of this assay to check genetic variants in the absence of patient RNA. Our goal was to investigate BRCA2 exon 16 with a view to characterizing spliceogenic variants recorded at the mutational databases. Seventy-two different BIC and UMD variants were analyzed with NNSplice and Human Splicing Finder, 12 of which were selected because they were predicted to disrupt essential splice motifs: canonical splice sites (ss; 8 variants) and ESE/ESS (4 variants). These 12 candidate variants were introduced into the BRCA2 minigene with 7 exons (14 to 20) by site-directed mutagenesis and then transfected into MCF-7 cells. Seven variants (6 intronic and 1 missense) induced complete abnormal splicing patterns: c.7618-2A>T, c.7618-2A>G, c.7618-1G>C, c.7618-1G>A, c.7805G>C, c.7805+1G>A and c.7805+3A>C, as well as a partial anomalous outcome by c.7802A>G. They generated at least 10 different transcripts: 16p44 (alternative 3ss 44-nt downstream; acceptor variants), 16 (exon 16-skipping; donor variants), 16p55 (alternative 3ss 55-nt downstream), 16q4 (alternative 5ss 4-nt upstream), 16q100 (alternative 5ss 4-nt upstream), 16q20 (alternative 5ss 20-nt downstream) as well as minor (16p93 and 16,17p69) and uncharacterized transcripts of 893 and 954 nucleotides. Isoforms 16p44, 16, 16p55, 16q4, 16q100 and16q20 introduced premature termination codons which presumably inactivate BRCA2. According to the guidelines the American College of Medical Genetics and Genomics (ACMG) these eight variants could be classified as pathogenic or likely pathogenic whereas the Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) rules suggested seven class 4 and one class 3 variants. In conclusion, our study highlights the relevance of splicing functional assays by hybrid minigenes for the clinical classification of genetic variations. Hence, we provide new data about spliceogenic variants of BRCA2 exon 16 that are directly correlated with breast cancer susceptibility.">
<meta name="citation_article_type" content="Original Research">
<meta name="citation_pdf_url" content="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/pdf">
<meta name="citation_xml_url" content="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/xml">
<meta name="citation_fulltext_world_readable" content="yes">
<meta name="citation_online_date" content="2018/05/08">
<meta name="citation_publication_date" content="2018/05/24">
<meta name="citation_author" content="Fraile-Bethencourt, Eugenia ">
<meta name="citation_author_institution" content="Splicing and Genetic Susceptibility to Cancer, Instituto de Biologa y Gentica Molecular, Consejo Superior de Investigaciones Cientficas, Universidad de Valladolid, Spain">
<meta name="citation_author" content="Valenzuela-Palomo, Alberto ">
<meta name="citation_author_institution" content="Splicing and Genetic Susceptibility to Cancer, Instituto de Biologa y Gentica Molecular, Consejo Superior de Investigaciones Cientficas, Universidad de Valladolid, Spain">
<meta name="citation_author" content="Dez-Gmez, Beatriz ">
<meta name="citation_author_institution" content="Splicing and Genetic Susceptibility to Cancer, Instituto de Biologa y Gentica Molecular, Consejo Superior de Investigaciones Cientficas, Universidad de Valladolid, Spain">
<meta name="citation_author" content="Acedo, Alberto ">
<meta name="citation_author_institution" content="Splicing and Genetic Susceptibility to Cancer, Instituto de Biologa y Gentica Molecular, Consejo Superior de Investigaciones Cientficas, Universidad de Valladolid, Spain">
<meta name="citation_author" content="Velasco, Eladio A. ">
<meta name="citation_author_institution" content="Splicing and Genetic Susceptibility to Cancer, Instituto de Biologa y Gentica Molecular, Consejo Superior de Investigaciones Cientficas, Universidad de Valladolid, Spain">
<meta name="dc.identifier" content="doi:10.3389/fgene.2018.00188">
<script type="application/ld+json">{"@context":"https://schema.org","@type":"ScholarlyArticle","headline":"Identification of Eight Spliceogenic Variants in BRCA2 Exon 16 by Minigene Assays","author":[{"@type":"Person","name":"Eugenia Fraile-Bethencourt","affiliation":["Splicing and Genetic Susceptibility to Cancer, Instituto de Biologa y Gentica Molecular, Consejo Superior de Investigaciones Cientficas, Universidad de Valladolid, Spain"]},{"@type":"Person","name":"Alberto Valenzuela-Palomo","affiliation":["Splicing and Genetic Susceptibility to Cancer, Instituto de Biologa y Gentica Molecular, Consejo Superior de Investigaciones Cientficas, Universidad de Valladolid, Spain"]},{"@type":"Person","name":"Beatriz Dez-Gmez","affiliation":["Splicing and Genetic Susceptibility to Cancer, Instituto de Biologa y Gentica Molecular, Consejo Superior de Investigaciones Cientficas, Universidad de Valladolid, Spain"]},{"@type":"Person","name":"Alberto Acedo","affiliation":["Splicing and Genetic Susceptibility to Cancer, Instituto de Biologa y Gentica Molecular, Consejo Superior de Investigaciones Cientficas, Universidad de Valladolid, Spain","Biome Makers Inc., United States"]},{"@type":"Person","name":"Eladio A. Velasco","affiliation":["Splicing and Genetic Susceptibility to Cancer, Instituto de Biologa y Gentica Molecular, Consejo Superior de Investigaciones Cientficas, Universidad de Valladolid, Spain"]}],"datePublished":"2018-05-24","dateModified":"2025-11-25","publisher":{"@type":"Organization","name":"Frontiers"},"isPartOf":{"@type":"PublicationIssue","datePublished":"2018","isPartOf":{"@type":"PublicationVolume","volumeNumber":"9","isPartOf":{"@type":"Periodical","name":"Frontiers in Genetics"}}},"citation":["https://doi.org/10.3389/fgene.2018.00188"],"inLanguage":"en"}</script>
<script type="module" src="/ap-2024/_nuxt/v1IBIWh4.js" crossorigin></script>
<script id="unhead:payload" type="application/json">{"title":"Frontiers | Articles"}</script></head><body  class="body--v3"><div id="__nuxt"><!--[--><!----><div theme="purple"><nav class="Ibar"><div class="Ibar__main"><div class="Ibar__wrapper"><button class="Ibar__burger" aria-label="Open Menu" data-event="iBar-btn-openMenu"></button><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/genetics" class="Ibar__journalName" data-event="iBar-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Genetics</span></div></div></a><div class="Ibar__dropdown--aboutUs" parent-data-event="iBar"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIR Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=30&amp;specialtyid=0&amp;entitytype=2&amp;entityid=240" data-event="iBar-a-submit">Submit your research</a><div class="Ibar__spacer"></div><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><div><div class="Ibar__menu Ibar__menu--journal"><div class="Ibar__menu__header"><div class="Ibar__logo"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div></div><button class="Ibar__close" aria-label="Close Menu" data-event="iBarMenu-btn-closeMenu"></button></div><div class="Ibar__menu__wrapper"><div class="Ibar__menu__journal"><a href="//www.frontiersin.org/journals/genetics" data-event="iBarMenu-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Genetics</span></div></div></a><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/applied-genetic-epidemiology" data-event="iBarJournal-sections-a_id_549">Applied Genetic Epidemiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/behavioral-and-psychiatric-genetics" data-event="iBarJournal-sections-a_id_536">Behavioral and Psychiatric Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/cancer-genetics-and-oncogenomics" data-event="iBarJournal-sections-a_id_2030">Cancer Genetics and Oncogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/computational-genomics" data-event="iBarJournal-sections-a_id_551">Computational Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/cytogenomics" data-event="iBarJournal-sections-a_id_2512">Cytogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/elsi-in-science-and-genetics" data-event="iBarJournal-sections-a_id_650">ELSI in Science and Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/epigenomics-and-epigenetics" data-event="iBarJournal-sections-a_id_455">Epigenomics and Epigenetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/evolutionary-and-population-genetics" data-event="iBarJournal-sections-a_id_535">Evolutionary and Population Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genetics-of-aging" data-event="iBarJournal-sections-a_id_596">Genetics of Aging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genetics-of-common-and-rare-diseases" data-event="iBarJournal-sections-a_id_635">Genetics of Common and Rare Diseases</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genomic-assay-technology" data-event="iBarJournal-sections-a_id_557">Genomic Assay Technology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genomics-of-plants-and-the-phytoecosystem" data-event="iBarJournal-sections-a_id_1520">Genomics of Plants and the Phytoecosystem</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/human-and-medical-genomics" data-event="iBarJournal-sections-a_id_1419">Human and Medical Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/immunogenetics" data-event="iBarJournal-sections-a_id_2237">Immunogenetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/livestock-genomics" data-event="iBarJournal-sections-a_id_241">Livestock Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/neurogenomics" data-event="iBarJournal-sections-a_id_19">Neurogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/nutritional-genomics" data-event="iBarJournal-sections-a_id_3423">Nutritional Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/pharmacogenetics-and-pharmacogenomics" data-event="iBarJournal-sections-a_id_198">Pharmacogenetics and Pharmacogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/predictive-toxicology-and-exposomics" data-event="iBarJournal-sections-a_id_556">Predictive Toxicology and Exposomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/rna" data-event="iBarJournal-sections-a_id_555">RNA</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/statistical-genetics-and-methodology" data-event="iBarJournal-sections-a_id_454">Statistical Genetics and Methodology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/stem-cell-research" data-event="iBarJournal-sections-a_id_685">Stem Cell Research</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div></div><div class="Ibar__dropdown--aboutUs" parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIR Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><!----><!----><!----><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=30&amp;specialtyid=0&amp;entitytype=2&amp;entityid=240" data-event="iBarMenu-a-submit">Submit your research</a></div></div></div><!--[--><div class="Ibar__journal Ibar__journal--main"><div class="Ibar__wrapper Ibar__wrapper--journal"><a href="//www.frontiersin.org/journals/genetics" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Genetics</span></div></div></a><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/applied-genetic-epidemiology" data-event="iBarJournal-sections-a_id_549">Applied Genetic Epidemiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/behavioral-and-psychiatric-genetics" data-event="iBarJournal-sections-a_id_536">Behavioral and Psychiatric Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/cancer-genetics-and-oncogenomics" data-event="iBarJournal-sections-a_id_2030">Cancer Genetics and Oncogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/computational-genomics" data-event="iBarJournal-sections-a_id_551">Computational Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/cytogenomics" data-event="iBarJournal-sections-a_id_2512">Cytogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/elsi-in-science-and-genetics" data-event="iBarJournal-sections-a_id_650">ELSI in Science and Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/epigenomics-and-epigenetics" data-event="iBarJournal-sections-a_id_455">Epigenomics and Epigenetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/evolutionary-and-population-genetics" data-event="iBarJournal-sections-a_id_535">Evolutionary and Population Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genetics-of-aging" data-event="iBarJournal-sections-a_id_596">Genetics of Aging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genetics-of-common-and-rare-diseases" data-event="iBarJournal-sections-a_id_635">Genetics of Common and Rare Diseases</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genomic-assay-technology" data-event="iBarJournal-sections-a_id_557">Genomic Assay Technology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genomics-of-plants-and-the-phytoecosystem" data-event="iBarJournal-sections-a_id_1520">Genomics of Plants and the Phytoecosystem</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/human-and-medical-genomics" data-event="iBarJournal-sections-a_id_1419">Human and Medical Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/immunogenetics" data-event="iBarJournal-sections-a_id_2237">Immunogenetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/livestock-genomics" data-event="iBarJournal-sections-a_id_241">Livestock Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/neurogenomics" data-event="iBarJournal-sections-a_id_19">Neurogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/nutritional-genomics" data-event="iBarJournal-sections-a_id_3423">Nutritional Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/pharmacogenetics-and-pharmacogenomics" data-event="iBarJournal-sections-a_id_198">Pharmacogenetics and Pharmacogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/predictive-toxicology-and-exposomics" data-event="iBarJournal-sections-a_id_556">Predictive Toxicology and Exposomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/rna" data-event="iBarJournal-sections-a_id_555">RNA</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/statistical-genetics-and-methodology" data-event="iBarJournal-sections-a_id_454">Statistical Genetics and Methodology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/stem-cell-research" data-event="iBarJournal-sections-a_id_685">Stem Cell Research</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div></div></div><div class="Ibar__journal Ibar__journal--mix"><div class="Ibar__wrapper Ibar__wrapper--journal"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/genetics" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Genetics</span></div></div></a><div class="Ibar__spacer"></div><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/applied-genetic-epidemiology" data-event="iBarJournal-sections-a_id_549">Applied Genetic Epidemiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/behavioral-and-psychiatric-genetics" data-event="iBarJournal-sections-a_id_536">Behavioral and Psychiatric Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/cancer-genetics-and-oncogenomics" data-event="iBarJournal-sections-a_id_2030">Cancer Genetics and Oncogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/computational-genomics" data-event="iBarJournal-sections-a_id_551">Computational Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/cytogenomics" data-event="iBarJournal-sections-a_id_2512">Cytogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/elsi-in-science-and-genetics" data-event="iBarJournal-sections-a_id_650">ELSI in Science and Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/epigenomics-and-epigenetics" data-event="iBarJournal-sections-a_id_455">Epigenomics and Epigenetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/evolutionary-and-population-genetics" data-event="iBarJournal-sections-a_id_535">Evolutionary and Population Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genetics-of-aging" data-event="iBarJournal-sections-a_id_596">Genetics of Aging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genetics-of-common-and-rare-diseases" data-event="iBarJournal-sections-a_id_635">Genetics of Common and Rare Diseases</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genomic-assay-technology" data-event="iBarJournal-sections-a_id_557">Genomic Assay Technology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genomics-of-plants-and-the-phytoecosystem" data-event="iBarJournal-sections-a_id_1520">Genomics of Plants and the Phytoecosystem</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/human-and-medical-genomics" data-event="iBarJournal-sections-a_id_1419">Human and Medical Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/immunogenetics" data-event="iBarJournal-sections-a_id_2237">Immunogenetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/livestock-genomics" data-event="iBarJournal-sections-a_id_241">Livestock Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/neurogenomics" data-event="iBarJournal-sections-a_id_19">Neurogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/nutritional-genomics" data-event="iBarJournal-sections-a_id_3423">Nutritional Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/pharmacogenetics-and-pharmacogenomics" data-event="iBarJournal-sections-a_id_198">Pharmacogenetics and Pharmacogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/predictive-toxicology-and-exposomics" data-event="iBarJournal-sections-a_id_556">Predictive Toxicology and Exposomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/rna" data-event="iBarJournal-sections-a_id_555">RNA</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/statistical-genetics-and-methodology" data-event="iBarJournal-sections-a_id_454">Statistical Genetics and Methodology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/stem-cell-research" data-event="iBarJournal-sections-a_id_685">Stem Cell Research</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=30&amp;specialtyid=0&amp;entitytype=2&amp;entityid=240" data-event="iBarJournal-a-submit"><span>Submit</span><span>your research</span></a><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><!--]--></nav><div class="ArticlePage"><!--[--><div class="Layout Layout--withAside Layout--withIbarMix"><div class="Alert Alert--info Alert--noInfo ArticleTemplateBanner"><div class="Alert__icon"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" width="24px" class="FeedbackIcon"><path fill="#fff" d="M10 10h28v28H10z"></path><path fill="var(--blue50)" d="M24 2.88a21.12 21.12 0 1 0 0 42.24 21.12 21.12 0 0 0 0-42.24ZM22.08 13.4a.96.96 0 0 1 .96-.96h1.92a.96.96 0 0 1 .96.96v1.92a.96.96 0 0 1-.96.96h-1.92a.96.96 0 0 1-.96-.96V13.4Zm5.76 21.2a.96.96 0 0 1-.96.97h-5.76a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h.96v-7.68h-.96a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h3.84a.96.96 0 0 1 .96.96v10.56h.96a.96.96 0 0 1 .96.96v1.92Z"></path></svg></div><div class="Alert__main"><p class="Alert__message">Your new experience awaits. Try the new design now and help us make it even better</p><!--[--><button type="button" class="Button Button--outline Button--grey80 Button--small ArticleTemplateBanner__switchButton" data-event="btn-action"><span>Switch to the new experience</span></button><!--]--><!----></div><ol class="Alert__info"><!--[--><!--]--></ol></div><!----><main class="Layout__main"><!----><div class="ArticleDetails"><div class="ArticleLayoutHeader"><div class="ArticleLayoutHeader__info"><p class="ArticleLayoutHeader__info__title">ORIGINAL RESEARCH article</p><p class="ArticleLayoutHeader__info__journalDate"><span>Front. Genet.</span><span>, 24 May 2018</span></p><p class="ArticleLayoutHeader__info__journalDate"> Sec. Cancer Genetics</p><p class="ArticleLayoutHeader__info__doiVolume"><span>Volume 9 - 2018 | </span><a class="ArticleLayoutHeader__info__doi" href="https://doi.org/10.3389/fgene.2018.00188">https://doi.org/10.3389/fgene.2018.00188</a></p><!----></div><!----><p class="ArticleLayoutHeader__isPartOfRT"><span class="ArticleLayoutHeader__isPartOfRT__label">This article is part of the Research Topic</span><span class="ArticleLayoutHeader__isPartOfRT__title">Accomplishments, Collaborative Projects and Future Initiatives in Breast Cancer Genetic Predisposition</span><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View all 13 articles" href="https://www.frontiersin.org/research-topics/7106/accomplishments-collaborative-projects-and-future-initiatives-in-breast-cancer-genetic-predisposition/magazine" target="_self" data-event="customLink-linkType-a_viewAll13Articles"><span>View all 13 articles</span></a></span></p></div><div class="ArticleDetails__main__content"><div class="ArticleDetails__main__content__main ArticleDetails__main__content__main--fullArticle"><div class="JournalAbstract"><div class="JournalAbstract__titleWrapper"><h1>Identification of Eight Spliceogenic Variants in BRCA2 Exon 16 by Minigene Assays</h1><!----></div><!----></div><div class="JournalFullText"><div class="JournalAbstract">
<a id="h1" name="h1"></a>
<div class="authors"><span class="author-wrapper notranslate">
<a href="https://loop.frontiersin.org/people/496376" class="user-id-496376"><img class="pr5" src="https://loop.frontiersin.org/images/profile/496376/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="
Eugenia Fraile-Bethencourt">Eugenia Fraile-Bethencourt</a><sup>1</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/514162" class="user-id-514162"><img class="pr5" src="https://loop.frontiersin.org/images/profile/514162/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Alberto Valenzuela-Palomo">Alberto Valenzuela-Palomo</a><sup>1</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/563485" class="user-id-563485"><img class="pr5" src="https://loop.frontiersin.org/images/profile/563485/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Beatriz D&#xED;ez-G&#xF;mez">Beatriz D&#x00ED;ez-G&#x00F3;mez</a><sup>1</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/433023" class="user-id-433023"><img class="pr5" src="https://loop.frontiersin.org/images/profile/433023/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Alberto Acedo,&#x;">Alberto Acedo</a><sup>1,2&#x2020;</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/496947" class="user-id-496947"><img class="pr5" src="https://loop.frontiersin.org/images/profile/496947/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Eladio A. Velasco*">Eladio A. Velasco</a><sup>1*</sup></span></div>
<ul class="notes">
<li><span><sup>1</sup></span>Splicing and Genetic Susceptibility to Cancer, Instituto de Biolog&#x00ED;a y Gen&#x00E9;tica Molecular, Consejo Superior de Investigaciones Cient&#x00ED;ficas, Universidad de Valladolid, Valladolid, Spain</li>
<li><span><sup>2</sup></span>Biome Makers Inc., San Francisco, CA, United States</li>
</ul>
<p class="mb0">Genetic testing of <i>BRCA1</i> and <i>BRCA2</i> identifies a large number of variants of uncertain clinical significance whose functional and clinical interpretations pose a challenge for genetic counseling. Interestingly, a relevant fraction of DNA variants can disrupt the splicing process in cancer susceptibility genes. We have tested more than 200 variants throughout 19 BRCA2 exons mostly by minigene assays, 54% of which displayed aberrant splicing, thus confirming the utility of this assay to check genetic variants in the absence of patient RNA. Our goal was to investigate <i>BRCA2</i> exon 16 with a view to characterizing spliceogenic variants recorded at the mutational databases. Seventy-two different BIC and UMD variants were analyzed with NNSplice and Human Splicing Finder, 12 of which were selected because they were predicted to disrupt essential splice motifs: canonical splice sites (ss; eight variants) and exonic/intronic splicing enhancers (four variants). These 12 candidate variants were introduced into the BRCA2 minigene with seven exons (14&#x2013;20) by site-directed mutagenesis and then transfected into MCF-7 cells. Seven variants (six intronic and one missense) induced complete abnormal splicing patterns: c.7618-2A>T, c.7618-2A>G, c.7618-1G>C, c.7618-1G>A, c.7805G>C, c.7805+1G>A, and c.7805+3A>C, as well as a partial anomalous outcome by c.7802A>G. They generated at least 10 different transcripts: &#x0394;16p<sub>44</sub> (alternative 3&#x2019;ss 44-nt downstream; acceptor variants), &#x0394;16 (exon 16-skipping; donor variants), &#x0394;16p<sub>55</sub> (alternative 3&#x2019;ss 55-nt downstream), &#x0394;16q<sub>4</sub> (alternative 5&#x2019;ss 4-nt upstream), &#x0394;16q<sub>100</sub> (alternative 5&#x2019;ss 4-nt upstream), &#x25BE;16q<sup>20</sup> (alternative 5&#x2019;ss 20-nt downstream), as well as minor (&#x0394;16p<sub>93</sub> and &#x0394;16,17p<sub>69</sub>) and uncharacterized transcripts of 893 and 954 nucleotides. Isoforms &#x0394;16p<sub>44</sub>, &#x0394;16, &#x0394;16p<sub>55</sub>, &#x0394;16q<sub>4</sub>, &#x0394;16q<sub>100</sub>, and &#x25BE;16q<sup>20</sup> introduced premature termination codons which presumably inactivate BRCA2. According to the guidelines the American College of Medical Genetics and Genomics these eight variants could be classified as pathogenic or likely pathogenic whereas the Evidence-based Network for the Interpretation of Germline Mutant Alleles rules suggested seven class 4 and one class 3 variants. In conclusion, our study highlights the relevance of splicing functional assays by hybrid minigenes for the clinical classification of genetic variations. Hence, we provide new data about spliceogenic variants of BRCA2 exon 16 that are directly correlated with breast cancer susceptibility.</p>
<div class="clear"></div>
</div>
<div class="JournalFullText">
<a id="h2" name="h2"></a><h2>Introduction</h2>
<p class="mb15">Hereditary Breast and Ovarian Cancer (HBOC) represents 5&#x2013;10% of all breast cancers. Nowadays, more than 25 HBOC susceptibility genes have been identified, most of them involved in DNA repair pathways (<a href="#B25">Nielsen et al., 2016</a>). Deleterious variants of the most prevalent genes <i>BRCA1</i> (MIM# 113705) and <i>BRCA2</i> (MIM# 600185) confer up to 87% of risk to develop breast cancer by the age of 70 years (<a href="#B26">Petrucelli et al., 2013</a>). Apart from specific founder deleterious mutations (<a href="#B20">Levy-Lahad et al., 1997</a>; <a href="#B18">Infante et al., 2013</a>), there have been described thousands of different BRCA1/2 variants at the mutation databases. According to Universal Mutation Database (UMD, http://www.umd.be; date last accessed 2017/06/16) 2,495 and 3,454 different variants have been detected in <i>BRCA1</i> and <i>BRCA2</i>, respectively, where a relevant fraction of them has been classified as variants of uncertain significance (VUS). These pose a challenge in clinical genetics since mutation carriers could benefit from preventive and prophylactic measures as well as new targeted therapies such as the Poly-ADP Ribose Polymerase Inhibitors (<a href="#B30">Ricks et al., 2015</a>).</p>
<p class="mb15">Standard approaches tend to classify DNA variants from the protein point of view. In this way, nonsense variants and frameshift insertions and deletions are automatically classified as pathogenic if they truncate critical protein domains [Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) class 5<sup id="footnotesuper1"><a id="note1a"></a><a class="footnoteanchor" href="#note1">1</a></sup>]. However, upstream gene expression mechanisms, such as splicing, can be disrupted by DNA changes. In fact, splicing is a critical highly regulated process involved in many cell functions whose disruption has been directly related with disease, being common in cancer (<a href="#B37">Wang and Cooper, 2007</a>; <a href="#B11">Douglas and Wood, 2011</a>). Likewise, spliceogenic variants are more common than they are thought, and they are not restricted to the sequences of the canonical donor and acceptor sites since it has been suggested that up to 50% of exon variants could also affect splicing (<a href="#B22">L&#x00F3;pez-Bigas et al., 2005</a>). This can be explained by the wide range of splicing regulatory elements (SREs) that control this process, which include the conserved splice sites (5&#x2019;ss and 3&#x2019;ss), the branch point, polypyrimidine track, exonic/intronic splicing enhancers (ESEs/ISEs) and exonic/intronic splicing silencers (ESSs/ISSs) (<a href="#B16">Grodeck&#x00E1; et al., 2017</a>), as well as other regulatory components or the RNA secondary structure (<a href="#B35">Soemedi et al., 2017</a>). Thus, all these factors cooperate with splicing factors and the spliceosome, to accurately remove introns (<a href="#B40">Will and L&#x00FC;hrmann, 2011</a>).</p>
<p class="mb0">Interestingly, spliceogenic variants are often found in <i>BRCA2</i>. Our previous results showed that more than a half of tested <i>BRCA2</i> variants impaired splicing (<a href="#B2">Acedo et al., 2012</a>, <a href="#B1">2015</a>; <a href="#B15">Fraile-Bethencourt et al., 2017</a>). Moreover, the minigene technology was confirmed as a reliable tool to functionally assay potential splicing variants. Here, we aimed to check <i>BRCA2</i> exon 16 candidate variants to characterize the splicing effects using the pSAD-based minigene MGBR2_14-20, previously employed to assay DNA variants of exons 17 and 18 (<a href="#B15">Fraile-Bethencourt et al., 2017</a>). We have assayed 12 likely spliceogenic variants from HBOC patients reported in databases and selected after bioinformatics predictions. Wild-type (wt) and mutant minigenes assays showed that eight variants altered the splicing. Thus, we provide valuable information of spliceogenic <i>BRCA2</i> exon 16 variants that could be classified following ENIGMA and American College of Medical Genetics and Genomics (ACMG) guidelines (<a href="#B29">Richards et al., 2015</a>).</p>
<a id="h3" name="h3"></a><h2>Materials and Methods</h2>
<p class="mb0">Ethical approval for this study was obtained from the Ethics Review Committee of the Hospital Universitario R&#x00ED;o Hortega de Valladolid (6/11/2014).</p>
<h3>Variant Collection and <i>In Silico</i> Analyses</h3>
<p class="mb15"><i>BRCA2</i> introns 15 and 16 and exon 16 variants were collected from the BIC database<sup id="footnotesuper2"><a id="note2a"></a><a class="footnoteanchor" href="#note2">2</a></sup> and the BRCA Share Database (UMD, date last accessed 2017/06/16; http://www.umd.be/BRCA2/) (<a href="#B4">Beroud et al., 2016</a>). Variant descriptions were according to the <i>BRCA2</i> GenBank sequence NM000059.1 and the guidelines of the Human Genome Variation Society (HGVS<sup id="footnotesuper3"><a id="note3a"></a><a class="footnoteanchor" href="#note3">3</a></sup>).</p>
<p class="mb0">Wild-type and mutant sequences were analyzed with NNSPLICE<sup id="footnotesuper4"><a id="note4a"></a><a class="footnoteanchor" href="#note4">4</a></sup> (<a href="#B28">Reese et al., 1997</a>) and Human Splicing Finder version 3.0 (HSF<sup id="footnotesuper5"><a id="note5a"></a><a class="footnoteanchor" href="#note5">5</a></sup>) (<a href="#B10">Desmet et al., 2009</a>), which includes algorithms to detect splice sites, branch point, silencers, and enhancers (<a href="#B14">Fairbrother et al., 2002</a>; <a href="#B6">Cartegni et al., 2003</a>; <a href="#B33">Sironi et al., 2004</a>; <a href="#B38">Wang et al., 2004</a>; <a href="#B41">Yeo and Burge, 2004</a>; <a href="#B43">Zhang and Chasin, 2004</a>).</p>
<h3>Minigene and Mutagenesis</h3>
<p class="mb0">MGBR2_ex14-20 was assembled as previously described (<a href="#B15">Fraile-Bethencourt et al., 2017</a>). DNA variants and deletions were introduced by the QuikChange Lightning Kit (Agilent, Santa Clara, CA, United States). The wt minigene MGBR2_ex14-20 was used as template to generate 12 BIC/BRCA Share DNA variants and 4 microdeletions (Table <a href="#T1">1</a>). They were checked by SANGER sequencing at the Macrogen Spain facility (Macrogen, Madrid, Spain).</p>
<div class="DottedLine"></div>
<div class="Imageheaders">TABLE 1</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t001.jpg" name="table1" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t001.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t001.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t001.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t001.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t001.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t001.jpg" alt="www.frontiersin.org" id="T1" loading="lazy">
  </picture>
</a>
<p><strong>TABLE 1.</strong> Mutagenesis primers of candidate splicing variants.</p>
</div>
<div class="clear"></div>
<div class="DottedLine"></div>
<h3>Transfection of Eukaryotic Cells</h3>
<p class="mb0">MCF-7 cells were plated (&#x223C;2 &#x00D7; 10<sup>5</sup> cells/well) and grown to 90% confluency in 0.5 mL of medium (MEME, 10% fetal bovine serum, 2 mM glutamine, 1% non-essential amino acids, and 1% penicillin/streptomycin) in four-well plates (Nunc, Roskilde, Denmark). Transfections were made with 1 &#x03BC;g of minigene and 2 &#x03BC;L of low toxicity Lipofectamine (Life Technologies, Carlsbad, CA, United States) in Gibco<sup>TM</sup> Opti-Mem<sup>TM</sup> (Thermo Fisher Scientific, Waltham, MA, United States). Cells were incubated with 300 &#x03BC;g/mL of cycloheximide (Sigma-Aldrich, St. Louis, MO, United States) for 4 h to inhibit nonsense-mediated decay (NMD). RNA was purified with the Genematrix Universal RNA Purification Kit (EURx, Gdansk, Poland) with on-column DNAse I digestion to degrade genomic DNA that could interfere with RT-PCR.</p>
<h3>RT-PCR of Minigenes</h3>
<p class="mb0">Approximately 400 ng of RNA was retrotranscribed using RevertAid H Minus First Strand cDNA Synthesis Kit (Life Technologies, Carlsbad, CA, United States) and the gene-specific primer RTPSPL3-RV (5&#x2032;-TGAGGAGTGAATTGGTCGAA-3&#x2032;). Samples were incubated at 42&#x00B0;C for 1 h, and reactions were inactivated at 70&#x00B0;C for 5 min. Then, 40 ng of cDNA was amplified in 50 &#x03BC;L reaction with pMAD_607FW (Patent P201231427, CSIC) and RTBR2_ex17RV2 (5&#x2032;-GGCTTAGGCATCTATTAGCA-3&#x2032;) or with RT_ex15FW (5&#x2032;-CGAATTAAGAAGAAACAAAGG-3&#x2032;) and pSAD_RT_RV (Patent P201231427, CSIC) using Platinum Taq DNA polymerase (Life Technologies, Carlsbad, CA, United States) (size of transcripts: 1018 and 1250 nt, respectively). Samples were denatured at 94&#x00B0;C for 2 min, followed by 35 cycles consisting of 94&#x00B0;C for 30 s, Td-2&#x00B0;C for 30 s, and 72&#x00B0;C (1 min/kb), and a final extension step at 72&#x00B0;C for 5 min. Sequencing reactions were performed by the sequencing facility of Macrogen Spain. Semi-quantitative fluorescent 26 cycles PCRs were done in triplicate with primers pMAD_607FW-FAM and RTBR2_ex17RV2 using Platinum Taq DNA polymerase (Life Technologies, Carlsbad, CA, United States). FAM-labeled products were run with Genescan LIZ-1200 as size standard (Life Technologies, Carlsbad, CA, United States) at the Macrogen facility and analyzed with the Peak Scanner software V1.0. Only peaks with heights &#x2265;50 relative fluorescence unit (RFU) were considered. Mean peak areas of each transcript of three runs were used to quantify the relative abundance of each transcript.</p>
<a id="h4" name="h4"></a><h2>Results</h2>
<h3 class="pt0">Bioinformatics Analysis of Splicing Variants</h3>
<p class="mb0">Seventy-two variants were collected from the BIC and UMD databases. Among them, 35 had been previously classified as VUS and 34 as pathogenic or likely pathogenic. In order to select possible spliceogenic variants, they were analyzed by the splicing prediction software NNSplice and HSF (Supplementary Table S1). Selections were made following the next criteria: (a) ss creation or disruption; (b) branch point disruption; and (c) ESS creation (hnRNPA1). Curiously, NNSplice did not recognize exon 16 canonical 5&#x2032;ss. In contrast, a very strong 100-nt upstream cryptic donor (NNSplice score: 0.99) was identified at position c.7706_7707. The MaxEnt results showed a weak canonical donor (4.68) and a strong cryptic donor (8.92) (Table <a href="#T2">2</a>).</p>
<div class="DottedLine"></div>
<div class="Imageheaders">TABLE 2</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t002.jpg" name="table2" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t002.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t002.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t002.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t002.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t002.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t002.jpg" alt="www.frontiersin.org" id="T2" loading="lazy">
  </picture>
</a>
<p><strong>TABLE 2.</strong> Bioinformatics analysis of potential splicing variants of <i>BRCA2</i> exon 16.</p>
</div>
<div class="clear"></div>
<div class="DottedLine"></div>
<p class="mb15 w100pc float_left mt15">Twelve variants were selected (Figure <a href="#F1">1</a>): six intronic (c.7618-2A>T, c.7618-2A>G, c.7618-1G>C, c.7618-1G>A, c.7805+1G>A, and c.7805+3A>C), five missense (c.7625C>G, c.7753G>A, c.7772A>G, c.7802A>G, and c.7805G>C), and one nonsense (c.7738C>T) variants. Four missense variants (c.7625C>G, c.7753G>A, c.7772A>G, and c.7802A>G) and c.7805+3A>C had been previously classified as VUS. Intronic variants (c.7618-2, -1 and c.7805+1, +3) and c.7805G > C disrupted the canonical ss, whereas variants c.7625C>G and c.7753G>A created new ss. DNA change c.7802A>G was selected because of its proximity to the canonical donor site and the presumable generation of an alternative &#x201C;gt&#x201D; donor site 4-nt upstream (underlined, TTT<u>GT</u>AGgtactc). Finally, bioinformatics results of c.7738C>T and c.7772A>G suggested the creation of one ESS (hnRNPA1) (Table <a href="#T2">2</a>).</p>
<div class="DottedLine"></div>
<div class="Imageheaders">FIGURE 1</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g001.jpg" name="figure1" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g001.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g001.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g001.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g001.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g001.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g001.jpg" alt="www.frontiersin.org" id="F1" loading="lazy">
  </picture>
</a>
<p><strong>FIGURE 1.</strong> Functional assays of spliceogenic candidate variants of <i>BRCA2</i> exon 16. <b>(A)</b> Nucleotide (c.7618_7805) and amino acid (p.2540_2602) sequences of <i>BRCA2</i> exon 16. Arrows indicate selected variants. <b>(B)</b> Agarose gel electrophoresis of RT-PCR products of the wt and mutant minigenes and the size standard 1 Kb Plus DNA Ladder at both sides of the gel. Amplification was made with primers pMAD607-FW and RTBR2_ex17RV2. Full-length transcript (V1-EX17) size: 1018 nt. Red arrows point to exon 16 skipping band (&#x0394;16) (size: 830 nt).</p>
</div>
<div class="clear"></div>
<div class="DottedLine"></div>
<h3>Splicing Functional Assays of DNA Variants</h3>
<p class="mb15">The minigene MGBR2_ex14-20 had been already shown as a robust tool to assay possible spliceogenic variants contained in any of those exons and flanking introns (<a href="#B15">Fraile-Bethencourt et al., 2017</a>). The wt construct produced a full-length transcript of the expected size (1806 nt), sequence, and structure (V1-BRCA2 exons 14-20-V2). To map the presence of putative splicing enhancers, a set of four overlapping exonic microdeletions were generated, which spanned 55-nt of the 5&#x2032;- and 3&#x2032;-ends (<a href="#B13">Fairbrother et al., 2004</a>). This strategy had been previously shown to increase the accuracy of predictions of ESE disrupting variants (<a href="#B1">Acedo et al., 2015</a>; <a href="#B15">Fraile-Bethencourt et al., 2017</a>). None of the microdeletions induced splicing anomalies suggesting that this exon is not controlled by ESEs (data not shown). Consequently, ESE-disrupting variants, as unique selection criterion, were not chosen for subsequent functional tests (Table <a href="#T2">2</a>).</p>
<p class="mb0">Selected variants were introduced into the minigene and functionally assayed in MCF-7 cells. Agarose electrophoresis clearly showed that three of them (c.7805G>C, c.7805+1G>A, and c.7805+3A>C) induced aberrant splicing patterns (Figure <a href="#F1">1</a>). However, the high resolution and sensitivity of fluorescent capillary electrophoresis allowed us to identify a total of eight variants, including the three previous ones, that disrupted splicing: c.7618-2A>T, c.7618-2A>G, c.7618-1G>C, c.7618-1G>A, c.7802A>G, c.7805G>C, c.7805+1G>A, and c.7805+3A>C (Figure <a href="#F2">2</a>). Actually, this approach is able to detect rare transcripts with a relative abundance below 1% or can resolve transcripts that differ only in a few nucleotides (e.g., only 4-nt between the canonical and &#x0394;16q4 isoforms). A total of at least 10 different aberrant transcripts were characterized by fragment analysis and sequencing: &#x0394;16p44 (44-nt deletion; alternate 3&#x2032;ss 44-nt downstream), &#x0394;16p55 (55-nt del; alternate 3&#x2032;ss 55-nt downstream), &#x0394;16 (exon 16 skipping), &#x0394;16q4 (4-nt del; alternate 5&#x2032;ss 4-nt upstream), &#x0394;16q100 (100-nt del; alternate 5&#x2032;ss 100-nt upstream), &#x25BE;16q20 (20-nt insertion; alternate 5&#x2032;ss 20-nt downstream), minor (&#x0394;16p<sub>93</sub> and &#x0394;16,17p<sub>69</sub>), and uncharacterized transcripts of 893 and 954 nt (Figure <a href="#F2">2</a> and Table <a href="#T3">3</a>). On the one hand, fragments analysis and sequences revealed that 3&#x2032;ss disrupting variants (positions -2 and -1) provoked the use of a cryptic acceptor 44-nt downstream (&#x0394;16p<sub>44</sub>) within exon 16 (Figure <a href="#F2">2A</a>). Interestingly, this cryptic 3&#x2032;ss was not recognized either by NNSplice or MaxtEnt. The loss of 44-nt at 5&#x2032; of exon 16 would suppose a frameshift deletion and a premature termination codon (PTC) (p.L2540Qfs<sup>&#x2217;</sup>11). On the other hand, 5&#x2032;ss variants (positions +1 and +3) produced exon 16 skipping (&#x0394;16), which means a frameshift deletion through the loss of 188-nt from r.7618 to r.7805 (Figure <a href="#F2">2B</a>). Consequently, BRCA2 would be truncated with a PTC four codons downstream (p.L2540Gfs<sup>&#x2217;</sup>4). Last exon nucleotide variant (c.7805G>C) induced the same outcome (&#x0394;16) highlighting the importance of this position conservation (G in nearly 80% in all exons) in exon recognition (<a href="#B42">Zhang, 1998</a>). Fragment analysis of variants c.7805G>C, c.7805+1G>A, and c.7805+3A>C also showed &#x223C;14% of transcript &#x0394;16q<sub>100</sub>, which corresponds with the use of the previously mentioned cryptic 5&#x2032;ss within exon 16 (NNSplice: 0.99; MaxEnt: 8.92), provoking r.7706_7805del (p.K2570Lfs<sup>&#x2217;</sup>45) (Table <a href="#T3">3</a> and Figure <a href="#F2">2B</a>). Finally, missense variant c.7802A>G created a new 5&#x2032;ss, which resulted in &#x223C;45% of the aberrant transcript &#x0394;16q<sub>4</sub> (Figure <a href="#F2">2C</a>). The loss of four nucleotides would introduce a PTC into the protein (p.Y2601Wfs<sup>&#x2217;</sup>46). Thus, our results showed clearly how these eight variants disrupted splicing. Moreover, seven of them (c.7618-2A>T; c.7618-2A>G; c.7618-1G>C; c.7618-1G>A; c.7805G>C; c.7805+1G>A; c.7805+3A>C) generated more than &#x223C;92% of frameshift transcripts.</p>
<div class="DottedLine"></div>
<div class="Imageheaders">FIGURE 2</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g002.jpg" name="figure2" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g002.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g002.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g002.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g002.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g002.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g002.jpg" alt="www.frontiersin.org" id="F2" loading="lazy">
  </picture>
</a>
<p><strong>FIGURE 2.</strong> Fluorescent capillary electrophoresis of transcripts from <i>BRCA2</i> exon 16 variants. On the left, screenshots of electropherograms are shown. cDNA was amplified with primers FAM-labeled pMAD_607FW and RTBR2_ex17RV2. Arrows indicate transcripts (blue peaks). Full-length transcript: 1018 nt. Size standard was Genescan LIZ 1200 (orange/faint peaks). Fragments were analyzed with the Peak Scanner software v1.0. Fragment sizes (bp) and relative fluorescent units are indicated on the <i>x</i>- and <i>y</i>-axes, respectively. On the right, diagrams of the splicing patterns are shown. Boxes represent exons, discontinued black lines represent canonical splicing, and discontinue red lines represent aberrant splicing. <b>(A)</b> Acceptor site variants. <b>(B)</b> Donor site variants. <b>(C)</b> Alternative donor variant.</p>
</div>
<div class="clear"></div>
<div class="DottedLine mb15"></div>
<div class="Imageheaders">TABLE 3</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t003.jpg" name="table3" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t003.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t003.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t003.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t003.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t003.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t003.jpg" alt="www.frontiersin.org" id="T3" loading="lazy">
  </picture>
</a>
<p><strong>TABLE 3.</strong> Quantification of transcripts of spliceogenic variants of exon 16 by fluorescent capillary electrophoresis.</p>
</div>
<div class="clear"></div>
<div class="DottedLine"></div>
<a id="h5" name="h5"></a><h2>Discussion</h2>
<p class="mb15">Nowadays, with the advent of new generation sequencing technologies and, namely, cancer-gene panels (<a href="#B34">Slavin et al., 2015</a>), thousands of variants are being described. However, their classifications as neutral or deleterious variants pose a challenge in Human Genetics. In fact, some deleterious variants can be missed because they are synonymous or intronic. Moreover, a significant fraction of <i>BRCA2</i> variants are considered VUS and require additional proofs to be reclassified, including functional tests. Here, we have shown that the minigene MGBR2_14-20 is a robust tool to functionally assay candidate spliceogenic variants of the <i>BRCA2</i> exon 16. Until now, we have comprehensively studied candidate splicing variants from 20 out of 27 <i>BRCA2</i> exons (<a href="#B32">Sanz et al., 2010</a>; <a href="#B2">Acedo et al., 2012</a>, <a href="#B1">2015</a>; <a href="#B15">Fraile-Bethencourt et al., 2017</a>). Thus, we have found six intronic and two missense <i>BRCA2</i> variants which alter the splicing and could confer cancer risk.</p>
<p class="mb15"><i>BRCA2</i> exon 16 codifies from Leucine 2540 to Arginine 2602 (p.2540_2602). Interestingly, according to the International Agency for Research on Cancer (IARC<sup id="footnotesuper6"><a id="note6a"></a><a class="footnoteanchor" href="#note6">6</a></sup>), this is a conserved region, since there is &#x223C;22% of ultra-conserved aminoacids from human to sea urchin and &#x223C;54% between mammals. Furthermore, this protein segment belongs to FANCD2- and DSS1-binding domains. Fanconi Anemia group D2 (FANCD2) protein binds to aminoacids from position p.2350 to p.2545 of BRCA2 and it has been suggested to have a role in the repair process (<a href="#B17">Hussain et al., 2004</a>). DSS1 (Delete in Split hand/Split foot) protein, which binds to BRCA2 at positions p.2467_2957 (<a href="#B23">Marston et al., 1999</a>), is an essential element of BRCA2 stability, since its loss supposes a dramatic decrease of BRCA2 levels (<a href="#B21">Li et al., 2006</a>). Altogether, this highlights the value of exon 16 in BRCA2 function. Moreover, exon 16 skipping supposes a frame-shift deletion and the generation of a PTC (p.L2540Gfs<sup>&#x2217;</sup>4), which would truncate the protein and subsequently loss the C-terminal region that would compromise BRCA2 function.</p>
<p class="mb15">This study, based on minigene technology, provides detailed information about the impact on splicing of 12 <i>BRCA2</i> exon 16 variants. Aberrant splicing outcomes were found in eight of these variants, six intronic and two missense changes. Intriguingly, none of the aberrant transcripts described here was previously reported as natural alternative splicing events of the <i>BRCA2</i> gene (<a href="#B12">Fackenthal et al., 2016</a>). Among them, seven (c.7618-2A>T, c.7618-2A>G, c.7618-1G>A, c.7618-1G>C, c.7805G>C, c.7805+1G>A, and c.7805+3A>C) provoked more than &#x223C;92% of frameshift transcripts. Interestingly, previous studies of variant c.7618-1G>A in lymphoblastoid cells showed that 3&#x2032;ss disruption induced transcripts &#x0394;16p<sub>44</sub> and &#x0394;16,17p<sub>69</sub> (<a href="#B39">Whiley et al., 2011</a>). Here we found both transcripts, but also other minor ones: &#x0394;16p<sub>55</sub>, &#x0394;16p<sub>93</sub>, &#x0394;16 (Table <a href="#T3">3</a>). Additionally, according to our data &#x0394;16p<sub>44</sub> is the main transcript (&#x223C;91%) that other authors also identified but described as a minor transcript in agarose gels (<a href="#B39">Whiley et al., 2011</a>). These differences could be due to: (i) the cell line; (ii) the use of cycloheximide to inhibit the NMD; (iii) the fact that we work with a single-mutant allele, avoiding the wt counterpart effect; and (iv) the high sensitivity of fluorescent capillary electrophoresis, which can detect rare transcripts versus agarose electrophoresis. In any case, both results show that c.7618-1G>A severely disrupted splicing. On the other hand, variant c.7805G>C was previously reported to result in &#x0394;16 and &#x0394;16q<sub>100</sub>, with the total absence of the canonical transcript (<a href="#B5">Bonnet et al., 2008</a>). This outcome matches our results (Table <a href="#T3">3</a>): &#x0394;16 as the main transcript (&#x223C;78%), followed by &#x0394;16q<sub>100</sub> (&#x223C;14%), and the lack of the full-length transcript. It is also worthy to mention that we detected other minor transcripts due to the high sensitivity of fluorescent capillary electrophoresis (&#x25BE;16q<sup>20</sup> at &#x223C;6.5% and &#x0394;16,17p<sub>69</sub> at &#x223C;1.5%) that otherwise could not be easily detected on agarose gels. In any case, the spliceogenic effects of variants c.7618-1G>A and c.7805G>C were supported by our data.</p>
<p class="mb15">Variant c.7802A>G probably generated the most conflicting result since it triggered &#x223C;54% of canonical transcript and &#x223C;46% of &#x0394;16q<sub>4</sub>, so that its interpretation is more complex. The transcript &#x0394;16q<sub>4</sub>, caused by the use of a new 5&#x2032;ss, generated a frameshift deletion and the protein truncation by a PTC 46 codons downstream (p.Y2601Wfs<sup>&#x2217;</sup>46). However, it is still unclear if &#x223C;54% of full-length transcript can preserve BRCA2 function, given that, for example, 20&#x2013;30% of <i>BRCA1</i> transcript is able to maintain BRCA1 activity (<a href="#B8">de la Hoya et al., 2016</a>). It is also important to keep in mind that full-length transcript carries a missense variant (p.Y2601W) that, according to IARC alignment<sup id="footnotesuper7"><a id="note7a"></a><a class="footnoteanchor" href="#note7">7</a></sup>, Tyrosine 2601 is highly conserved from human to sea urchin, suggesting an important function in the protein. Moreover, PolyPhen-2 (<a href="#B3">Adzhubei et al., 2010</a>) predicted that this aminoacid change is damaging with the maximum score (1.0). Curiously, c.7802A>G was reported a family with a significant history of primary cancers (colorectal, lymphoma, and breast cancers) which carried biallelic <i>BRCA2</i> mutations (c.7802A>G and c.1845_1856delCT). However, patients did not present the typical FA phenotype, which suggested that p.Y2601W BRCA2 maintained at least enough BRCA2 activity to prevent early childhood FA features (<a href="#B9">Degrolard-Courcet et al., 2014</a>). Nevertheless, this missense change remains classified as VUS in ClinVar<sup id="footnotesuper8"><a id="note8a"></a><a class="footnoteanchor" href="#note8">8</a></sup>.</p>
<p class="mb15">On the other hand, variant c.7625C>G was previously computed to disrupt one SRp55 motif (<a href="#B27">Pettigrew et al., 2008</a>), although functional mapping by microdeletions indicated that exon 16 is likely not regulated by splicing enhancers. Nevertheless, this change was selected because it presumably created new strong 3&#x2032; and 5&#x2032;ss as well, both with a NNSplice score >0.9 (Table <a href="#T2">2</a>). However, c.7625C>G only produced the full-length transcript without any splicing anomaly. The protein would even carry the missense variant p.T2542R. However, consistent with PolyPhen, this change might be considered as benign with a score of 0.0, which could be explained by the low conservation of the affected threonine. Anyway, further functional and association studies must be performed to interpret this variant. Other variant that resulted in a normal splicing pattern was the nonsense variant c.7738C>T (p.Q2580X), that <i>a priori</i> had been classified as pathogenic. In this case, the protein would be truncated at codon 2580 losing 839 aminoacids of the C-terminal where the DSS1-binding site, the DNA-binding domain, the RAD51C-binding site, and the cyclin-dependent kinase (CDK) phosphorylation site are located (<a href="#B31">Roy et al., 2012</a>). Interestingly, this variant was found in an Italian non-Ashkenazi <i>BRCA1</i> and <i>BRCA2</i> double heterozygote family (<a href="#B24">Musolino et al., 2005</a>).</p>
<p class="mb0">According to the ACMG guidelines (Table <a href="#T4">4</a>; <a href="#B29">Richards et al., 2015</a>), five variants (c.7618-2A>T, c.7618-2A>G, c.7618-1G>A, c.7618-1G>C, and c.7805+1G>A) can be classified as pathogenic as they match criteria PVS1 (very strong evidence of pathogenicity: null variant &#x2013; nonsense, frameshift, canonical &#x00B1;1 or 2 ss, initiation codon, single or multiexon deletion &#x2013; in a gene where LOF is a known mechanism of disease), PS3 (strong evidence: well-established <i>in vitro</i> or <i>in vivo</i> functional studies supportive of a damaging effect on the gene or gene product), PM2 (moderate evidence: absent from controls in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium), PP3 (supporting evidence: multiple lines of computational evidence support a deleterious effect on the gene or gene product: conservation, evolutionary, splicing impact, etc.), and PP5 (reputable source recently reports variant as pathogenic, but the evidence is not available to the laboratory to perform an independent evaluation). On the other hand, variants c.7802A>G, c.7805G>C, and c.7805+3A>C were classified as likely pathogenic as they match criteria PS3, PM2, PP3, and PP5.</p>
<div class="DottedLine"></div>
<div class="Imageheaders">TABLE 4</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t004.jpg" name="table4" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t004.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t004.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t004.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t004.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t004.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t004.jpg" alt="www.frontiersin.org" id="T4" loading="lazy">
  </picture>
</a>
<p><strong>TABLE 4.</strong> Classification of variants according to the ENIGMA and ACMG rules.</p>
</div>
<div class="clear"></div>
<div class="DottedLine"></div>
<p class="mb15 w100pc float_left mt15">Similarly, following the ENIGMA rules for variant classification<sup id="footnotesuper9"><a id="note9a"></a><a class="footnoteanchor" href="#note9">9</a></sup>, all variants, except for c.7802A>G, should be reclassified as class 4 (likely pathogenic) because they are &#x201C;considered extremely likely to alter splicing based on position&#x201D; and are &#x201C;predicted bioinformatically to alter the use of the native donor/acceptor site.&#x201D; Conversely, minigenes are not considered robust approaches to functionally test these variants yet (&#x201C;&#x2026; results from construct-based mRNA assays alone are not considered sufficiently robust to be used as evidence for variant classification &#x2026;&#x201D;). However, this specific minigene with <i>BRCA2</i> exons 14&#x2013;20 was confirmed as a robust tool since it reproduced patient RNA results from eight variants (<a href="#B15">Fraile-Bethencourt et al., 2017</a>), and also c.7618-1G>A and c.7805G>C of this study, so that these seven class 4 variants could be even reclassified as class 5. Finally, c.7802A>G was classified as class 3 because it did not meet the above standards and induce a partial aberrant outcome with more than 50% of the canonical transcript.</p>
<p class="mb0">In summary, we detected eight spliceogenic <i>BRCA2</i> exon 16 variants that should be classified as pathogenic or likely pathogenic according to the ACMG guidelines (Table <a href="#T4">4</a>). Moreover, they account for 22% of causal variants of exon 16 and 11% of all recorded variants of this exon at the mutation databases. Taken together this and our previous studies, we have tested 283 <i>BRCA1/2</i> variants under the splicing perspective, 154 of which induced anomalous patterns and 111 could be classified as pathogenic or likely pathogenic. These data remark the importance of variants of splicing regulatory sequences, which are often underestimated because most of them are placed in non-coding regions of the protein. Until now, genetic family-based studies have set up the impact of some variants on cancer risk. However, because of the exponential increment in the number of variants, their low frequencies and different nature, functional assays are strictly required. In this context, minigene technology constitutes a robust tool which can be used to functionally test spliceogenic candidate variants of any disease-gene without the interference of the counterpart wt allele. Certainly, pSAD-based minigenes represented valuable tools to functionally check variants of the SERPINA1 (severe alpha-1 antitrypsin deficiency) and CHD7 (Charge Syndrome) genes (<a href="#B19">Lara et al., 2014</a>; <a href="#B36">Villate et al., 2018</a>). RNA assays provide essential data for the initial characterization of VUS and improve the genetic counseling of hereditary diseases.</p>
<a id="h6" name="h6"></a><h2>Author Contributions</h2>
<p class="mb0">EF-B contributed to the bioinformatics analysis, minigene construction, manuscript writing, and performed most of the splicing functional assays. BD-G and AV-P participated in minigene construction, mutagenesis experiments, and functional assays. AA participated in minigene construction and functional mapping experiments. EV conceived the study and the experimental design, supervised all the experiments, and wrote the manuscript. All authors contributed to data interpretation, revisions of the manuscript, and approved the final version of the manuscript.</p>
<a id="h7" name="h7"></a><h2>Funding</h2>
<p class="mb0">EV&#x2019;s lab was supported by grants from the Spanish Ministry of Economy and Competitivity, Plan Nacional de I+D+I 2013&#x2013;2016, ISCIII (Grants: PI13/01749 and PI17/00227) co-funded by FEDER from European Regional Development Funds (European Union), and grant CSI090U14 from the Consejer&#x00ED;a de Educaci&#x00F3;n (ORDEN EDU/122/2014) and Junta de Castilla y Le&#x00F3;n. EF-B was supported by a predoctoral fellowship from the University of Valladolid and Banco Santander (2015&#x2013;2019).</p>
<a id="h8" name="h8"></a><h2>Conflict of Interest Statement</h2>
<p class="mb0">The authors declare that theresearch was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<a id="h9" name="h9"></a><h2>Acknowledgments</h2>
<p class="mb0">We acknowledge the support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI).</p>
<a id="h10" name="h10"></a><h2>Supplementary Material</h2>
<p class="mb0">The Supplementary Material for this article can be found online at: <a href="https://www.frontiersin.org/articles/10.3389/fgene.2018.00188/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fgene.2018.00188/full#supplementary-material</a></p>
<a id="h11" name="h11"></a><h2>Footnotes</h2>
<ol>
<li id="note1"><strong><a style="color:gray;" class="footnotetextanchor" href="#note1a" title="">^</a></strong> <a style="color:gray;" href="https://enigmaconsortium.org/library/general-documents/enigma-classification-criteria/">https://enigmaconsortium.org/library/general-documents/enigma-classification-criteria/</a></li>
<li id="note2"><strong><a style="color:gray;" class="footnotetextanchor" href="#note2a" title="">^</a></strong><a style="color:gray;" href="https://research.nhgri.nih.gov/projects/bic/Member/index.shtml">https://research.nhgri.nih.gov/projects/bic/Member/index.shtml</a></li>
<li id="note3"><strong><a style="color:gray;" class="footnotetextanchor" href="#note3a" title="">^</a></strong><a style="color:gray;" href="http://www.hgvs.org/mutnomen/">http://www.hgvs.org/mutnomen/</a></li>
<li id="note4"><strong><a style="color:gray;" class="footnotetextanchor" href="#note4a" title="">^</a></strong><a style="color:gray;" href="http://www.fruitfly.org/seq_tools/splice.html">http://www.fruitfly.org/seq_tools/splice.html</a></li>
<li id="note5"><strong><a style="color:gray;" class="footnotetextanchor" href="#note5a" title="">^</a></strong><a style="color:gray;" href="http://www.umd.be/HSF3/">http://www.umd.be/HSF3/</a></li>
<li id="note6"><strong><a style="color:gray;" class="footnotetextanchor" href="#note6a" title="">^</a></strong><a style="color:gray;" href="http://agvgd.hci.utah.edu/BRCA2_Spur.html">http://agvgd.hci.utah.edu/BRCA2_Spur.html</a></li>
<li id="note7"><strong><a style="color:gray;" class="footnotetextanchor" href="#note7a" title="">^</a></strong><a style="color:gray;" href="http://agvgd.hci.utah.edu/BRCA2_Spur.html">http://agvgd.hci.utah.edu/BRCA2_Spur.html</a></li>
<li id="note8"><strong><a style="color:gray;" class="footnotetextanchor" href="#note8a" title="">^</a></strong><a style="color:gray;" href="https://www.ncbi.nlm.nih.gov/clinvar/variation/185651/#clinical-assertions">https://www.ncbi.nlm.nih.gov/clinvar/variation/185651/#clinical-assertions</a></li>
<li id="note9"><strong><a style="color:gray;" class="footnotetextanchor" href="#note9a" title="">^</a></strong><a style="color:gray;" href="https://enigmaconsortium.org/library/general-documents/enigma-classification-criteria/">https://enigmaconsortium.org/library/general-documents/enigma-classification-criteria/</a></li>
</ol>
<a id="h12" name="h12"></a><h2>References</h2>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B1" id="B1"></a>Acedo, A., Hern&#x00E1;ndez-Moro, C., Curiel-Garc&#x00ED;a,&#x00C1;, D&#x00ED;ez-G&#x00F3;mez, B., and Velasco, E. A. (2015). Functional classification of <i>BRCA2</i> DNA variants by splicing assays in a large minigene with 9 exons. <i>Hum. Mutat.</i> 36, 210&#x2013;221. doi: 10.1002/humu.22725</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=25382762" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/humu.22725" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Functional+classification+of+BRCA2+DNA+variants+by+splicing+assays+in+a+large+minigene+with+9+exons%2E&#x0026;journal=Hum%2E+Mutat%2E&#x0026;author=Acedo+A.&#x0026;author=Hern&#x00E1;ndez-Moro+C.+Curiel-Garc&#x00ED;a&#x0026;author=&#x00C1;+D&#x00ED;ez-G&#x00F3;mez+B.&#x0026;author=and+Velasco+E.+A.&#x0026;publication_year=2015&#x0026;volume=36&#x0026;pages=210-221" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B2" id="B2"></a>Acedo, A., Sanz, D. J., Dur&#x00E1;n, M., Infante, M., P&#x00E9;rez-Cabornero, L., Miner, C., et al. (2012). Comprehensive splicing functional analysis of DNA variants of the <i>BRCA2</i> gene by hybrid minigenes. <i>Breast Cancer Res.</i> 14:R87. doi: 10.1186/bcr3202</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=22632462" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1186/bcr3202" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Comprehensive+splicing+functional+analysis+of+DNA+variants+of+the+BRCA2+gene+by+hybrid+minigenes%2E&#x0026;journal=Breast+Cancer+Res%2E&#x0026;author=Acedo+A.&#x0026;author=Sanz+D.+J.&#x0026;author=Dur&#x00E1;n+M.&#x0026;author=Infante+M.&#x0026;author=P&#x00E9;rez-Cabornero+L.&#x0026;author=Miner+C.&#x0026;publication_year=2012" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B3" id="B3"></a>Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., et al. (2010). A method and server for predicting damaging missense mutations. <i>Nat. Methods</i> 7, 248&#x2013;249. doi: 10.1038/nmeth0410-248</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=20354512" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nmeth0410-248" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=A+method+and+server+for+predicting+damaging+missense+mutations%2E&#x0026;journal=Nat%2E+Methods&#x0026;author=Adzhubei+I.+A.&#x0026;author=Schmidt+S.&#x0026;author=Peshkin+L.&#x0026;author=Ramensky+V.+E.&#x0026;author=Gerasimova+A.&#x0026;author=Bork+P.&#x0026;publication_year=2010&#x0026;volume=7&#x0026;pages=248-249" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B4" id="B4"></a>Beroud, C., Letovsky, S. I., Braastad, C. D., Caputo, S. M., Beaudoux, O., Bignon, Y. J., et al. (2016). BRCA share: a collection of clinical BRCA gene variants. <i>Hum. Mutat.</i> 37, 1318&#x2013;1328. doi: 10.1002/humu.23113</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=27633797" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/humu.23113" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=BRCA+share%3A+a+collection+of+clinical+BRCA+gene+variants%2E&#x0026;journal=Hum%2E+Mutat%2E&#x0026;author=Beroud+C.&#x0026;author=Letovsky+S.+I.&#x0026;author=Braastad+C.+D.&#x0026;author=Caputo+S.+M.&#x0026;author=Beaudoux+O.&#x0026;author=Bignon+Y.+J.&#x0026;publication_year=2016&#x0026;volume=37&#x0026;pages=1318-1328" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B5" id="B5"></a>Bonnet, C., Krieger, S., Vezain, M., Rousselin, A., Tournier, I., Martins, A., et al. (2008). Screening <i>BRCA1</i> and <i>BRCA2</i> unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene. <i>J. Med. Genet.</i> 45, 438&#x2013;446. doi: 10.1136/jmg.2007.056895</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=18424508" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1136/jmg.2007.056895" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Screening+BRCA1+and+BRCA2+unclassified+variants+for+splicing+mutations+using+reverse+transcription+PCR+on+patient+RNA+and+an+ex+vivo+assay+based+on+a+splicing+reporter+minigene%2E&#x0026;journal=J%2E+Med%2E+Genet%2E&#x0026;author=Bonnet+C.&#x0026;author=Krieger+S.&#x0026;author=Vezain+M.&#x0026;author=Rousselin+A.&#x0026;author=Tournier+I.&#x0026;author=Martins+A.&#x0026;publication_year=2008&#x0026;volume=45&#x0026;pages=438-446" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B6" id="B6"></a>Cartegni, L., Wang, J., Zhu, Z., Zhang, M. Q., and Krainer, A. R. (2003). ESEfinder: A web resource to identify exonic splicing enhancers. <i>Nucleic Acids Res.</i> 31, 3568&#x2013;3571. doi: 10.1093/nar/gkg616</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=12824367" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/nar/gkg616" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=ESEfinder%3A+A+web+resource+to+identify+exonic+splicing+enhancers%2E&#x0026;journal=Nucleic+Acids+Res%2E&#x0026;author=Cartegni+L.&#x0026;author=Wang+J.&#x0026;author=Zhu+Z.&#x0026;author=Zhang+M.+Q.&#x0026;author=and+Krainer+A.+R.&#x0026;publication_year=2003&#x0026;volume=31&#x0026;pages=3568-3571" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B7" id="B7"></a>Colombo, M., Blok, M. J., Whiley, P., Santamari&#x00F1;a, M., Guti&#x00E9;rrez-Enr&#x00ED;quez, S., Romero, A., et al. (2014). Comprehensive annotation of splice junctions supports pervasive alternative splicing at the <i>BRCA1</i> locus: a report from the ENIGMA consortium. <i>Hum. Mol. Genet.</i> 23, 3666&#x2013;3680. doi: 10.1093/hmg/ddu075</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=24569164" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/hmg/ddu075" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Comprehensive+annotation+of+splice+junctions+supports+pervasive+alternative+splicing+at+the+BRCA1+locus%3A+a+report+from+the+ENIGMA+consortium%2E&#x0026;journal=Hum%2E++Mol%2E+Genet%2E&#x0026;author=Colombo+M.&#x0026;author=Blok+M.++J.&#x0026;author=Whiley+P.&#x0026;author=Santamari&#x00F1;a+M.&#x0026;author=Guti&#x00E9;rrez-Enr&#x00ED;quez+S.&#x0026;author=Romero+A.&#x0026;publication_year=2014&#x0026;volume=23&#x0026;pages=3666-3680" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B8" id="B8"></a>de la Hoya, M., Soukarieh, O., L&#x00F3;pez-Perolio, I., Vega, A., Walker, L. C., van Ierland, Y., et al. (2016). Combined genetic and splicing analysis of <i>BRCA1</i> c.[594-2A > C; 641A > G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms. <i>Hum. Mol. Genet.</i> 25, 2256&#x2013;2268. doi: 10.1093/hmg/ddw094</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=27008870" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/hmg/ddw094" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Combined+genetic+and+splicing+analysis+of+BRCA1+c%2E%5B594-2A+>+C;+641A+>+G%5D+highlights+the+relevance+of+naturally+occurring+in-frame+transcripts+for+developing+disease+gene+variant+classification+algorithms%2E&#x0026;journal=Hum%2E+Mol%2E+Genet%2E&#x0026;author=de+la+Hoya+M.&#x0026;author=Soukarieh+O.&#x0026;author=L&#x00F3;pez-Perolio+I.&#x0026;author=Vega+A.&#x0026;author=Walker+L.++C.&#x0026;author=van+Ierland+Y.&#x0026;publication_year=2016&#x0026;volume=25&#x0026;pages=2256-2268" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B9" id="B9"></a>Degrolard-Courcet, E., Sokolowska, J., Padeano, M. M., Guiu, S., Bronner, M., Chery, C., et al. (2014). Development of primary early-onset colorectal cancers due to biallelic mutations of the FANCD1/<i>BRCA2</i> gene. <i>Eur. J. Hum. Genet.</i> 22, 979&#x2013;987. doi: 10.1038/ejhg.2013.278</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=24301060" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/ejhg.2013.278" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Development+of+primary+early-onset+colorectal++cancers+due+to+biallelic+mutations+of+the+FANCD1%2FBRCA2+gene%2E&#x0026;journal=Eur%2E+J%2E+Hum%2E++Genet%2E&#x0026;author=Degrolard-Courcet+E.&#x0026;author=Sokolowska+J.&#x0026;author=Padeano+M.+M.&#x0026;author=Guiu+S.&#x0026;author=Bronner+M.&#x0026;author=Chery+C.&#x0026;publication_year=2014&#x0026;volume=22&#x0026;pages=979-987" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B10" id="B10"></a>Desmet, F.-O., Hamroun, D., Lalande, M., Collod-B&#x00E9;roud, G., Claustres, M., and B&#x00E9;roud, C. (2009). Human Splicing Finder: an online bioinformatics tool to predict splicing signals. <i>Nucleic Acids Res.</i> 37:e67. doi: 10.1093/nar/gkp215</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=19339519" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/nar/gkp215" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Human+Splicing+Finder%3A+an+online+bioinformatics+tool+to+predict+splicing+signals%2E&#x0026;journal=Nucleic+Acids+Res%2E&#x0026;author=Desmet+F.-O.&#x0026;author=Hamroun+D.&#x0026;author=Lalande+M.&#x0026;author=Collod-B&#x00E9;roud+G.&#x0026;author=Claustres+M.&#x0026;author=and+B&#x00E9;roud+C.&#x0026;publication_year=2009" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B11" id="B11"></a>Douglas, A. G., and Wood, M. J. (2011). RNA splicing: disease and therapy. <i>Brief Funct. Genomics</i> 10, 151&#x2013;164. doi: 10.1093/bfgp/elr020</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=21628314" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/bfgp/elr020" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=RNA+splicing%3A+disease+and+therapy%2E&#x0026;journal=Brief+Funct%2E+Genomics&#x0026;author=Douglas+A.+G.&#x0026;author=and+Wood+M.+J.&#x0026;publication_year=2011&#x0026;volume=10&#x0026;pages=151-164" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B12" id="B12"></a>Fackenthal, J. D., Yoshimatsu, T., Zhang, B., de Garibay, G. R., Colombo, M., De Vecchi, G., et al. (2016). Naturally occurring <i>BRCA2</i> alternative mRNA splicing events in clinically relevant samples. <i>J. Med. Genet.</i> 53, 548&#x2013;558. doi: 10.1136/jmedgenet-2015-103570</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=27060066" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1136/jmedgenet-2015-103570" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Naturally+occurring+BRCA2+alternative+mRNA+splicing+events+in+clinically+relevant+samples%2E&#x0026;journal=J%2E+Med%2E+Genet%2E&#x0026;author=Fackenthal+J.+D.&#x0026;author=Yoshimatsu+T.&#x0026;author=Zhang+B.&#x0026;author=de+Garibay+G.+R.&#x0026;author=Colombo+M.&#x0026;author=De+Vecchi+G.&#x0026;publication_year=2016&#x0026;volume=53&#x0026;pages=548-558" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B13" id="B13"></a>Fairbrother, W. G., Holste, D., Burge, C. B., and Sharp, P. A. (2004). Single nucleotide polymorphism-based validation of exonic splicing enhancers. <i>PLoS Biol.</i> 2:E268. doi: 10.1371/journal.pbio.0020268</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=15340491" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pbio.0020268" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Single+nucleotide+polymorphism-based+validation+of+exonic+splicing+enhancers%2E&#x0026;journal=PLoS+Biol%2E&#x0026;author=Fairbrother+W.+G.&#x0026;author=Holste+D.&#x0026;author=Burge+C.+B.&#x0026;author=and+Sharp+P.+A.&#x0026;publication_year=2004" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B14" id="B14"></a>Fairbrother, W. G., Yeh, R.-F., Sharp, P. A., and Burge, C. B. (2002). Predictive identification of exonic splicing enhancers in human genes. <i>Science</i> 297, 1007&#x2013;1013. doi: 10.1126/science.1073774</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=12114529" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1126/science.1073774" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Predictive+identification+of+exonic+splicing+enhancers+in+human+genes%2E&#x0026;journal=Science&#x0026;author=Fairbrother+W.++G.&#x0026;author=Yeh+R.-F.&#x0026;author=Sharp+P.++A.&#x0026;author=and+Burge+C.++B.&#x0026;publication_year=2002&#x0026;volume=297&#x0026;pages=1007-1013" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B15" id="B15"></a>Fraile-Bethencourt, E., D&#x00ED;ez-G&#x00F3;mez, B., Vel&#x00E1;squez-Zapata, V., Acedo, A., Sanz, D. J., and Velasco, E. A. (2017). Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of <i>BRCA2</i> exons 17 and 18. <i>PLoS Genet.</i> 13:e1006691. doi: 10.1371/journal.pgen.1006691</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=28339459" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pgen.1006691" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Functional+classification+of+DNA+variants+by+hybrid+minigenes%3A+Identification+of+30+spliceogenic+variants+of+BRCA2+exons+17+and+18%2E&#x0026;journal=PLoS+Genet%2E&#x0026;author=Fraile-Bethencourt+E.&#x0026;author=D&#x00ED;ez-G&#x00F3;mez+B.&#x0026;author=Vel&#x00E1;squez-Zapata+V.&#x0026;author=Acedo+A.&#x0026;author=Sanz+D.++J.&#x0026;author=and+Velasco+E.++A.&#x0026;publication_year=2017" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B16" id="B16"></a>Grodeck&#x00E1;, L., Buratti, E., and Freiberger, T. (2017). Mutations of pre-mRNA splicing regulatory elements: Are predictions moving forward to clinical diagnostics? <i>Int. J. Mol. Sci.</i> 18:E1668. doi: 10.3390/ijms18081668</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=28758972" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3390/ijms18081668" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Mutations+of+pre-mRNA+splicing+regulatory+elements%3A+Are+predictions+moving+forward+to+clinical+diagnostics%B4&#x0026;journal=Int%2E+J%2E+Mol%2E+Sci%2E&#x0026;author=Grodeck&#x00E1;+L.&#x0026;author=Buratti+E.&#x0026;author=and+Freiberger+T.&#x0026;publication_year=2017" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B17" id="B17"></a>Hussain, S., Wilson, J. B., Medhurst, A. L., Hejna, J., Witt, E., Ananth, S., et al. (2004). Direct interaction of FANCD2 with <i>BRCA2</i> in DNA damage response pathways. <i>Hum. Mol. Genet.</i> 13, 1241&#x2013;1248. doi: 10.1093/hmg/ddh135</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=15115758" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/hmg/ddh135" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Direct+interaction+of+FANCD2+with+BRCA2+in+DNA+damage+response+pathways%2E&#x0026;journal=Hum%2E++Mol%2E++Genet%2E&#x0026;author=Hussain+S.&#x0026;author=Wilson+J.++B.&#x0026;author=Medhurst+A.++L.&#x0026;author=Hejna+J.&#x0026;author=Witt+E.&#x0026;author=Ananth+S.&#x0026;publication_year=2004&#x0026;volume=13&#x0026;pages=1241-1248" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B18" id="B18"></a>Infante, M., Dur&#x00E1;n, M., Acedo, A., S&#x00E1;nchez-Tapia, E. M., D&#x00ED;ez-G&#x00F3;mez, B., Barroso, A., et al. (2013). The highly prevalent <i>BRCA2</i> mutation c.2808_2811del (3036delACAA) is located in a mutational hotspot and has multiple origins. <i>Carcinogenesis</i> 34, 2505&#x2013;2511. doi: 10.1093/carcin/bgt272</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=23929434" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/carcin/bgt272" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=The+highly+prevalent+BRCA2+mutation++c%2E2808%5F2811del+%283036delACAA%29+is+located+in+a+mutational+hotspot+and+has+multiple+origins%2E&#x0026;journal=Carcinogenesis&#x0026;author=Infante+M.&#x0026;author=Dur&#x00E1;n+M.&#x0026;author=Acedo+A.&#x0026;author=S&#x00E1;nchez-Tapia+E.+M.&#x0026;author=D&#x00ED;ez-G&#x00F3;mez+B.&#x0026;author=Barroso+A.&#x0026;publication_year=2013&#x0026;volume=34&#x0026;pages=2505-2511" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B19" id="B19"></a>Lara, B., Mart&#x00ED;nez, M. T., Blanco, I., Hern&#x00E1;ndez-Moro, C., Velasco, E. A., Ferrarotti, I., et al. (2014). Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid. <i>Respir. Res.</i> 15:125. doi: 10.1186/s12931-014-0125-y</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=25287719" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1186/s12931-014-0125-y" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Severe+alpha-1+antitrypsin+deficiency+in+composite+heterozygotes+inheriting+a+new+splicing+mutation+QOMadrid%2E&#x0026;journal=Respir%2E++Res%2E&#x0026;author=Lara+B.&#x0026;author=Mart&#x00ED;nez+M.+T.&#x0026;author=Blanco+I.&#x0026;author=Hern&#x00E1;ndez-Moro+C.&#x0026;author=Velasco+E.+A.&#x0026;author=Ferrarotti+I.&#x0026;publication_year=2014" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B20" id="B20"></a>Levy-Lahad, E., Catane, R., Eisenberg, S., Kaufman, B., Hornreich, G., Lishinsky, E., et al. (1997). Founder <i>BRCA1</i> and <i>BRCA2</i> mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. <i>Am. J. Hum. Genet.</i> 60, 1059&#x2013;1067.</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=9150153" target="_blank">PubMed Abstract</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Founder+BRCA1+and+BRCA2+mutations+in+Ashkenazi+Jews+in+Israel%3A+frequency+and+differential+penetrance+in+ovarian+cancer+and+in+breast-ovarian+cancer+families%2E&#x0026;journal=Am%2E++J%2E++Hum%2E++Genet%2E&#x0026;author=Levy-Lahad+E.&#x0026;author=Catane+R.&#x0026;author=Eisenberg+S.&#x0026;author=Kaufman+B.&#x0026;author=Hornreich+G.&#x0026;author=Lishinsky+E.&#x0026;publication_year=1997&#x0026;volume=60&#x0026;pages=1059-1067" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B21" id="B21"></a>Li, J., Zou, C., Bai, Y., Wazer, D. E., Band, V., and Gao, Q. (2006). DSS1 is required for the stability of <i>BRCA2</i>. <i>Oncogene</i> 25, 1186&#x2013;1194. doi: 10.1038/sj.onc.1209153</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=16205630" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/sj.onc.1209153" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=DSS1+is+required+for+the+stability+of+BRCA2%2E&#x0026;journal=Oncogene&#x0026;author=Li+J.&#x0026;author=Zou+C.&#x0026;author=Bai+Y.&#x0026;author=Wazer+D.++E.&#x0026;author=Band+V.&#x0026;author=and+Gao+Q.&#x0026;publication_year=2006&#x0026;volume=25&#x0026;pages=1186-1194" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B22" id="B22"></a>L&#x00F3;pez-Bigas, N., Audit, B., Ouzounis, C., Parra, G., and Guig&#x00F3;, R. (2005). Are splicing mutations the most frequent cause of hereditary disease? <i>FEBS Lett.</i> 579, 1900&#x2013;1903. doi: 10.1016/j.febslet.2005.02.047</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=15792793" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.febslet.2005.02.047" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Are+splicing+mutations+the+most+frequent+cause+of+hereditary+disease%B4&#x0026;journal=FEBS+Lett%2E&#x0026;author=L&#x00F3;pez-Bigas+N.&#x0026;author=Audit+B.&#x0026;author=Ouzounis+C.&#x0026;author=Parra+G.&#x0026;author=and+Guig&#x00F3;+R.&#x0026;publication_year=2005&#x0026;volume=579&#x0026;pages=1900-1903" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B23" id="B23"></a>Marston, N. J., Richards, W. J., Hughes, D., Bertwistle, D., Marshall, C. J., and Ashworth, A. (1999). Interaction between the product of the breast cancer susceptibility gene <i>BRCA2</i> and DSS1, a protein functionally conserved from yeast to mammals. <i>Mol. Cell. Biol.</i> 19, 4633&#x2013;4642. doi: 10.1128/MCB.19.7.4633</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=10373512" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1128/MCB.19.7.4633" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Interaction+between+the+product+of+the+breast+cancer+susceptibility+gene+BRCA2+and+DSS1%2C+a+protein+functionally+conserved+from+yeast+to+mammals%2E&#x0026;journal=Mol%2E+Cell%2E+Biol%2E&#x0026;author=Marston+N.+J.&#x0026;author=Richards+W.+J.&#x0026;author=Hughes+D.&#x0026;author=Bertwistle+D.&#x0026;author=Marshall+C.+J.&#x0026;author=and+Ashworth+A.&#x0026;publication_year=1999&#x0026;volume=19&#x0026;pages=4633-4642" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B24" id="B24"></a>Musolino, A., Naldi, N., Michiara, M., Bella, M. A., Zanelli, P., Bortesi, B., et al. (2005). A breast cancer patient from Italy with germline mutations in both the <i>BRCA1</i> and <i>BRCA2</i> genes. <i>Breast Cancer Res. Treat.</i> 91, 203&#x2013;205. doi: 10.1007/s10549-004-7704-4</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=15868448" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s10549-004-7704-4" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=A+breast+cancer+patient+from+Italy+with+germline+mutations+in+both+the+BRCA1+and+BRCA2+genes%2E&#x0026;journal=Breast+Cancer+Res%2E+Treat%2E&#x0026;author=Musolino+A.&#x0026;author=Naldi+N.&#x0026;author=Michiara+M.&#x0026;author=Bella+M.+A.&#x0026;author=Zanelli+P.&#x0026;author=Bortesi+B.&#x0026;publication_year=2005&#x0026;volume=91&#x0026;pages=203-205" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B25" id="B25"></a>Nielsen, F. C., van Overeem Hansen, T., and S&#x00F8;rensen, C. S. (2016). Hereditary breast and ovarian cancer: new genes in confined pathways. <i>Nat. Rev. Cancer</i> 16, 599&#x2013;612. doi: 10.1038/nrc.2016.72</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=27515922" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nrc.2016.72" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Hereditary+breast+and+ovarian+cancer%3A+new+genes+in+confined+pathways%2E&#x0026;journal=Nat%2E++Rev%2E+Cancer&#x0026;author=Nielsen+F.++C.&#x0026;author=van+Overeem+Hansen+T.&#x0026;author=and+S&#x00F8;rensen+C.++S.&#x0026;publication_year=2016&#x0026;volume=16&#x0026;pages=599-612" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B26" id="B26"></a>Petrucelli, N., Daly, M. B., and Feldman, G. L. (2013). <i>BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer.</i> Seattle, WA: University of Washington.</p>
<p class="ReferencesCopy2"><a href="http://scholar.google.com/scholar_lookup?&#x0026;title=BRCA1+and+BRCA2+Hereditary+Breast+and+Ovarian+Cancer%2E&#x0026;author=Petrucelli+N.&#x0026;author=Daly+M.+B.&#x0026;author=and+Feldman+G.+L.&#x0026;publication_year=2013" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B27" id="B27"></a>Pettigrew, C. A., Wayte, N., Wronski, A., Lovelock, P. K., Spurdle, A. B., and Brown, M. A. (2008). Colocalisation of predicted exonic splicing enhancers in <i>BRCA2</i> with reported sequence variants. <i>Breast Cancer Res. Treat.</i> 110, 227&#x2013;234. doi: 10.1007/s10549-007-9714-5</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=17899372" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s10549-007-9714-5" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Colocalisation+of+predicted+exonic+splicing+enhancers+in+BRCA2+with+reported+sequence+variants%2E&#x0026;journal=Breast+Cancer+Res%2E+Treat%2E&#x0026;author=Pettigrew+C.+A.&#x0026;author=Wayte+N.&#x0026;author=Wronski+A.&#x0026;author=Lovelock+P.+K.&#x0026;author=Spurdle+A.+B.&#x0026;author=and+Brown+M.+A.&#x0026;publication_year=2008&#x0026;volume=110&#x0026;pages=227-234" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B28" id="B28"></a>Reese, M. G., Eeckman, F. H., Kulp, D., and Haussler, D. (1997). Improved splice site detection in Genie. <i>J. Comput. Biol.</i> 4, 311&#x2013;323. doi: 10.1089/cmb.1997.4.311</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=9278062" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1089/cmb.1997.4.311" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Improved+splice+site+detection+in+Genie%2E&#x0026;journal=J%2E+Comput%2E+Biol%2E&#x0026;author=Reese+M.++G.&#x0026;author=Eeckman+F.++H.&#x0026;author=Kulp+D.&#x0026;author=and+Haussler+D.&#x0026;publication_year=1997&#x0026;volume=4&#x0026;pages=311-323" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B29" id="B29"></a>Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., et al. (2015). Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. <i>Genet. Med.</i> 17, 405&#x2013;423. doi: 10.1038/gim.2015.30</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=25741868" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/gim.2015.30" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Standards+and+guidelines+for+the+interpretation+of+sequence+variants%3A+a+joint+consensus+recommendation+of+the+American+college+of+medical+genetics+and+genomics+and+the+association+for+molecular+pathology%2E&#x0026;journal=Genet%2E+Med%2E&#x0026;author=Richards+S.&#x0026;author=Aziz+N.&#x0026;author=Bale+S.&#x0026;author=Bick+D.&#x0026;author=Das+S.&#x0026;author=Gastier-Foster+J.&#x0026;publication_year=2015&#x0026;volume=17&#x0026;pages=405-423" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B30" id="B30"></a>Ricks, T. K., Chiu, H.-J., Ison, G., Kim, G., McKee, A. E., Kluetz, P., et al. (2015). Successes and challenges of PARP inhibitors in cancer therapy. <i>Front. Oncol.</i> 5:222. doi: 10.3389/fonc.2015.00222</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=26528434" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fonc.2015.00222" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Successes+and+challenges+of+PARP+inhibitors+in+cancer+therapy%2E&#x0026;journal=Front%2E++Oncol%2E&#x0026;author=Ricks+T.+K.&#x0026;author=Chiu+H.-J.&#x0026;author=Ison+G.&#x0026;author=Kim+G.&#x0026;author=McKee+A.+E.&#x0026;author=Kluetz+P.&#x0026;publication_year=2015" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B31" id="B31"></a>Roy, R., Chun, J., and Powell, S. N. (2012). <i>BRCA1</i> and <i>BRCA2</i>: different roles in a common pathway of genome protection. <i>Nat. Rev. Cancer</i> 12, 68&#x2013;78. doi: 10.1038/nrc3181</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=22193408" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nrc3181" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=BRCA1+and+BRCA2%3A+different+roles+in+a+common+pathway+of+genome+protection%2E&#x0026;journal=Nat%2E+Rev%2E+Cancer&#x0026;author=Roy+R.&#x0026;author=Chun+J.&#x0026;author=and+Powell+S.+N.&#x0026;publication_year=2012&#x0026;volume=12&#x0026;pages=68-78" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B32" id="B32"></a>Sanz, D. J., Acedo, A., Infante, M., Dur&#x00E1;n, M., P&#x00E9;rez-Cabornero, L., Esteban-Carde&#x00F1;osa, E., et al. (2010). A high proportion of DNA variants of <i>BRCA1</i> and <i>BRCA2</i> is associated with aberrant splicing in breast/ovarian cancer patients. <i>Clin. Cancer Res.</i> 16, 1957&#x2013;1967. doi: 10.1158/1078-0432.CCR-09-2564</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=20215541" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1158/1078-0432.CCR-09-2564" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=A+high+proportion+of+DNA+variants+of+BRCA1+and+BRCA2+is+associated+with+aberrant+splicing+in+breast%2Fovarian+cancer+patients%2E&#x0026;journal=Clin%2E++Cancer+Res%2E&#x0026;author=Sanz+D.++J.&#x0026;author=Acedo+A.&#x0026;author=Infante+M.&#x0026;author=Dur&#x00E1;n+M.&#x0026;author=P&#x00E9;rez-Cabornero+L.&#x0026;author=Esteban-Carde&#x00F1;osa+E.&#x0026;publication_year=2010&#x0026;volume=16&#x0026;pages=1957-1967" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B33" id="B33"></a>Sironi, M., Menozzi, G., Riva, L., Cagliani, R., Comi, G. P., Bresolin, N., et al. (2004). Silencer elements as possible inhibitors of pseudoexon splicing. <i>Nucleic Acids Res.</i> 32, 1783&#x2013;1791. doi: 10.1093/nar/gkh341</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=15034146" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/nar/gkh341" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Silencer+elements+as+possible+inhibitors+of+pseudoexon+splicing%2E&#x0026;journal=Nucleic+Acids+Res%2E&#x0026;author=Sironi+M.&#x0026;author=Menozzi+G.&#x0026;author=Riva+L.&#x0026;author=Cagliani+R.&#x0026;author=Comi+G.+P.&#x0026;author=Bresolin+N.&#x0026;publication_year=2004&#x0026;volume=32&#x0026;pages=1783-1791" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B34" id="B34"></a>Slavin, T. P., Niell-Swiller, M., Solomon, I., Nehoray, B., Rybak, C., Blazer, K. R., et al. (2015). Clinical application of multigene panels: challenges of next-generation counseling and cancer risk management. <i>Front. Oncol.</i> 5:208. doi: 10.3389/fonc.2015.00208</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=26484312" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fonc.2015.00208" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Clinical+application+of+multigene+panels%3A+challenges+of+next-generation+counseling+and+cancer+risk+management%2E&#x0026;journal=Front%2E+Oncol%2E&#x0026;author=Slavin+T.+P.&#x0026;author=Niell-Swiller+M.&#x0026;author=Solomon+I.&#x0026;author=Nehoray+B.&#x0026;author=Rybak+C.&#x0026;author=Blazer+K.+R.&#x0026;publication_year=2015" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B35" id="B35"></a>Soemedi, R., Cygan, K. J., Rhine, C. L., Glidden, D. T., Taggart, A. J., Lin, C.-L., et al. (2017). The effects of structure on pre-mRNA processing and stability. <i>Methods</i> 125, 36&#x2013;44. doi: 10.1016/j.ymeth.2017.06.001</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=28595983" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.ymeth.2017.06.001" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=The+effects+of+structure+on+pre-mRNA+processing+and+stability%2E&#x0026;journal=Methods&#x0026;author=Soemedi+R.&#x0026;author=Cygan+K.+J.&#x0026;author=Rhine+C.+L.&#x0026;author=Glidden+D.+T.&#x0026;author=Taggart+A.+J.&#x0026;author=Lin+C.-L.&#x0026;publication_year=2017&#x0026;volume=125&#x0026;pages=36-44" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B36" id="B36"></a>Villate, O., Ibarluzea, N., Fraile-bethencourt, E., and Valenzuela, A. (2018). Functional analyses of a novel splice variant in the CHD7 gene, found by next generation sequencing, confirm its pathogenicity in a Spanish patient and diagnose him with CHARGE syndrome. 9, 26&#x2013;31. doi: 10.3389/fgene.2018.00007</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.3389/fgene.2018.00007" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;author=Villate+O.&#x0026;author=Ibarluzea+N.&#x0026;author=Fraile-bethencourt+E.&#x0026;author=and+Valenzuela+A.&#x0026;publication_year=2018&#x0026;volume=9&#x0026;pages=26-31" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B37" id="B37"></a>Wang, G.-S., and Cooper, T. A. (2007). Splicing in disease: disruption of the splicing code and the decoding machinery. <i>Nat. Rev. Genet.</i> 8, 749&#x2013;761. doi: 10.1038/nrg2164</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=17726481" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nrg2164" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Splicing+in+disease%3A+disruption+of+the+splicing+code+and+the+decoding+machinery%2E&#x0026;journal=Nat%2E+Rev%2E+Genet%2E&#x0026;author=Wang+G.-S.&#x0026;author=and+Cooper+T.+A.&#x0026;publication_year=2007&#x0026;volume=8&#x0026;pages=749-761" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B38" id="B38"></a>Wang, Z., Rolish, M. E., Yeo, G., Tung, V., Mawson, M., and Burge, C. B. (2004). Systematic identification and analysis of exonic splicing silencers. <i>Cell</i> 119, 831&#x2013;845. doi: 10.1016/j.cell.2004.11.010</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=15607979" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.cell.2004.11.010" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Systematic+identification+and+analysis+of+exonic+splicing+silencers%2E&#x0026;journal=Cell&#x0026;author=Wang+Z.&#x0026;author=Rolish+M.+E.&#x0026;author=Yeo+G.&#x0026;author=Tung+V.&#x0026;author=Mawson+M.&#x0026;author=and+Burge+C.+B.&#x0026;publication_year=2004&#x0026;volume=119&#x0026;pages=831-845" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B39" id="B39"></a>Whiley, P. J., Guidugli, L., Walker, L. C., Healey, S., Thompson, B. A., Lakhani, S. R., et al. (2011). Splicing and multifactorial analysis of intronic <i>BRCA1</i> and <i>BRCA2</i> sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundary. <i>Hum. Mutat.</i> 32, 678&#x2013;687. doi: 10.1002/humu.21495</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=21394826" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/humu.21495" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Splicing+and+multifactorial+analysis+of+intronic+BRCA1+and+BRCA2+sequence+variants+identifies+clinically+significant+splicing+aberrations+up+to+12+nucleotides+from+the+intron%2Fexon+boundary%2E&#x0026;journal=Hum%2E+Mutat%2E&#x0026;author=Whiley+P.+J.&#x0026;author=Guidugli+L.&#x0026;author=Walker+L.+C.&#x0026;author=Healey+S.&#x0026;author=Thompson+B.+A.&#x0026;author=Lakhani+S.+R.&#x0026;publication_year=2011&#x0026;volume=32&#x0026;pages=678-687" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B40" id="B40"></a>Will, C. L., and L&#x00FC;hrmann, R. (2011). Spliceosome structure and function. <i>Cold Spring Harb. Perspect. Biol.</i> 3:a003707. doi: 10.1101/cshperspect.a003707</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=21441581" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1101/cshperspect.a003707" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Spliceosome+structure+and+function%2E&#x0026;journal=Cold+Spring+Harb%2E+Perspect%2E+Biol%2E&#x0026;author=Will+C.+L.&#x0026;author=and+L&#x00FC;hrmann+R.&#x0026;publication_year=2011" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B41" id="B41"></a>Yeo, G., and Burge, C. B. (2004). Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. <i>J. Comput. Biol.</i> 11, 377&#x2013;394. doi: 10.1089/1066527041410418</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=15285897" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1089/1066527041410418" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Maximum+entropy+modeling+of+short+sequence+motifs+with+applications+to+RNA+splicing+signals%2E&#x0026;journal=J%2E+Comput%2E+Biol%2E&#x0026;author=Yeo+G.&#x0026;author=and+Burge+C.++B.&#x0026;publication_year=2004&#x0026;volume=11&#x0026;pages=377-394" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B42" id="B42"></a>Zhang, M. (1998). Statistical features of human exons and their flanking regions. <i>Hum. Mol. Genet.</i> 7, 919&#x2013;932. doi: 10.1093/hmg/7.5.919</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1093/hmg/7.5.919" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Statistical+features+of+human+exons+and+their+flanking+regions%2E&#x0026;journal=Hum%2E+Mol%2E+Genet%2E&#x0026;author=Zhang+M.&#x0026;publication_year=1998&#x0026;volume=7&#x0026;pages=919-932" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B43" id="B43"></a>Zhang, X. H., and Chasin, L. A. (2004). Computational definition of sequence motifs governing constitutive exon splicing. <i>Genes Dev.</i> 18, 1241&#x2013;1250. doi: 10.1101/gad.1195304</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=15145827" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1101/gad.1195304" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Computational+definition+of+sequence+motifs+governing+constitutive+exon+splicing%2E&#x0026;journal=Genes+Dev%2E&#x0026;author=Zhang+X.+H.&#x0026;author=and+Chasin+L.+A.&#x0026;publication_year=2004&#x0026;volume=18&#x0026;pages=1241-1250" target="_blank">Google Scholar</a></p>
</div>
</div>
<div class="thinLineM20"></div>
<div class="AbstractSummary">
<p><span>Keywords</span>: breast cancer, BRCA2, DNA variants, splicing, hybrid minigenes</p>
<p><span>Citation:</span> Fraile-Bethencourt E, Valenzuela-Palomo A, D&#x00ED;ez-G&#x00F3;mez B, Acedo A and Velasco EA (2018) Identification of Eight Spliceogenic Variants in BRCA2 Exon 16 by Minigene Assays. <i>Front. Genet.</i> 9:188. doi: 10.3389/fgene.2018.00188</p>
<p id="timestamps">
<span>Received:</span> 16 March 2018; <span>Accepted:</span> 08 May 2018;<br><span>Published:</span> 24 May 2018.</p>
<div>
<p>Edited by:</p>
<a href="http://loop.frontiersin.org/people/489555/overview">Paolo Peterlongo</a>, IFOM &#x2013; The FIRC Institute of Molecular Oncology, Italy</div>
<div>
<p>Reviewed by:</p>
<a href="http://loop.frontiersin.org/people/302927/overview">Logan Walker</a>, University of Otago, New Zealand<br>
<a href="http://loop.frontiersin.org/people/53480/overview">John Frederick Pearson</a>, University of Otago, New Zealand</div>
<p><span>Copyright</span> &#x00A9; 2018 Fraile-Bethencourt, Valenzuela-Palomo, D&#x00ED;ez -G&#x00F3;mez, Acedo and Velasco. This is an open-access article distributed under the terms of the <a rel="license" href="http://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution License (CC BY)</a>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
<p><span>*Correspondence:</span> Eladio A. Velasco, <a id="encmail">ZWF2ZWxzYW1AaWJnbS51dmEuZXM=</a></p>
<p><span><sup>&#x2020;</sup>Present address:</span> Alberto Acedo, AC-Gen Reading Life SL, Valladolid, Spain</p>
<div class="clear"></div>
</div></div></div><p class="AbstractSummary__disclaimer"><span>Disclaimer: </span> All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. </p></div></div><!----></main><aside class="Layout__aside"><div class="ArticleDetails__wrapper"><div class="ArticleDetails__aside"><div class="ArticleDetails__aside__responsiveButtons"><div class="ActionsDropDown" id="FloatingButtonsEl"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--icon ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fgene.2018.00188" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">EPUB</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="ArticleDetails__aside__responsiveButtons__items"><span></span><div class="ArticleDetailsShare__responsive"><button class="ArticleDetailsShare__trigger" aria-label="Open share options"></button><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div></div><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeIconButton ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><!----></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Export citation</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div></div></div><div class="TotalViews"><div class="TotalViews__data"><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">6,7K</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Total views</div></div></div><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">1,8K</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Downloads</div></div></div><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">21</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Citations</div></div></div><div class="ImpactMetricsInfoPopover"><button aria-label="Open impact metrics info" class="ImpactMetricsInfoPopover__button"></button><div class="ImpactMetricsInfoPopover__tooltip"><button aria-label="Close impact metrics info" class="ImpactMetricsInfoPopover__tooltip__closeButton"></button><div class="ImpactMetricsInfoPopover__tooltip__text"> Citation numbers are available from Dimensions </div></div></div></div><div class="TotalViews__viewImpactLink"><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View article impact" href="http://loop-impact.frontiersin.org/impact/article/340287#totalviews/views" target="_blank" data-event="customLink-link-a_viewArticleImpact"><span>View article impact</span></a></span></div><div class="TotalViews__altmetric"><div data-badge-popover="bottom" data-badge-type="donut" data-doi="10.3389/fgene.2018.00188" data-condensed="true" data-link-target="new" class="altmetric-embed"></div><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View altmetric score" href="https://www.altmetric.com/details/doi/10.3389/fgene.2018.00188" target="_blank" data-event="customLink-link-a_viewAltmetricScore"><span>View altmetric score</span></a></span></div></div><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Edited by</div><!--[--><a href="https://loop.frontiersin.org/people/489555/overview" data-event="editorInfo-a-paoloPeterlongo" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">P</span><span class="notranslate">P</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Paolo  Peterlongo</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">European Institute of Oncology (IEO), Italy</div></div></a><!--]--></div></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Reviewed by</div><!--[--><a href="https://loop.frontiersin.org/people/53480/overview" data-event="editorInfo-a-johnFrederickPearson" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">J</span><span class="notranslate">F</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">John  Frederick Pearson</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">University of Otago, New Zealand</div></div></a><a href="https://loop.frontiersin.org/people/302927/overview" data-event="editorInfo-a-loganWalker" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">L</span><span class="notranslate">W</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Logan  Walker</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">University of Otago, New Zealand</div></div></a><!--]--></div></div><div class="ArticleDetailsGlossary ArticleDetailsGlossary--open"><button class="ArticleDetailsGlossary__header"><div class="ArticleDetailsGlossary__header__title">Table of contents</div><div class="ArticleDetailsGlossary__header__arrow"></div></button><div class="ArticleDetailsGlossary__content"><ul class="flyoutJournal">
<li><a href="#h1">Abstract</a></li>
<li><a href="#h2">Introduction</a></li>
<li><a href="#h3">Materials and Methods</a></li>
<li><a href="#h4">Results</a></li>
<li><a href="#h5">Discussion</a></li>
<li><a href="#h6">Author Contributions</a></li>
<li><a href="#h7">Funding</a></li>
<li><a href="#h8">Conflict of Interest Statement</a></li>
<li><a href="#h9">Acknowledgments</a></li>
<li><a href="#h10">Supplementary Material</a></li>
<li><a href="#h11">Footnotes</a></li>
<li><a href="#h12">References</a></li>
</ul>
</div></div><span></span><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeOutline ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Export citation</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="CheckForUpdates"><button data-target="crossmark" class="CheckForUpdates__link" data-event="checkForUpdates-btn-openModal"><img class="CheckForUpdates__link__img" src="/ap-2024/images/crossmark.svg" alt="Crossmark icon"><div class="CheckForUpdates__link__text">Check for updates</div></button></div><div class="AnnouncementCard"><p class="AnnouncementCard__title">Frontiers&#39; impact</p><article class="CardA"><div class="CardA__wrapper CardA__wrapper--vertical"><figure class="FrontiersImage CardA__img"><picture class="FrontiersImage"><!--[--><source srcset="https://images-provider.frontiersin.org/api/ipx/w=440&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 563px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=320x400&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1024px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=268x280&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1441px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><!--]--><img src="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" class="is-inside-mask" alt loading="eager"></picture><!----></figure><div class="CardA__info"><!--[--><h2 class="CardA__title">Articles published with Frontiers have received 12 million total citations</h2><p class="CardA__text">Your research is the real superpower - learn how we maximise its impact through our leading community journals</p><br><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--small Link--icon Link--chevronRight Link--right" aria-label="Explore our impact metrics" href="https://www.frontiersin.org/about/impact" target="_self" data-event="customLink-linkType-a_exploreOurImpactMe"><span>Explore our impact metrics</span></a></span><!--]--></div></div></article></div><!----><!----></div><div><div class="Modal Modal--noFooter"><button aria-label="Close modal" class="Modal__overlay" data-event="modal-overlay-close"></button><div class="Modal__container"><div class="Modal__header"><p class="Modal__title">Supplementary Material</p><button aria-label="Close modal" class="Modal__close" data-event="modal-button-close"></button></div><div class="Modal__body"><!--[--><div class="SupplementalData"><ul class="SupplementalData__list"><!--[--><!--]--></ul></div><!--]--><!----></div><!----><!----></div></div></div><div><div class="FloatingButtons"><!----><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--iconDownload ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Download</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fgene.2018.00188" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">EPUB</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><!----></div></div></div></aside></div><div class=""><!----></div><!--]--></div><!----><footer class="Footer"><div class="Footer__wrapper"><div class="Footer__sections"><ul class="Accordion"><!--[--><!--[--><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Guidelines</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/guidelines/author-guidelines" target="_self" data-event="footer-block_0-a_authorGuidelines">Author guidelines</a></li><li><a href="https://www.frontiersin.org/for-authors/author-services" target="_self" data-event="footer-block_0-a_servicesForAuthors">Services for authors</a></li><li><a href="https://www.frontiersin.org/guidelines/policies-and-publication-ethics" target="_self" data-event="footer-block_0-a_policiesAndPublicationE">Policies and publication ethics</a></li><li><a href="https://www.frontiersin.org/guidelines/editor-guidelines" target="_self" data-event="footer-block_0-a_editorGuidelines">Editor guidelines</a></li><li><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="footer-block_0-a_feePolicy">Fee policy</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Explore</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/articles" target="_self" data-event="footer-block_1-a_articles">Articles</a></li><li><a href="https://www.frontiersin.org/research-topics" target="_self" data-event="footer-block_1-a_researchTopics">Research Topics </a></li><li><a href="https://www.frontiersin.org/journals" target="_self" data-event="footer-block_1-a_journals">Journals</a></li><li><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="footer-block_1-a_howWePublish">How we publish</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Outreach</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://forum.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForum">Frontiers Forum </a></li><li><a href="https://policylabs.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersPolicyLabs">Frontiers Policy Labs </a></li><li><a href="https://kids.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForYoungMinds">Frontiers for Young Minds</a></li><li><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="footer-block_2-a_frontiersPlanetPrize">Frontiers Planet Prize</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Connect</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://helpcenter.frontiersin.org" target="_blank" data-event="footer-block_3-a_helpCenter">Help center</a></li><li><a href="https://subscription-management.frontiersin.org/emails/preferences#block0" target="_blank" data-event="footer-block_3-a_emailsAndAlerts">Emails and alerts </a></li><li><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="footer-block_3-a_contactUs">Contact us </a></li><li><a href="https://www.frontiersin.org/submission/submit" target="_self" data-event="footer-block_3-a_submit">Submit</a></li><li><a href="https://careers.frontiersin.org/" target="_blank" data-event="footer-block_3-a_careerOpportunities">Career opportunities</a></li><!--]--></ul><!--]--></div></li><!--]--><!--]--></ul><div class="Footer__socialLinks"><div class="Footer__socialLinks__title">Follow us</div><!--[--><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--facebook Link--right" aria-label="Frontiers Facebook" href="https://www.facebook.com/Frontiersin" target="_blank" data-event="footer-facebook-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--twitter Link--right" aria-label="Frontiers Twitter" href="https://twitter.com/frontiersin" target="_blank" data-event="footer-twitter-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--linkedin Link--right" aria-label="Frontiers LinkedIn" href="https://www.linkedin.com/company/frontiers" target="_blank" data-event="footer-linkedIn-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--instagram Link--right" aria-label="Frontiers Instagram" href="https://www.instagram.com/frontiersin_" target="_blank" data-event="footer-instagram-a_true"><span></span></a></span><!--]--></div></div><div class="Footer__copyright"><div><span> 2025 Frontiers Media SA. All rights reserved.</span></div><div><a href="https://www.frontiersin.org/legal/privacy-policy" target="_blank">Privacy policy</a><span>|</span><a href="https://www.frontiersin.org/legal/terms-and-conditions" target="_blank">Terms and conditions</a></div></div></div></footer><div class="SnackbarWrapper"><div class="SnackbarManager"><!--[--><!--]--></div></div></div><noscript><iframe
            src="https://tag-manager.frontiersin.org/ns.html?id=GTM-M322FV2&gtm_auth=owVbWxfaJr21yQv1fe1cAQ&gtm_preview=env-1&gtm_cookies_win=x"
            height="0"
            width="0"
            style="display: none; visibility: hidden">
          </iframe></noscript><!--]--></div><div id="teleports"></div><script type="application/json" id="__NUXT_DATA__" data-ssr="true">[["ShallowReactive",1],{"data":2,"state":4,"once":10,"_errors":11,"serverRendered":13,"path":14,"pinia":15},["ShallowReactive",3],{},["Reactive",5],{"$ssite-config":6},{"env":7,"name":8,"url":9},"production","Frontiers articles","https://article-pages-2024.frontiersin.org/",["Set"],["ShallowReactive",12],{},true,"/journals/genetics/articles/10.3389/fgene.2018.00188/full",["Reactive",16],{"main":17,"user":514,"article":515,"articleHub":779,"mainHeader":783},{"ibar":18,"footer":276,"newsletterComponent":-1,"snackbarItem":358,"toggleShowSnackbar":359,"contentfulJournal":360,"graphJournal":414,"settingsFeaturesSwitchers":418,"templateToggleBanner":419,"tenantConfig":479},{"tenantLogo":19,"journalLogo":19,"aboutUs":20,"submitUrl":113,"showSubmitButton":13,"journal":114,"sectionTerm":207,"aboutJournal":208,"mainLinks":257,"journalLinks":264,"helpCenterLink":273},"",[21,38,47,71,87],{"title":22,"links":23},"Who we are",[24,29,32,35],{"text":25,"url":26,"target":27,"ariaLabel":28},"Mission and values","https://www.frontiersin.org/about/mission","_self",null,{"text":30,"url":31,"target":27,"ariaLabel":28},"History","https://www.frontiersin.org/about/history",{"text":33,"url":34,"target":27,"ariaLabel":28},"Leadership","https://www.frontiersin.org/about/leadership",{"text":36,"url":37,"target":27,"ariaLabel":28},"Awards","https://www.frontiersin.org/about/awards",{"title":39,"links":40},"Impact and progress",[41,44],{"text":42,"url":43,"target":27,"ariaLabel":28},"Frontiers' impact","https://www.frontiersin.org/about/impact",{"text":45,"url":46,"target":27,"ariaLabel":28},"Our annual reports","https://www.frontiersin.org/about/annual-reports",{"title":48,"links":49},"Publishing model",[50,53,56,59,62,65,68],{"text":51,"url":52,"target":27,"ariaLabel":28},"How we publish","https://www.frontiersin.org/about/how-we-publish",{"text":54,"url":55,"target":27,"ariaLabel":28},"Open access","https://www.frontiersin.org/about/open-access",{"text":57,"url":58,"target":27,"ariaLabel":28},"Peer review","https://www.frontiersin.org/about/peer-review",{"text":60,"url":61,"target":27,"ariaLabel":28},"Research integrity","https://www.frontiersin.org/about/research-integrity",{"text":63,"url":64,"target":27,"ariaLabel":28},"Research Topics","https://www.frontiersin.org/about/research-topics",{"text":66,"url":67,"target":27,"ariaLabel":28},"FAIR Data Management","https://www.frontiersin.org/about/fair-data-management",{"text":69,"url":70,"target":27,"ariaLabel":28},"Fee policy","https://www.frontiersin.org/about/fee-policy",{"title":72,"links":73},"Services",[74,78,81,84],{"text":75,"url":76,"target":77,"ariaLabel":28},"Societies","https://publishingpartnerships.frontiersin.org/","_blank",{"text":79,"url":80,"target":27,"ariaLabel":28},"National consortia","https://www.frontiersin.org/open-access-agreements/consortia",{"text":82,"url":83,"target":27,"ariaLabel":28},"Institutional partnerships","https://www.frontiersin.org/about/open-access-agreements",{"text":85,"url":86,"target":27,"ariaLabel":28},"Collaborators","https://www.frontiersin.org/about/collaborators",{"title":88,"links":89},"More from Frontiers",[90,94,97,101,105,109],{"text":91,"url":92,"target":77,"ariaLabel":93},"Frontiers Forum","https://forum.frontiersin.org/","this link will take you to the Frontiers Forum website",{"text":95,"url":96,"target":27,"ariaLabel":28},"Frontiers Planet Prize","https://www.frontiersin.org/about/frontiers-planet-prize",{"text":98,"url":99,"target":77,"ariaLabel":100},"Press office","https://pressoffice.frontiersin.org/","this link will take you to the Frontiers press office website",{"text":102,"url":103,"target":27,"ariaLabel":104},"Sustainability","https://www.frontiersin.org/about/sustainability","link to information about Frontiers' sustainability",{"text":106,"url":107,"target":77,"ariaLabel":108},"Career opportunities","https://careers.frontiersin.org/","this link will take you to the Frontiers careers website",{"text":110,"url":111,"target":27,"ariaLabel":112},"Contact us","https://www.frontiersin.org/about/contact","this link will take you to the help pages to contact our support team","https://www.frontiersin.org/submission/submit?domainid=1&fieldid=30&specialtyid=0&entitytype=2&entityid=240",{"id":115,"name":116,"slug":117,"sections":118},240,"Frontiers in Genetics","genetics",[119,123,127,131,135,139,143,147,151,155,159,163,167,171,175,179,183,187,191,195,199,203],{"id":120,"name":121,"slug":122},549,"Applied Genetic Epidemiology","applied-genetic-epidemiology",{"id":124,"name":125,"slug":126},536,"Behavioral and Psychiatric Genetics","behavioral-and-psychiatric-genetics",{"id":128,"name":129,"slug":130},2030,"Cancer Genetics and Oncogenomics","cancer-genetics-and-oncogenomics",{"id":132,"name":133,"slug":134},551,"Computational Genomics","computational-genomics",{"id":136,"name":137,"slug":138},2512,"Cytogenomics","cytogenomics",{"id":140,"name":141,"slug":142},650,"ELSI in Science and Genetics","elsi-in-science-and-genetics",{"id":144,"name":145,"slug":146},455,"Epigenomics and Epigenetics","epigenomics-and-epigenetics",{"id":148,"name":149,"slug":150},535,"Evolutionary and Population Genetics","evolutionary-and-population-genetics",{"id":152,"name":153,"slug":154},596,"Genetics of Aging","genetics-of-aging",{"id":156,"name":157,"slug":158},635,"Genetics of Common and Rare Diseases","genetics-of-common-and-rare-diseases",{"id":160,"name":161,"slug":162},557,"Genomic Assay Technology","genomic-assay-technology",{"id":164,"name":165,"slug":166},1520,"Genomics of Plants and the Phytoecosystem","genomics-of-plants-and-the-phytoecosystem",{"id":168,"name":169,"slug":170},1419,"Human and Medical Genomics","human-and-medical-genomics",{"id":172,"name":173,"slug":174},2237,"Immunogenetics","immunogenetics",{"id":176,"name":177,"slug":178},241,"Livestock Genomics","livestock-genomics",{"id":180,"name":181,"slug":182},19,"Neurogenomics","neurogenomics",{"id":184,"name":185,"slug":186},3423,"Nutritional Genomics","nutritional-genomics",{"id":188,"name":189,"slug":190},198,"Pharmacogenetics and Pharmacogenomics","pharmacogenetics-and-pharmacogenomics",{"id":192,"name":193,"slug":194},556,"Predictive Toxicology and Exposomics","predictive-toxicology-and-exposomics",{"id":196,"name":197,"slug":198},555,"RNA","rna",{"id":200,"name":201,"slug":202},454,"Statistical Genetics and Methodology","statistical-genetics-and-methodology",{"id":204,"name":205,"slug":206},685,"Stem Cell Research","stem-cell-research","Sections",[209,233],{"title":210,"links":211},"Scope",[212,215,218,221,224,227,230],{"text":213,"url":214,"target":27,"ariaLabel":28},"Field chief editors","https://www.frontiersin.org/journals/genetics/about#about-editors",{"text":216,"url":217,"target":27,"ariaLabel":28},"Mission & scope","https://www.frontiersin.org/journals/genetics/about#about-scope",{"text":219,"url":220,"target":27,"ariaLabel":28},"Facts","https://www.frontiersin.org/journals/genetics/about#about-facts",{"text":222,"url":223,"target":27,"ariaLabel":28},"Journal sections","https://www.frontiersin.org/journals/genetics/about#about-submission",{"text":225,"url":226,"target":27,"ariaLabel":28},"Open access statement","https://www.frontiersin.org/journals/genetics/about#about-open",{"text":228,"url":229,"target":27,"ariaLabel":28},"Copyright statement","https://www.frontiersin.org/journals/genetics/about#copyright-statement",{"text":231,"url":232,"target":27,"ariaLabel":28},"Quality","https://www.frontiersin.org/journals/genetics/about#about-quality",{"title":234,"links":235},"For authors",[236,239,242,245,248,251,254],{"text":237,"url":238,"target":27,"ariaLabel":28},"Why submit?","https://www.frontiersin.org/journals/genetics/for-authors/why-submit",{"text":240,"url":241,"target":27,"ariaLabel":28},"Article types","https://www.frontiersin.org/journals/genetics/for-authors/article-types",{"text":243,"url":244,"target":27,"ariaLabel":28},"Author guidelines","https://www.frontiersin.org/journals/genetics/for-authors/author-guidelines",{"text":246,"url":247,"target":27,"ariaLabel":28},"Editor guidelines","https://www.frontiersin.org/journals/genetics/for-authors/editor-guidelines",{"text":249,"url":250,"target":27,"ariaLabel":28},"Publishing fees","https://www.frontiersin.org/journals/genetics/for-authors/publishing-fees",{"text":252,"url":253,"target":27,"ariaLabel":28},"Submission checklist","https://www.frontiersin.org/journals/genetics/for-authors/submission-checklist",{"text":255,"url":256,"target":27,"ariaLabel":28},"Contact editorial office","https://www.frontiersin.org/journals/genetics/for-authors/contact-editorial-office",[258,261],{"text":259,"url":260,"target":27,"ariaLabel":28},"All journals","https://www.frontiersin.org/journals",{"text":262,"url":263,"target":27,"ariaLabel":28},"All articles","https://www.frontiersin.org/articles",[265,268,270],{"text":266,"url":267,"target":27,"ariaLabel":28},"Articles","articles",{"text":63,"url":269,"target":27,"ariaLabel":28},"research-topics",{"text":271,"url":272,"target":27,"ariaLabel":28},"Editorial board","editors",{"text":274,"url":275,"target":77,"ariaLabel":274},"Help center","https://helpcenter.frontiersin.org",{"blocks":277,"socialLinks":331,"copyright":355,"termsAndConditionsUrl":356,"privacyPolicyUrl":357},[278,292,302,316],{"title":279,"links":280},"Guidelines",[281,283,286,289,291],{"text":243,"url":282,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/author-guidelines",{"text":284,"url":285,"target":27,"ariaLabel":28},"Services for authors","https://www.frontiersin.org/for-authors/author-services",{"text":287,"url":288,"target":27,"ariaLabel":28},"Policies and publication ethics","https://www.frontiersin.org/guidelines/policies-and-publication-ethics",{"text":246,"url":290,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/editor-guidelines",{"text":69,"url":70,"target":27,"ariaLabel":28},{"title":293,"links":294},"Explore",[295,296,299,301],{"text":266,"url":263,"target":27,"ariaLabel":28},{"text":297,"url":298,"target":27,"ariaLabel":28},"Research Topics ","https://www.frontiersin.org/research-topics",{"text":300,"url":260,"target":27,"ariaLabel":28},"Journals",{"text":51,"url":52,"target":27,"ariaLabel":28},{"title":303,"links":304},"Outreach",[305,308,311,315],{"text":306,"url":92,"target":77,"ariaLabel":307},"Frontiers Forum ","Frontiers Forum website",{"text":309,"url":310,"target":77,"ariaLabel":28},"Frontiers Policy Labs ","https://policylabs.frontiersin.org/",{"text":312,"url":313,"target":77,"ariaLabel":314},"Frontiers for Young Minds","https://kids.frontiersin.org/","Frontiers for Young Minds journal",{"text":95,"url":96,"target":27,"ariaLabel":28},{"title":317,"links":318},"Connect",[319,320,324,327,330],{"text":274,"url":275,"target":77,"ariaLabel":274},{"text":321,"url":322,"target":77,"ariaLabel":323},"Emails and alerts ","https://subscription-management.frontiersin.org/emails/preferences#block0","Subscribe to Frontiers emails",{"text":325,"url":111,"target":27,"ariaLabel":326},"Contact us ","Subscribe to newsletter",{"text":328,"url":329,"target":27,"ariaLabel":28},"Submit","https://www.frontiersin.org/submission/submit",{"text":106,"url":107,"target":77,"ariaLabel":28},[332,340,345,350],{"link":333,"type":336,"color":337,"icon":338,"size":339,"hiddenText":13},{"text":334,"url":335,"target":77,"ariaLabel":334},"Frontiers Facebook","https://www.facebook.com/Frontiersin","Link","Grey","Facebook","Medium",{"link":341,"type":336,"color":337,"icon":344,"size":339,"hiddenText":13},{"text":342,"url":343,"target":77,"ariaLabel":28},"Frontiers Twitter","https://twitter.com/frontiersin","Twitter",{"link":346,"type":336,"color":337,"icon":349,"size":339,"hiddenText":13},{"text":347,"url":348,"target":77,"ariaLabel":28},"Frontiers LinkedIn","https://www.linkedin.com/company/frontiers","LinkedIn",{"link":351,"type":336,"color":337,"icon":354,"size":339,"hiddenText":13},{"text":352,"url":353,"target":77,"ariaLabel":28},"Frontiers Instagram","https://www.instagram.com/frontiersin_","Instagram","Frontiers Media SA. All rights reserved.","https://www.frontiersin.org/legal/terms-and-conditions","https://www.frontiersin.org/legal/privacy-policy",{},false,{"__typename":361,"identifier":115,"name":116,"slug":117,"banner":362,"description":407,"mission":408,"palette":409,"impactFactor":410,"citeScore":411,"citations":412,"showTagline":28,"twitter":413},"Journal",[363],{"id":364,"src":365,"name":366,"type":367,"width":368,"height":369,"idHash":370,"archive":371,"brandId":372,"limited":371,"fileSize":373,"isPublic":374,"original":375,"copyright":19,"extension":376,"thumbnails":378,"dateCreated":386,"description":19,"orientation":387,"userCreated":388,"watermarked":371,"dateModified":386,"datePublished":389,"ecsArchiveFiles":390,"propertyOptions":391,"property_Channel":396,"property_Sub-Type":398,"property_Asset_Type":400,"activeOriginalFocusPoint":402,"property_Office_Department":405},"12AFEC62-10F2-4A9B-900C8422E4B53D54","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/webimage-A09D2065-D257-435D-987C43E79D7FBDFD.png","FGENE_Main Visual_Purple_Website","image",6016,4016,"3b54103c3aad636f",0,"22C10171-81B3-4DA6-99342F272A32E8BB",10275124,1,"https://brand.frontiersin.org/m/3b54103c3aad636f/original/FGENE_Main-Visual_Purple_Website.jpg",[377],"jpg",{"mini":379,"thul":380,"webimage":365,"Guidelines":381,"WebsiteJpg_XL":382,"WebsiteWebP_L":383,"WebsiteWebP_M":384,"WebsiteWebP_XL":385},"https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/mini-8741E412-02C1-4126-84DDA81B97389D5E.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/thul-D176A038-2FDA-438D-B9A7E98CF3926BBE.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/511D4207-6085-4D24-9E5E56EBCA9EBCD2/Guidelines-FGENE_Main Visual_Purple_Website.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/511D4207-6085-4D24-9E5E56EBCA9EBCD2/WebsiteJpg_XL-FGENE_Main Visual_Purple_Website.jpg","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/511D4207-6085-4D24-9E5E56EBCA9EBCD2/WebsiteWebP_L-FGENE_Main Visual_Purple_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/511D4207-6085-4D24-9E5E56EBCA9EBCD2/WebsiteWebP_M-FGENE_Main Visual_Purple_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/511D4207-6085-4D24-9E5E56EBCA9EBCD2/WebsiteWebP_XL-FGENE_Main Visual_Purple_Website.webp","2022-06-27T09:59:48Z","landscape","Caroline Sutter","2022-06-27T09:27:09Z",[],[392,393,394,395],"414FB2D4-2283-43FD-BE14E534ECA67928","6C18119B-14BD-4951-B437696F4357BD33","7C692885-DB25-4858-B1FB4FF47B241E9B","D88C0047-EC30-4506-A7DF28A4D765E1CF",[397],"frontiersin_org",[399],"Main_Visual",[401],"Photography",{"x":403,"y":404},3008,2008,[406],"Publishing","Explore research from the world's most cited genetics and heredity journal, advancing our understanding of genes from humans to plants and other model organisms.","\u003Cp>Frontiers in Genetics publishes research on genes and genomes relating to all the domains of life, from humans to livestock, and plants to other model organisms.\u003C/p>\n\n\u003Cp>Led by Field Chief Editor Enrico Domenici (Department of Cellular, Computational and Integrated Biology, University of Trento, Italy) Frontiers in Genetics is indexed in PubMed Central (PMC) and Scopus, among others, and explores the full spectrum of genetic and genomic research, encompassing fundamental studies and their clinical applications, while also embracing methodological advancements and exploring their applications and implications. Topics of interest include, but are not limited to:\u003C/p>\n\n\u003Cdiv> &bull; how genes or genomes relate to traits and humanpathophysiology\u003C/div>\n\u003Cdiv> &bull; advances in genomic data technology and analysis\u003C/div>\n\u003Cdiv> &bull; gene flow among species and populations\u003C/div>\n\u003Cdiv> &bull; livestock genome research Interactions between organisms, theirenvironment, and xenobiotics\u003C/div>\n\u003Cdiv> &bull; molecular and cellular genetics\u003C/div>\n\u003Cdiv> &bull; societal implicationsof genetic research.\u003C/div>\n\u003Cbr>\n\u003Cp>Submissions that emphasize advancement in the understanding of the function and variability of the genome, the use of genetic and genomic tools, and the analysis of the genetic underpinnings of biological processes are of particular interest to this journal.\u003Cp>\n\u003Cp>Furthermore, the journal actively welcomes submissions which support and advance the UNs Sustainable Development Goals (SDGs), notably SDG 3: good health and well-being.\u003C/p>\n\u003Cp>Manuscripts that focus solely on clinical outcomes, patient management, or therapeutic interventions without a clear genetic or genomic component are not suitable for publication in this journal. Studies that are purely epidemiological or observational, without a foundation in genetic or genomic mechanisms, are also not within the scope of this journal. Manuscripts consisting solely of bioinformatics, computational analyses of public data which are not accompanied by validation (independent clinical or patient cohort, or biological validation in vitro or in vivo) or are not highly innovative are not suitable for publication in this journal. Please refer to the \u003Ca href=\"https://www.frontiersin.org/guidelines/policies-and-publication-ethics#standards-for-research-methodology:~:text=complaints%20and%20allegations.-,Standards%20for%20research%20methodology,-Experiments\">Frontiers Standards for research methodology policy\u003C/a>, for more information.\u003C/p>\n\u003Cp>Frontiers in Genetics is committed to advancing developments in the field of genetics and genomics by allowing unrestricted access to articles, and communicating scientific knowledge to both researchers and the public, to enable the scientific breakthroughs of the future.\u003C/p>","purple","3.7","5.2","277710","@FrontGenetics",{"id":115,"name":116,"slug":117,"abbreviation":415,"isOnline":13,"isOpenForSubmissions":13,"citeScore":416,"impactFactor":417},"fgene",6.2,2.8,{"displayTitlePillLabels":13,"displayRelatedArticlesBox":13,"showEditors":13,"showReviewers":13,"showLoopImpactLink":13,"enableFigshare":359},{"isPublic":13,"allowCompanyUsers":359,"whiteListEmails":420,"enableAllJournals":13,"whiteListJournals":442},[421,422,423,424,425,426,427,428,429,426,430,431,432,433,434,435,436,437,438,439,440,441],"Y2FybG9zLmxvcmNhQGZyb250aWVyc2luLm9yZw==","ZGFuaWVsLmx1ekBmcm9udGllcnNpbi5vcmc=","bGF1cmEudGVuYUBmcm9udGllcnNpbi5vcmc=","cmFmYWVsLnJpYW5jaG9AZnJvbnRpZXJzaW4ub3Jn","amFtZXMuc21hbGxib25lQGZyb250aWVyc2luLm9yZw==","ZnJhbi5tb3Jlbm9AZnJvbnRpZXJzaW4ub3Jn","c2FtdWVsLmZlcm5hbmRlekBmcm9udGllcnNpbi5vcmc=","YmFyYmFyYS5jYXJjYW5naXVAZnJvbnRpZXJzaW4ub3Jn","aXZhbi5zYW50YW1hcmlhQGZyb250aWVyc2luLm9yZw==","aHVlLnRyYW5AZnJvbnRpZXJzaW4ub3Jn","Z29uY2Fsby52YXJnYXNAZnJvbnRpZXJzaW4ub3Jn","bHVjaWUuc2VubkBmcm9udGllcnNpbi5vcmc=","bG9ybi5mcmFzZXJAZnJvbnRpZXJzaW4ub3Jn","ZWxzYS5jYXJyb25AZnJvbnRpZXJzaW4ub3Jn","bWFhcnRlbi52YW5kaWpja0Bmcm9udGllcnNpbi5vcmc=","YmluZGh1LmtyaXNobmFuQGZyb250aWVyc2luLm9yZw==","bWF0dGhldy5hdHR3YXRlcnNAZnJvbnRpZXJzaW4ub3Jn","Z2l1bGlhLnZhbHNlY2NoaUBmcm9udGllcnNpbi5vcmc=","ZmFiaWFuLmRlbGxhbW9ydGVAZnJvbnRpZXJzaW4ub3Jn","dmlqYXlhbi5wcEBwaXRzb2x1dGlvbnMuY29t","Z3VpbGxhdW1lLnNldXJhdEBmcm9udGllcnNpbi5vcmc=",[443,444,445,446,447,448,374,449,450,451,452,453,454,455,456,457,458,459,460,461,462,463,464,465,466,467,468,469,470,471,472,473,474,475,476,477,478],2232,1729,2357,2456,2176,2333,1843,602,106,616,310,657,3123,1468,2137,628,1566,2726,2086,1490,451,141,1335,2655,1238,604,698,1547,176,1440,403,1239,755,2136,609,1534,{"spaceId":374,"name":374,"availableJournalPages":480,"announcement":484},[267,272,269,481,482,483],"volumes","about","community-reviewers",{"__typename":485,"sys":486,"preHeader":42,"title":488,"description":489,"image":490,"link":512},"Announcement",{"id":487},"5ITtnTtQgAzPPGH6rX0AlM","Articles published with Frontiers have received 12 million total citations","Your research is the real superpower - learn how we maximise its impact through our leading community journals",[491],{"archive":371,"brandId":372,"copyright":28,"dateCreated":492,"dateModified":493,"datePublished":494,"description":28,"extension":495,"fileSize":497,"height":498,"id":499,"isPublic":371,"limited":371,"name":500,"orientation":387,"original":28,"thumbnails":501,"type":367,"watermarked":371,"width":508,"videoPreviewURLs":509,"tags":510,"textMetaproperties":511,"src":502},"2025-06-18T12:58:01Z","2025-06-18T14:15:34Z","2025-06-18T12:57:32Z",[496],"png",1365026,920,"7C5269C4-3C83-4591-951A74D15B95DAEA","Impact metrics banner for article pages",{"webimage":502,"thul":503,"mini":504,"WebsiteWebP_L":505,"WebsiteWebP_M":506,"Guidelines":507},"https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/thul-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/mini-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_L/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_M/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/Guidelines/Impact-metrics-banner-for-article-pages.png",1600,[],[],[],{"text":513,"url":43,"target":27,"ariaLabel":28},"Explore our impact metrics",{"loggedUserInfo":-1},{"currentArticle":516,"isPreviewPage":359,"hasSupplementalData":359,"showCrossmarkWidget":13,"articleTemplate":656,"currentArticlePageMetaInfo":657,"xmlParsedArticleContent":-1,"xmlParsingError":-1},{"id":517,"doi":518,"title":519,"acceptanceDate":520,"receptionDate":521,"publicationDate":522,"lastModifiedDate":523,"isPublished":13,"abstract":524,"researchTopic":525,"articleType":531,"stage":534,"keywords":536,"authors":542,"editors":581,"reviewers":591,"journal":609,"section":616,"impactMetrics":621,"volume":625,"articleVolume":626,"relatedArticles":627,"isPublishedV2":359,"contents":628,"files":631},340287,"10.3389/fgene.2018.00188","Identification of Eight Spliceogenic Variants in BRCA2 Exon 16 by Minigene Assays",["Date","2018-05-08T10:58:54.000Z"],["Date","2018-03-16T12:51:34.000Z"],["Date","2018-05-24T00:00:00.000Z"],["Date","2025-11-25T05:17:45.348Z"],"Genetic testing of BRCA1 and BRCA2 identifies a large number of variants of uncertain clinical significance (VUS) whose functional and clinical interpretations pose a challenge for genetic counselling.  Interestingly, a relevant fraction of DNA variants can disrupt the splicing process in cancer susceptibility genes.  We have tested more than 200 variants throughout 19 BRCA2 exons mostly by minigene assays, 54% of which displayed aberrant splicing, thus confirming the utility of this assay to check genetic variants in the absence of patient RNA. \nOur goal was to investigate BRCA2 exon 16 with a view to characterizing spliceogenic variants recorded at the mutational databases. Seventy-two different BIC and UMD variants were analyzed with NNSplice and Human Splicing Finder, 12 of which were selected because they were predicted to disrupt essential splice motifs: canonical splice sites (ss; 8 variants) and ESE/ESS (4 variants). These 12 candidate variants were introduced into the BRCA2 minigene with 7 exons (14 to 20) by site-directed mutagenesis and then transfected into MCF-7 cells. Seven variants (6 intronic and 1 missense) induced complete abnormal splicing patterns: c.7618-2A>T, c.7618-2A>G, c.7618-1G>C, c.7618-1G>A, c.7805G>C, c.7805+1G>A and c.7805+3A>C, as well as a partial anomalous outcome by c.7802A>G. They generated at least 10 different transcripts: 16p44 (alternative 3ss 44-nt downstream; acceptor variants), 16 (exon 16-skipping; donor variants), 16p55 (alternative 3ss 55-nt downstream), 16q4 (alternative 5ss 4-nt upstream), 16q100 (alternative 5ss 4-nt upstream), 16q20 (alternative 5ss 20-nt downstream) as well as minor (16p93 and 16,17p69) and uncharacterized transcripts of 893 and 954 nucleotides. Isoforms 16p44, 16, 16p55, 16q4, 16q100 and16q20 introduced premature termination codons which presumably inactivate BRCA2. According to the guidelines the American College of Medical Genetics and Genomics (ACMG) these eight variants could be classified as pathogenic or likely pathogenic whereas the Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) rules suggested seven class 4 and one class 3 variants. \nIn conclusion, our study highlights the relevance of splicing functional assays by hybrid minigenes for the clinical classification of genetic variations. Hence, we provide new data about spliceogenic variants of BRCA2 exon 16 that are directly correlated with breast cancer susceptibility.",{"id":526,"title":527,"articlesCount":528,"isMagazinePage":13,"slug":529,"isOpenForSubmission":359,"views":530},7106,"Accomplishments, Collaborative Projects and Future Initiatives in Breast Cancer Genetic Predisposition",13,"accomplishments-collaborative-projects-and-future-initiatives-in-breast-cancer-genetic-predisposition",115658,{"id":532,"name":533},24,"Original Research",{"id":535,"name":19},18,[537,538,539,540,541],"breast cancer","BRCA2","DNA variants","Splicing","hybrid minigenes",[543,552,559,566,574],{"id":544,"firstName":545,"middleName":19,"lastName":546,"givenNames":547,"isCorresponding":359,"isProfilePublic":13,"userId":544,"email":-1,"affiliations":548},496376,"Eugenia","Fraile-Bethencourt","Eugenia ",[549],{"organizationName":550,"countryName":551,"cityName":19,"stateName":19,"zipCode":19},"Splicing and Genetic Susceptibility to Cancer, Instituto de Biologa y Gentica Molecular, Consejo Superior de Investigaciones Cientficas, Universidad de Valladolid","Spain",{"id":553,"firstName":554,"middleName":19,"lastName":555,"givenNames":556,"isCorresponding":359,"isProfilePublic":13,"userId":553,"email":-1,"affiliations":557},514162,"Alberto","Valenzuela-Palomo","Alberto ",[558],{"organizationName":550,"countryName":551,"cityName":19,"stateName":19,"zipCode":19},{"id":560,"firstName":561,"middleName":19,"lastName":562,"givenNames":563,"isCorresponding":359,"isProfilePublic":13,"userId":560,"email":-1,"affiliations":564},563485,"Beatriz","Dez-Gmez","Beatriz ",[565],{"organizationName":550,"countryName":551,"cityName":19,"stateName":19,"zipCode":19},{"id":567,"firstName":554,"middleName":19,"lastName":568,"givenNames":556,"isCorresponding":359,"isProfilePublic":13,"userId":567,"email":-1,"affiliations":569},433023,"Acedo",[570,571],{"organizationName":550,"countryName":551,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":572,"countryName":573,"cityName":19,"stateName":19,"zipCode":19},"Biome Makers Inc.","United States",{"id":575,"firstName":576,"middleName":19,"lastName":577,"givenNames":578,"isCorresponding":359,"isProfilePublic":13,"userId":575,"email":-1,"affiliations":579},496947,"Eladio A.","Velasco","Eladio A. ",[580],{"organizationName":550,"countryName":551,"cityName":19,"stateName":19,"zipCode":19},[582],{"id":583,"firstName":584,"middleName":19,"lastName":585,"givenNames":586,"isCorresponding":359,"isProfilePublic":13,"userId":583,"email":-1,"affiliations":587},489555,"Paolo","Peterlongo","Paolo ",[588],{"organizationName":589,"countryName":590,"cityName":19,"stateName":19,"zipCode":19},"European Institute of Oncology (IEO)","Italy",[592,602],{"id":593,"firstName":594,"middleName":595,"lastName":596,"givenNames":597,"isCorresponding":359,"isProfilePublic":13,"userId":593,"email":-1,"affiliations":598},53480,"John","Frederick","Pearson","John  Frederick",[599],{"organizationName":600,"countryName":601,"cityName":19,"stateName":19,"zipCode":19},"University of Otago","New Zealand",{"id":603,"firstName":604,"middleName":19,"lastName":605,"givenNames":606,"isCorresponding":359,"isProfilePublic":13,"userId":603,"email":-1,"affiliations":607},302927,"Logan","Walker","Logan ",[608],{"organizationName":600,"countryName":601,"cityName":19,"stateName":19,"zipCode":19},{"id":115,"slug":117,"name":116,"shortName":610,"electronicISSN":611,"field":612,"specialtyId":28,"journalSectionPaths":614},"Front. Genet.","1664-8021",{"id":613,"domainId":374},30,[615],{"section":616},{"id":617,"name":618,"slug":619,"specialtyId":620},506,"Cancer Genetics","cancer-genetics",129,{"views":622,"downloads":623,"citations":624},6662,1812,21,9,"Volume 9 - 2018",[],{"titleHtml":519,"fullTextHtml":629,"menuHtml":630},"\u003Cdiv class=\"JournalAbstract\">\r\n\u003Ca id=\"h1\" name=\"h1\">\u003C/a>\r\n\u003Cdiv class=\"authors\">\u003Cspan class=\"author-wrapper notranslate\">\r\n\u003Ca href=\"https://loop.frontiersin.org/people/496376\" class=\"user-id-496376\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/496376/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"\r\nEugenia Fraile-Bethencourt\">Eugenia Fraile-Bethencourt\u003C/a>\u003Csup>1\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/514162\" class=\"user-id-514162\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/514162/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Alberto Valenzuela-Palomo\">Alberto Valenzuela-Palomo\u003C/a>\u003Csup>1\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/563485\" class=\"user-id-563485\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/563485/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Beatriz D&#xED;ez-G&#xF;mez\">Beatriz D&#x00ED;ez-G&#x00F3;mez\u003C/a>\u003Csup>1\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/433023\" class=\"user-id-433023\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/433023/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Alberto Acedo,&#x;\">Alberto Acedo\u003C/a>\u003Csup>1,2&#x2020;\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/496947\" class=\"user-id-496947\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/496947/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Eladio A. Velasco*\">Eladio A. Velasco\u003C/a>\u003Csup>1*\u003C/sup>\u003C/span>\u003C/div>\r\n\u003Cul class=\"notes\">\r\n\u003Cli>\u003Cspan>\u003Csup>1\u003C/sup>\u003C/span>Splicing and Genetic Susceptibility to Cancer, Instituto de Biolog&#x00ED;a y Gen&#x00E9;tica Molecular, Consejo Superior de Investigaciones Cient&#x00ED;ficas, Universidad de Valladolid, Valladolid, Spain\u003C/li>\r\n\u003Cli>\u003Cspan>\u003Csup>2\u003C/sup>\u003C/span>Biome Makers Inc., San Francisco, CA, United States\u003C/li>\r\n\u003C/ul>\r\n\u003Cp class=\"mb0\">Genetic testing of \u003Ci>BRCA1\u003C/i> and \u003Ci>BRCA2\u003C/i> identifies a large number of variants of uncertain clinical significance whose functional and clinical interpretations pose a challenge for genetic counseling. Interestingly, a relevant fraction of DNA variants can disrupt the splicing process in cancer susceptibility genes. We have tested more than 200 variants throughout 19 BRCA2 exons mostly by minigene assays, 54% of which displayed aberrant splicing, thus confirming the utility of this assay to check genetic variants in the absence of patient RNA. Our goal was to investigate \u003Ci>BRCA2\u003C/i> exon 16 with a view to characterizing spliceogenic variants recorded at the mutational databases. Seventy-two different BIC and UMD variants were analyzed with NNSplice and Human Splicing Finder, 12 of which were selected because they were predicted to disrupt essential splice motifs: canonical splice sites (ss; eight variants) and exonic/intronic splicing enhancers (four variants). These 12 candidate variants were introduced into the BRCA2 minigene with seven exons (14&#x2013;20) by site-directed mutagenesis and then transfected into MCF-7 cells. Seven variants (six intronic and one missense) induced complete abnormal splicing patterns: c.7618-2A>T, c.7618-2A>G, c.7618-1G>C, c.7618-1G>A, c.7805G>C, c.7805+1G>A, and c.7805+3A>C, as well as a partial anomalous outcome by c.7802A>G. They generated at least 10 different transcripts: &#x0394;16p\u003Csub>44\u003C/sub> (alternative 3&#x2019;ss 44-nt downstream; acceptor variants), &#x0394;16 (exon 16-skipping; donor variants), &#x0394;16p\u003Csub>55\u003C/sub> (alternative 3&#x2019;ss 55-nt downstream), &#x0394;16q\u003Csub>4\u003C/sub> (alternative 5&#x2019;ss 4-nt upstream), &#x0394;16q\u003Csub>100\u003C/sub> (alternative 5&#x2019;ss 4-nt upstream), &#x25BE;16q\u003Csup>20\u003C/sup> (alternative 5&#x2019;ss 20-nt downstream), as well as minor (&#x0394;16p\u003Csub>93\u003C/sub> and &#x0394;16,17p\u003Csub>69\u003C/sub>) and uncharacterized transcripts of 893 and 954 nucleotides. Isoforms &#x0394;16p\u003Csub>44\u003C/sub>, &#x0394;16, &#x0394;16p\u003Csub>55\u003C/sub>, &#x0394;16q\u003Csub>4\u003C/sub>, &#x0394;16q\u003Csub>100\u003C/sub>, and &#x25BE;16q\u003Csup>20\u003C/sup> introduced premature termination codons which presumably inactivate BRCA2. According to the guidelines the American College of Medical Genetics and Genomics these eight variants could be classified as pathogenic or likely pathogenic whereas the Evidence-based Network for the Interpretation of Germline Mutant Alleles rules suggested seven class 4 and one class 3 variants. In conclusion, our study highlights the relevance of splicing functional assays by hybrid minigenes for the clinical classification of genetic variations. Hence, we provide new data about spliceogenic variants of BRCA2 exon 16 that are directly correlated with breast cancer susceptibility.\u003C/p>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003C/div>\r\n\u003Cdiv class=\"JournalFullText\">\r\n\u003Ca id=\"h2\" name=\"h2\">\u003C/a>\u003Ch2>Introduction\u003C/h2>\r\n\u003Cp class=\"mb15\">Hereditary Breast and Ovarian Cancer (HBOC) represents 5&#x2013;10% of all breast cancers. Nowadays, more than 25 HBOC susceptibility genes have been identified, most of them involved in DNA repair pathways (\u003Ca href=\"#B25\">Nielsen et al., 2016\u003C/a>). Deleterious variants of the most prevalent genes \u003Ci>BRCA1\u003C/i> (MIM# 113705) and \u003Ci>BRCA2\u003C/i> (MIM# 600185) confer up to 87% of risk to develop breast cancer by the age of 70 years (\u003Ca href=\"#B26\">Petrucelli et al., 2013\u003C/a>). Apart from specific founder deleterious mutations (\u003Ca href=\"#B20\">Levy-Lahad et al., 1997\u003C/a>; \u003Ca href=\"#B18\">Infante et al., 2013\u003C/a>), there have been described thousands of different BRCA1/2 variants at the mutation databases. According to Universal Mutation Database (UMD, http://www.umd.be; date last accessed 2017/06/16) 2,495 and 3,454 different variants have been detected in \u003Ci>BRCA1\u003C/i> and \u003Ci>BRCA2\u003C/i>, respectively, where a relevant fraction of them has been classified as variants of uncertain significance (VUS). These pose a challenge in clinical genetics since mutation carriers could benefit from preventive and prophylactic measures as well as new targeted therapies such as the Poly-ADP Ribose Polymerase Inhibitors (\u003Ca href=\"#B30\">Ricks et al., 2015\u003C/a>).\u003C/p>\r\n\u003Cp class=\"mb15\">Standard approaches tend to classify DNA variants from the protein point of view. In this way, nonsense variants and frameshift insertions and deletions are automatically classified as pathogenic if they truncate critical protein domains [Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) class 5\u003Csup id=\"footnotesuper1\">\u003Ca id=\"note1a\">\u003C/a>\u003Ca class=\"footnoteanchor\" href=\"#note1\">1\u003C/a>\u003C/sup>]. However, upstream gene expression mechanisms, such as splicing, can be disrupted by DNA changes. In fact, splicing is a critical highly regulated process involved in many cell functions whose disruption has been directly related with disease, being common in cancer (\u003Ca href=\"#B37\">Wang and Cooper, 2007\u003C/a>; \u003Ca href=\"#B11\">Douglas and Wood, 2011\u003C/a>). Likewise, spliceogenic variants are more common than they are thought, and they are not restricted to the sequences of the canonical donor and acceptor sites since it has been suggested that up to 50% of exon variants could also affect splicing (\u003Ca href=\"#B22\">L&#x00F3;pez-Bigas et al., 2005\u003C/a>). This can be explained by the wide range of splicing regulatory elements (SREs) that control this process, which include the conserved splice sites (5&#x2019;ss and 3&#x2019;ss), the branch point, polypyrimidine track, exonic/intronic splicing enhancers (ESEs/ISEs) and exonic/intronic splicing silencers (ESSs/ISSs) (\u003Ca href=\"#B16\">Grodeck&#x00E1; et al., 2017\u003C/a>), as well as other regulatory components or the RNA secondary structure (\u003Ca href=\"#B35\">Soemedi et al., 2017\u003C/a>). Thus, all these factors cooperate with splicing factors and the spliceosome, to accurately remove introns (\u003Ca href=\"#B40\">Will and L&#x00FC;hrmann, 2011\u003C/a>).\u003C/p>\r\n\u003Cp class=\"mb0\">Interestingly, spliceogenic variants are often found in \u003Ci>BRCA2\u003C/i>. Our previous results showed that more than a half of tested \u003Ci>BRCA2\u003C/i> variants impaired splicing (\u003Ca href=\"#B2\">Acedo et al., 2012\u003C/a>, \u003Ca href=\"#B1\">2015\u003C/a>; \u003Ca href=\"#B15\">Fraile-Bethencourt et al., 2017\u003C/a>). Moreover, the minigene technology was confirmed as a reliable tool to functionally assay potential splicing variants. Here, we aimed to check \u003Ci>BRCA2\u003C/i> exon 16 candidate variants to characterize the splicing effects using the pSAD-based minigene MGBR2_14-20, previously employed to assay DNA variants of exons 17 and 18 (\u003Ca href=\"#B15\">Fraile-Bethencourt et al., 2017\u003C/a>). We have assayed 12 likely spliceogenic variants from HBOC patients reported in databases and selected after bioinformatics predictions. Wild-type (wt) and mutant minigenes assays showed that eight variants altered the splicing. Thus, we provide valuable information of spliceogenic \u003Ci>BRCA2\u003C/i> exon 16 variants that could be classified following ENIGMA and American College of Medical Genetics and Genomics (ACMG) guidelines (\u003Ca href=\"#B29\">Richards et al., 2015\u003C/a>).\u003C/p>\r\n\u003Ca id=\"h3\" name=\"h3\">\u003C/a>\u003Ch2>Materials and Methods\u003C/h2>\r\n\u003Cp class=\"mb0\">Ethical approval for this study was obtained from the Ethics Review Committee of the Hospital Universitario R&#x00ED;o Hortega de Valladolid (6/11/2014).\u003C/p>\r\n\u003Ch3>Variant Collection and \u003Ci>In Silico\u003C/i> Analyses\u003C/h3>\r\n\u003Cp class=\"mb15\">\u003Ci>BRCA2\u003C/i> introns 15 and 16 and exon 16 variants were collected from the BIC database\u003Csup id=\"footnotesuper2\">\u003Ca id=\"note2a\">\u003C/a>\u003Ca class=\"footnoteanchor\" href=\"#note2\">2\u003C/a>\u003C/sup> and the BRCA Share Database (UMD, date last accessed 2017/06/16; http://www.umd.be/BRCA2/) (\u003Ca href=\"#B4\">Beroud et al., 2016\u003C/a>). Variant descriptions were according to the \u003Ci>BRCA2\u003C/i> GenBank sequence NM000059.1 and the guidelines of the Human Genome Variation Society (HGVS\u003Csup id=\"footnotesuper3\">\u003Ca id=\"note3a\">\u003C/a>\u003Ca class=\"footnoteanchor\" href=\"#note3\">3\u003C/a>\u003C/sup>).\u003C/p>\r\n\u003Cp class=\"mb0\">Wild-type and mutant sequences were analyzed with NNSPLICE\u003Csup id=\"footnotesuper4\">\u003Ca id=\"note4a\">\u003C/a>\u003Ca class=\"footnoteanchor\" href=\"#note4\">4\u003C/a>\u003C/sup> (\u003Ca href=\"#B28\">Reese et al., 1997\u003C/a>) and Human Splicing Finder version 3.0 (HSF\u003Csup id=\"footnotesuper5\">\u003Ca id=\"note5a\">\u003C/a>\u003Ca class=\"footnoteanchor\" href=\"#note5\">5\u003C/a>\u003C/sup>) (\u003Ca href=\"#B10\">Desmet et al., 2009\u003C/a>), which includes algorithms to detect splice sites, branch point, silencers, and enhancers (\u003Ca href=\"#B14\">Fairbrother et al., 2002\u003C/a>; \u003Ca href=\"#B6\">Cartegni et al., 2003\u003C/a>; \u003Ca href=\"#B33\">Sironi et al., 2004\u003C/a>; \u003Ca href=\"#B38\">Wang et al., 2004\u003C/a>; \u003Ca href=\"#B41\">Yeo and Burge, 2004\u003C/a>; \u003Ca href=\"#B43\">Zhang and Chasin, 2004\u003C/a>).\u003C/p>\r\n\u003Ch3>Minigene and Mutagenesis\u003C/h3>\r\n\u003Cp class=\"mb0\">MGBR2_ex14-20 was assembled as previously described (\u003Ca href=\"#B15\">Fraile-Bethencourt et al., 2017\u003C/a>). DNA variants and deletions were introduced by the QuikChange Lightning Kit (Agilent, Santa Clara, CA, United States). The wt minigene MGBR2_ex14-20 was used as template to generate 12 BIC/BRCA Share DNA variants and 4 microdeletions (Table \u003Ca href=\"#T1\">1\u003C/a>). They were checked by SANGER sequencing at the Macrogen Spain facility (Macrogen, Madrid, Spain).\u003C/p>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">TABLE 1\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t001.jpg\" name=\"table1\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t001.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t001.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t001.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t001.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t001.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t001.jpg\" alt=\"www.frontiersin.org\" id=\"T1\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>TABLE 1.\u003C/strong> Mutagenesis primers of candidate splicing variants.\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Ch3>Transfection of Eukaryotic Cells\u003C/h3>\r\n\u003Cp class=\"mb0\">MCF-7 cells were plated (&#x223C;2 &#x00D7; 10\u003Csup>5\u003C/sup> cells/well) and grown to 90% confluency in 0.5 mL of medium (MEME, 10% fetal bovine serum, 2 mM glutamine, 1% non-essential amino acids, and 1% penicillin/streptomycin) in four-well plates (Nunc, Roskilde, Denmark). Transfections were made with 1 &#x03BC;g of minigene and 2 &#x03BC;L of low toxicity Lipofectamine (Life Technologies, Carlsbad, CA, United States) in Gibco\u003Csup>TM\u003C/sup> Opti-Mem\u003Csup>TM\u003C/sup> (Thermo Fisher Scientific, Waltham, MA, United States). Cells were incubated with 300 &#x03BC;g/mL of cycloheximide (Sigma-Aldrich, St. Louis, MO, United States) for 4 h to inhibit nonsense-mediated decay (NMD). RNA was purified with the Genematrix Universal RNA Purification Kit (EURx, Gdansk, Poland) with on-column DNAse I digestion to degrade genomic DNA that could interfere with RT-PCR.\u003C/p>\r\n\u003Ch3>RT-PCR of Minigenes\u003C/h3>\r\n\u003Cp class=\"mb0\">Approximately 400 ng of RNA was retrotranscribed using RevertAid H Minus First Strand cDNA Synthesis Kit (Life Technologies, Carlsbad, CA, United States) and the gene-specific primer RTPSPL3-RV (5&#x2032;-TGAGGAGTGAATTGGTCGAA-3&#x2032;). Samples were incubated at 42&#x00B0;C for 1 h, and reactions were inactivated at 70&#x00B0;C for 5 min. Then, 40 ng of cDNA was amplified in 50 &#x03BC;L reaction with pMAD_607FW (Patent P201231427, CSIC) and RTBR2_ex17RV2 (5&#x2032;-GGCTTAGGCATCTATTAGCA-3&#x2032;) or with RT_ex15FW (5&#x2032;-CGAATTAAGAAGAAACAAAGG-3&#x2032;) and pSAD_RT_RV (Patent P201231427, CSIC) using Platinum Taq DNA polymerase (Life Technologies, Carlsbad, CA, United States) (size of transcripts: 1018 and 1250 nt, respectively). Samples were denatured at 94&#x00B0;C for 2 min, followed by 35 cycles consisting of 94&#x00B0;C for 30 s, Td-2&#x00B0;C for 30 s, and 72&#x00B0;C (1 min/kb), and a final extension step at 72&#x00B0;C for 5 min. Sequencing reactions were performed by the sequencing facility of Macrogen Spain. Semi-quantitative fluorescent 26 cycles PCRs were done in triplicate with primers pMAD_607FW-FAM and RTBR2_ex17RV2 using Platinum Taq DNA polymerase (Life Technologies, Carlsbad, CA, United States). FAM-labeled products were run with Genescan LIZ-1200 as size standard (Life Technologies, Carlsbad, CA, United States) at the Macrogen facility and analyzed with the Peak Scanner software V1.0. Only peaks with heights &#x2265;50 relative fluorescence unit (RFU) were considered. Mean peak areas of each transcript of three runs were used to quantify the relative abundance of each transcript.\u003C/p>\r\n\u003Ca id=\"h4\" name=\"h4\">\u003C/a>\u003Ch2>Results\u003C/h2>\r\n\u003Ch3 class=\"pt0\">Bioinformatics Analysis of Splicing Variants\u003C/h3>\r\n\u003Cp class=\"mb0\">Seventy-two variants were collected from the BIC and UMD databases. Among them, 35 had been previously classified as VUS and 34 as pathogenic or likely pathogenic. In order to select possible spliceogenic variants, they were analyzed by the splicing prediction software NNSplice and HSF (Supplementary Table S1). Selections were made following the next criteria: (a) ss creation or disruption; (b) branch point disruption; and (c) ESS creation (hnRNPA1). Curiously, NNSplice did not recognize exon 16 canonical 5&#x2032;ss. In contrast, a very strong 100-nt upstream cryptic donor (NNSplice score: 0.99) was identified at position c.7706_7707. The MaxEnt results showed a weak canonical donor (4.68) and a strong cryptic donor (8.92) (Table \u003Ca href=\"#T2\">2\u003C/a>).\u003C/p>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">TABLE 2\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t002.jpg\" name=\"table2\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t002.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t002.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t002.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t002.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t002.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t002.jpg\" alt=\"www.frontiersin.org\" id=\"T2\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>TABLE 2.\u003C/strong> Bioinformatics analysis of potential splicing variants of \u003Ci>BRCA2\u003C/i> exon 16.\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cp class=\"mb15 w100pc float_left mt15\">Twelve variants were selected (Figure \u003Ca href=\"#F1\">1\u003C/a>): six intronic (c.7618-2A>T, c.7618-2A>G, c.7618-1G>C, c.7618-1G>A, c.7805+1G>A, and c.7805+3A>C), five missense (c.7625C>G, c.7753G>A, c.7772A>G, c.7802A>G, and c.7805G>C), and one nonsense (c.7738C>T) variants. Four missense variants (c.7625C>G, c.7753G>A, c.7772A>G, and c.7802A>G) and c.7805+3A>C had been previously classified as VUS. Intronic variants (c.7618-2, -1 and c.7805+1, +3) and c.7805G > C disrupted the canonical ss, whereas variants c.7625C>G and c.7753G>A created new ss. DNA change c.7802A>G was selected because of its proximity to the canonical donor site and the presumable generation of an alternative &#x201C;gt&#x201D; donor site 4-nt upstream (underlined, TTT\u003Cu>GT\u003C/u>AGgtactc). Finally, bioinformatics results of c.7738C>T and c.7772A>G suggested the creation of one ESS (hnRNPA1) (Table \u003Ca href=\"#T2\">2\u003C/a>).\u003C/p>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">FIGURE 1\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g001.jpg\" name=\"figure1\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g001.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g001.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g001.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g001.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g001.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g001.jpg\" alt=\"www.frontiersin.org\" id=\"F1\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>FIGURE 1.\u003C/strong> Functional assays of spliceogenic candidate variants of \u003Ci>BRCA2\u003C/i> exon 16. \u003Cb>(A)\u003C/b> Nucleotide (c.7618_7805) and amino acid (p.2540_2602) sequences of \u003Ci>BRCA2\u003C/i> exon 16. Arrows indicate selected variants. \u003Cb>(B)\u003C/b> Agarose gel electrophoresis of RT-PCR products of the wt and mutant minigenes and the size standard 1 Kb Plus DNA Ladder at both sides of the gel. Amplification was made with primers pMAD607-FW and RTBR2_ex17RV2. Full-length transcript (V1-EX17) size: 1018 nt. Red arrows point to exon 16 skipping band (&#x0394;16) (size: 830 nt).\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Ch3>Splicing Functional Assays of DNA Variants\u003C/h3>\r\n\u003Cp class=\"mb15\">The minigene MGBR2_ex14-20 had been already shown as a robust tool to assay possible spliceogenic variants contained in any of those exons and flanking introns (\u003Ca href=\"#B15\">Fraile-Bethencourt et al., 2017\u003C/a>). The wt construct produced a full-length transcript of the expected size (1806 nt), sequence, and structure (V1-BRCA2 exons 14-20-V2). To map the presence of putative splicing enhancers, a set of four overlapping exonic microdeletions were generated, which spanned 55-nt of the 5&#x2032;- and 3&#x2032;-ends (\u003Ca href=\"#B13\">Fairbrother et al., 2004\u003C/a>). This strategy had been previously shown to increase the accuracy of predictions of ESE disrupting variants (\u003Ca href=\"#B1\">Acedo et al., 2015\u003C/a>; \u003Ca href=\"#B15\">Fraile-Bethencourt et al., 2017\u003C/a>). None of the microdeletions induced splicing anomalies suggesting that this exon is not controlled by ESEs (data not shown). Consequently, ESE-disrupting variants, as unique selection criterion, were not chosen for subsequent functional tests (Table \u003Ca href=\"#T2\">2\u003C/a>).\u003C/p>\r\n\u003Cp class=\"mb0\">Selected variants were introduced into the minigene and functionally assayed in MCF-7 cells. Agarose electrophoresis clearly showed that three of them (c.7805G>C, c.7805+1G>A, and c.7805+3A>C) induced aberrant splicing patterns (Figure \u003Ca href=\"#F1\">1\u003C/a>). However, the high resolution and sensitivity of fluorescent capillary electrophoresis allowed us to identify a total of eight variants, including the three previous ones, that disrupted splicing: c.7618-2A>T, c.7618-2A>G, c.7618-1G>C, c.7618-1G>A, c.7802A>G, c.7805G>C, c.7805+1G>A, and c.7805+3A>C (Figure \u003Ca href=\"#F2\">2\u003C/a>). Actually, this approach is able to detect rare transcripts with a relative abundance below 1% or can resolve transcripts that differ only in a few nucleotides (e.g., only 4-nt between the canonical and &#x0394;16q4 isoforms). A total of at least 10 different aberrant transcripts were characterized by fragment analysis and sequencing: &#x0394;16p44 (44-nt deletion; alternate 3&#x2032;ss 44-nt downstream), &#x0394;16p55 (55-nt del; alternate 3&#x2032;ss 55-nt downstream), &#x0394;16 (exon 16 skipping), &#x0394;16q4 (4-nt del; alternate 5&#x2032;ss 4-nt upstream), &#x0394;16q100 (100-nt del; alternate 5&#x2032;ss 100-nt upstream), &#x25BE;16q20 (20-nt insertion; alternate 5&#x2032;ss 20-nt downstream), minor (&#x0394;16p\u003Csub>93\u003C/sub> and &#x0394;16,17p\u003Csub>69\u003C/sub>), and uncharacterized transcripts of 893 and 954 nt (Figure \u003Ca href=\"#F2\">2\u003C/a> and Table \u003Ca href=\"#T3\">3\u003C/a>). On the one hand, fragments analysis and sequences revealed that 3&#x2032;ss disrupting variants (positions -2 and -1) provoked the use of a cryptic acceptor 44-nt downstream (&#x0394;16p\u003Csub>44\u003C/sub>) within exon 16 (Figure \u003Ca href=\"#F2\">2A\u003C/a>). Interestingly, this cryptic 3&#x2032;ss was not recognized either by NNSplice or MaxtEnt. The loss of 44-nt at 5&#x2032; of exon 16 would suppose a frameshift deletion and a premature termination codon (PTC) (p.L2540Qfs\u003Csup>&#x2217;\u003C/sup>11). On the other hand, 5&#x2032;ss variants (positions +1 and +3) produced exon 16 skipping (&#x0394;16), which means a frameshift deletion through the loss of 188-nt from r.7618 to r.7805 (Figure \u003Ca href=\"#F2\">2B\u003C/a>). Consequently, BRCA2 would be truncated with a PTC four codons downstream (p.L2540Gfs\u003Csup>&#x2217;\u003C/sup>4). Last exon nucleotide variant (c.7805G>C) induced the same outcome (&#x0394;16) highlighting the importance of this position conservation (G in nearly 80% in all exons) in exon recognition (\u003Ca href=\"#B42\">Zhang, 1998\u003C/a>). Fragment analysis of variants c.7805G>C, c.7805+1G>A, and c.7805+3A>C also showed &#x223C;14% of transcript &#x0394;16q\u003Csub>100\u003C/sub>, which corresponds with the use of the previously mentioned cryptic 5&#x2032;ss within exon 16 (NNSplice: 0.99; MaxEnt: 8.92), provoking r.7706_7805del (p.K2570Lfs\u003Csup>&#x2217;\u003C/sup>45) (Table \u003Ca href=\"#T3\">3\u003C/a> and Figure \u003Ca href=\"#F2\">2B\u003C/a>). Finally, missense variant c.7802A>G created a new 5&#x2032;ss, which resulted in &#x223C;45% of the aberrant transcript &#x0394;16q\u003Csub>4\u003C/sub> (Figure \u003Ca href=\"#F2\">2C\u003C/a>). The loss of four nucleotides would introduce a PTC into the protein (p.Y2601Wfs\u003Csup>&#x2217;\u003C/sup>46). Thus, our results showed clearly how these eight variants disrupted splicing. Moreover, seven of them (c.7618-2A>T; c.7618-2A>G; c.7618-1G>C; c.7618-1G>A; c.7805G>C; c.7805+1G>A; c.7805+3A>C) generated more than &#x223C;92% of frameshift transcripts.\u003C/p>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">FIGURE 2\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g002.jpg\" name=\"figure2\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g002.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g002.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g002.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g002.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g002.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g002.jpg\" alt=\"www.frontiersin.org\" id=\"F2\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>FIGURE 2.\u003C/strong> Fluorescent capillary electrophoresis of transcripts from \u003Ci>BRCA2\u003C/i> exon 16 variants. On the left, screenshots of electropherograms are shown. cDNA was amplified with primers FAM-labeled pMAD_607FW and RTBR2_ex17RV2. Arrows indicate transcripts (blue peaks). Full-length transcript: 1018 nt. Size standard was Genescan LIZ 1200 (orange/faint peaks). Fragments were analyzed with the Peak Scanner software v1.0. Fragment sizes (bp) and relative fluorescent units are indicated on the \u003Ci>x\u003C/i>- and \u003Ci>y\u003C/i>-axes, respectively. On the right, diagrams of the splicing patterns are shown. Boxes represent exons, discontinued black lines represent canonical splicing, and discontinue red lines represent aberrant splicing. \u003Cb>(A)\u003C/b> Acceptor site variants. \u003Cb>(B)\u003C/b> Donor site variants. \u003Cb>(C)\u003C/b> Alternative donor variant.\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine mb15\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">TABLE 3\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t003.jpg\" name=\"table3\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t003.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t003.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t003.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t003.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t003.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t003.jpg\" alt=\"www.frontiersin.org\" id=\"T3\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>TABLE 3.\u003C/strong> Quantification of transcripts of spliceogenic variants of exon 16 by fluorescent capillary electrophoresis.\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Ca id=\"h5\" name=\"h5\">\u003C/a>\u003Ch2>Discussion\u003C/h2>\r\n\u003Cp class=\"mb15\">Nowadays, with the advent of new generation sequencing technologies and, namely, cancer-gene panels (\u003Ca href=\"#B34\">Slavin et al., 2015\u003C/a>), thousands of variants are being described. However, their classifications as neutral or deleterious variants pose a challenge in Human Genetics. In fact, some deleterious variants can be missed because they are synonymous or intronic. Moreover, a significant fraction of \u003Ci>BRCA2\u003C/i> variants are considered VUS and require additional proofs to be reclassified, including functional tests. Here, we have shown that the minigene MGBR2_14-20 is a robust tool to functionally assay candidate spliceogenic variants of the \u003Ci>BRCA2\u003C/i> exon 16. Until now, we have comprehensively studied candidate splicing variants from 20 out of 27 \u003Ci>BRCA2\u003C/i> exons (\u003Ca href=\"#B32\">Sanz et al., 2010\u003C/a>; \u003Ca href=\"#B2\">Acedo et al., 2012\u003C/a>, \u003Ca href=\"#B1\">2015\u003C/a>; \u003Ca href=\"#B15\">Fraile-Bethencourt et al., 2017\u003C/a>). Thus, we have found six intronic and two missense \u003Ci>BRCA2\u003C/i> variants which alter the splicing and could confer cancer risk.\u003C/p>\r\n\u003Cp class=\"mb15\">\u003Ci>BRCA2\u003C/i> exon 16 codifies from Leucine 2540 to Arginine 2602 (p.2540_2602). Interestingly, according to the International Agency for Research on Cancer (IARC\u003Csup id=\"footnotesuper6\">\u003Ca id=\"note6a\">\u003C/a>\u003Ca class=\"footnoteanchor\" href=\"#note6\">6\u003C/a>\u003C/sup>), this is a conserved region, since there is &#x223C;22% of ultra-conserved aminoacids from human to sea urchin and &#x223C;54% between mammals. Furthermore, this protein segment belongs to FANCD2- and DSS1-binding domains. Fanconi Anemia group D2 (FANCD2) protein binds to aminoacids from position p.2350 to p.2545 of BRCA2 and it has been suggested to have a role in the repair process (\u003Ca href=\"#B17\">Hussain et al., 2004\u003C/a>). DSS1 (Delete in Split hand/Split foot) protein, which binds to BRCA2 at positions p.2467_2957 (\u003Ca href=\"#B23\">Marston et al., 1999\u003C/a>), is an essential element of BRCA2 stability, since its loss supposes a dramatic decrease of BRCA2 levels (\u003Ca href=\"#B21\">Li et al., 2006\u003C/a>). Altogether, this highlights the value of exon 16 in BRCA2 function. Moreover, exon 16 skipping supposes a frame-shift deletion and the generation of a PTC (p.L2540Gfs\u003Csup>&#x2217;\u003C/sup>4), which would truncate the protein and subsequently loss the C-terminal region that would compromise BRCA2 function.\u003C/p>\r\n\u003Cp class=\"mb15\">This study, based on minigene technology, provides detailed information about the impact on splicing of 12 \u003Ci>BRCA2\u003C/i> exon 16 variants. Aberrant splicing outcomes were found in eight of these variants, six intronic and two missense changes. Intriguingly, none of the aberrant transcripts described here was previously reported as natural alternative splicing events of the \u003Ci>BRCA2\u003C/i> gene (\u003Ca href=\"#B12\">Fackenthal et al., 2016\u003C/a>). Among them, seven (c.7618-2A>T, c.7618-2A>G, c.7618-1G>A, c.7618-1G>C, c.7805G>C, c.7805+1G>A, and c.7805+3A>C) provoked more than &#x223C;92% of frameshift transcripts. Interestingly, previous studies of variant c.7618-1G>A in lymphoblastoid cells showed that 3&#x2032;ss disruption induced transcripts &#x0394;16p\u003Csub>44\u003C/sub> and &#x0394;16,17p\u003Csub>69\u003C/sub> (\u003Ca href=\"#B39\">Whiley et al., 2011\u003C/a>). Here we found both transcripts, but also other minor ones: &#x0394;16p\u003Csub>55\u003C/sub>, &#x0394;16p\u003Csub>93\u003C/sub>, &#x0394;16 (Table \u003Ca href=\"#T3\">3\u003C/a>). Additionally, according to our data &#x0394;16p\u003Csub>44\u003C/sub> is the main transcript (&#x223C;91%) that other authors also identified but described as a minor transcript in agarose gels (\u003Ca href=\"#B39\">Whiley et al., 2011\u003C/a>). These differences could be due to: (i) the cell line; (ii) the use of cycloheximide to inhibit the NMD; (iii) the fact that we work with a single-mutant allele, avoiding the wt counterpart effect; and (iv) the high sensitivity of fluorescent capillary electrophoresis, which can detect rare transcripts versus agarose electrophoresis. In any case, both results show that c.7618-1G>A severely disrupted splicing. On the other hand, variant c.7805G>C was previously reported to result in &#x0394;16 and &#x0394;16q\u003Csub>100\u003C/sub>, with the total absence of the canonical transcript (\u003Ca href=\"#B5\">Bonnet et al., 2008\u003C/a>). This outcome matches our results (Table \u003Ca href=\"#T3\">3\u003C/a>): &#x0394;16 as the main transcript (&#x223C;78%), followed by &#x0394;16q\u003Csub>100\u003C/sub> (&#x223C;14%), and the lack of the full-length transcript. It is also worthy to mention that we detected other minor transcripts due to the high sensitivity of fluorescent capillary electrophoresis (&#x25BE;16q\u003Csup>20\u003C/sup> at &#x223C;6.5% and &#x0394;16,17p\u003Csub>69\u003C/sub> at &#x223C;1.5%) that otherwise could not be easily detected on agarose gels. In any case, the spliceogenic effects of variants c.7618-1G>A and c.7805G>C were supported by our data.\u003C/p>\r\n\u003Cp class=\"mb15\">Variant c.7802A>G probably generated the most conflicting result since it triggered &#x223C;54% of canonical transcript and &#x223C;46% of &#x0394;16q\u003Csub>4\u003C/sub>, so that its interpretation is more complex. The transcript &#x0394;16q\u003Csub>4\u003C/sub>, caused by the use of a new 5&#x2032;ss, generated a frameshift deletion and the protein truncation by a PTC 46 codons downstream (p.Y2601Wfs\u003Csup>&#x2217;\u003C/sup>46). However, it is still unclear if &#x223C;54% of full-length transcript can preserve BRCA2 function, given that, for example, 20&#x2013;30% of \u003Ci>BRCA1\u003C/i> transcript is able to maintain BRCA1 activity (\u003Ca href=\"#B8\">de la Hoya et al., 2016\u003C/a>). It is also important to keep in mind that full-length transcript carries a missense variant (p.Y2601W) that, according to IARC alignment\u003Csup id=\"footnotesuper7\">\u003Ca id=\"note7a\">\u003C/a>\u003Ca class=\"footnoteanchor\" href=\"#note7\">7\u003C/a>\u003C/sup>, Tyrosine 2601 is highly conserved from human to sea urchin, suggesting an important function in the protein. Moreover, PolyPhen-2 (\u003Ca href=\"#B3\">Adzhubei et al., 2010\u003C/a>) predicted that this aminoacid change is damaging with the maximum score (1.0). Curiously, c.7802A>G was reported a family with a significant history of primary cancers (colorectal, lymphoma, and breast cancers) which carried biallelic \u003Ci>BRCA2\u003C/i> mutations (c.7802A>G and c.1845_1856delCT). However, patients did not present the typical FA phenotype, which suggested that p.Y2601W BRCA2 maintained at least enough BRCA2 activity to prevent early childhood FA features (\u003Ca href=\"#B9\">Degrolard-Courcet et al., 2014\u003C/a>). Nevertheless, this missense change remains classified as VUS in ClinVar\u003Csup id=\"footnotesuper8\">\u003Ca id=\"note8a\">\u003C/a>\u003Ca class=\"footnoteanchor\" href=\"#note8\">8\u003C/a>\u003C/sup>.\u003C/p>\r\n\u003Cp class=\"mb15\">On the other hand, variant c.7625C>G was previously computed to disrupt one SRp55 motif (\u003Ca href=\"#B27\">Pettigrew et al., 2008\u003C/a>), although functional mapping by microdeletions indicated that exon 16 is likely not regulated by splicing enhancers. Nevertheless, this change was selected because it presumably created new strong 3&#x2032; and 5&#x2032;ss as well, both with a NNSplice score >0.9 (Table \u003Ca href=\"#T2\">2\u003C/a>). However, c.7625C>G only produced the full-length transcript without any splicing anomaly. The protein would even carry the missense variant p.T2542R. However, consistent with PolyPhen, this change might be considered as benign with a score of 0.0, which could be explained by the low conservation of the affected threonine. Anyway, further functional and association studies must be performed to interpret this variant. Other variant that resulted in a normal splicing pattern was the nonsense variant c.7738C>T (p.Q2580X), that \u003Ci>a priori\u003C/i> had been classified as pathogenic. In this case, the protein would be truncated at codon 2580 losing 839 aminoacids of the C-terminal where the DSS1-binding site, the DNA-binding domain, the RAD51C-binding site, and the cyclin-dependent kinase (CDK) phosphorylation site are located (\u003Ca href=\"#B31\">Roy et al., 2012\u003C/a>). Interestingly, this variant was found in an Italian non-Ashkenazi \u003Ci>BRCA1\u003C/i> and \u003Ci>BRCA2\u003C/i> double heterozygote family (\u003Ca href=\"#B24\">Musolino et al., 2005\u003C/a>).\u003C/p>\r\n\u003Cp class=\"mb0\">According to the ACMG guidelines (Table \u003Ca href=\"#T4\">4\u003C/a>; \u003Ca href=\"#B29\">Richards et al., 2015\u003C/a>), five variants (c.7618-2A>T, c.7618-2A>G, c.7618-1G>A, c.7618-1G>C, and c.7805+1G>A) can be classified as pathogenic as they match criteria PVS1 (very strong evidence of pathogenicity: null variant &#x2013; nonsense, frameshift, canonical &#x00B1;1 or 2 ss, initiation codon, single or multiexon deletion &#x2013; in a gene where LOF is a known mechanism of disease), PS3 (strong evidence: well-established \u003Ci>in vitro\u003C/i> or \u003Ci>in vivo\u003C/i> functional studies supportive of a damaging effect on the gene or gene product), PM2 (moderate evidence: absent from controls in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium), PP3 (supporting evidence: multiple lines of computational evidence support a deleterious effect on the gene or gene product: conservation, evolutionary, splicing impact, etc.), and PP5 (reputable source recently reports variant as pathogenic, but the evidence is not available to the laboratory to perform an independent evaluation). On the other hand, variants c.7802A>G, c.7805G>C, and c.7805+3A>C were classified as likely pathogenic as they match criteria PS3, PM2, PP3, and PP5.\u003C/p>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">TABLE 4\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t004.jpg\" name=\"table4\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t004.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t004.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t004.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t004.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t004.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-t004.jpg\" alt=\"www.frontiersin.org\" id=\"T4\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>TABLE 4.\u003C/strong> Classification of variants according to the ENIGMA and ACMG rules.\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cp class=\"mb15 w100pc float_left mt15\">Similarly, following the ENIGMA rules for variant classification\u003Csup id=\"footnotesuper9\">\u003Ca id=\"note9a\">\u003C/a>\u003Ca class=\"footnoteanchor\" href=\"#note9\">9\u003C/a>\u003C/sup>, all variants, except for c.7802A>G, should be reclassified as class 4 (likely pathogenic) because they are &#x201C;considered extremely likely to alter splicing based on position&#x201D; and are &#x201C;predicted bioinformatically to alter the use of the native donor/acceptor site.&#x201D; Conversely, minigenes are not considered robust approaches to functionally test these variants yet (&#x201C;&#x2026; results from construct-based mRNA assays alone are not considered sufficiently robust to be used as evidence for variant classification &#x2026;&#x201D;). However, this specific minigene with \u003Ci>BRCA2\u003C/i> exons 14&#x2013;20 was confirmed as a robust tool since it reproduced patient RNA results from eight variants (\u003Ca href=\"#B15\">Fraile-Bethencourt et al., 2017\u003C/a>), and also c.7618-1G>A and c.7805G>C of this study, so that these seven class 4 variants could be even reclassified as class 5. Finally, c.7802A>G was classified as class 3 because it did not meet the above standards and induce a partial aberrant outcome with more than 50% of the canonical transcript.\u003C/p>\r\n\u003Cp class=\"mb0\">In summary, we detected eight spliceogenic \u003Ci>BRCA2\u003C/i> exon 16 variants that should be classified as pathogenic or likely pathogenic according to the ACMG guidelines (Table \u003Ca href=\"#T4\">4\u003C/a>). Moreover, they account for 22% of causal variants of exon 16 and 11% of all recorded variants of this exon at the mutation databases. Taken together this and our previous studies, we have tested 283 \u003Ci>BRCA1/2\u003C/i> variants under the splicing perspective, 154 of which induced anomalous patterns and 111 could be classified as pathogenic or likely pathogenic. These data remark the importance of variants of splicing regulatory sequences, which are often underestimated because most of them are placed in non-coding regions of the protein. Until now, genetic family-based studies have set up the impact of some variants on cancer risk. However, because of the exponential increment in the number of variants, their low frequencies and different nature, functional assays are strictly required. In this context, minigene technology constitutes a robust tool which can be used to functionally test spliceogenic candidate variants of any disease-gene without the interference of the counterpart wt allele. Certainly, pSAD-based minigenes represented valuable tools to functionally check variants of the SERPINA1 (severe alpha-1 antitrypsin deficiency) and CHD7 (Charge Syndrome) genes (\u003Ca href=\"#B19\">Lara et al., 2014\u003C/a>; \u003Ca href=\"#B36\">Villate et al., 2018\u003C/a>). RNA assays provide essential data for the initial characterization of VUS and improve the genetic counseling of hereditary diseases.\u003C/p>\r\n\u003Ca id=\"h6\" name=\"h6\">\u003C/a>\u003Ch2>Author Contributions\u003C/h2>\r\n\u003Cp class=\"mb0\">EF-B contributed to the bioinformatics analysis, minigene construction, manuscript writing, and performed most of the splicing functional assays. BD-G and AV-P participated in minigene construction, mutagenesis experiments, and functional assays. AA participated in minigene construction and functional mapping experiments. EV conceived the study and the experimental design, supervised all the experiments, and wrote the manuscript. All authors contributed to data interpretation, revisions of the manuscript, and approved the final version of the manuscript.\u003C/p>\r\n\u003Ca id=\"h7\" name=\"h7\">\u003C/a>\u003Ch2>Funding\u003C/h2>\r\n\u003Cp class=\"mb0\">EV&#x2019;s lab was supported by grants from the Spanish Ministry of Economy and Competitivity, Plan Nacional de I+D+I 2013&#x2013;2016, ISCIII (Grants: PI13/01749 and PI17/00227) co-funded by FEDER from European Regional Development Funds (European Union), and grant CSI090U14 from the Consejer&#x00ED;a de Educaci&#x00F3;n (ORDEN EDU/122/2014) and Junta de Castilla y Le&#x00F3;n. EF-B was supported by a predoctoral fellowship from the University of Valladolid and Banco Santander (2015&#x2013;2019).\u003C/p>\r\n\u003Ca id=\"h8\" name=\"h8\">\u003C/a>\u003Ch2>Conflict of Interest Statement\u003C/h2>\r\n\u003Cp class=\"mb0\">The authors declare that theresearch was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.\u003C/p>\r\n\u003Ca id=\"h9\" name=\"h9\">\u003C/a>\u003Ch2>Acknowledgments\u003C/h2>\r\n\u003Cp class=\"mb0\">We acknowledge the support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI).\u003C/p>\r\n\u003Ca id=\"h10\" name=\"h10\">\u003C/a>\u003Ch2>Supplementary Material\u003C/h2>\r\n\u003Cp class=\"mb0\">The Supplementary Material for this article can be found online at: \u003Ca href=\"https://www.frontiersin.org/articles/10.3389/fgene.2018.00188/full#supplementary-material\">https://www.frontiersin.org/articles/10.3389/fgene.2018.00188/full#supplementary-material\u003C/a>\u003C/p>\r\n\u003Ca id=\"h11\" name=\"h11\">\u003C/a>\u003Ch2>Footnotes\u003C/h2>\r\n\u003Col>\r\n\u003Cli id=\"note1\">\u003Cstrong>\u003Ca style=\"color:gray;\" class=\"footnotetextanchor\" href=\"#note1a\" title=\"\">^\u003C/a>\u003C/strong> \u003Ca style=\"color:gray;\" href=\"https://enigmaconsortium.org/library/general-documents/enigma-classification-criteria/\">https://enigmaconsortium.org/library/general-documents/enigma-classification-criteria/\u003C/a>\u003C/li>\r\n\u003Cli id=\"note2\">\u003Cstrong>\u003Ca style=\"color:gray;\" class=\"footnotetextanchor\" href=\"#note2a\" title=\"\">^\u003C/a>\u003C/strong>\u003Ca style=\"color:gray;\" href=\"https://research.nhgri.nih.gov/projects/bic/Member/index.shtml\">https://research.nhgri.nih.gov/projects/bic/Member/index.shtml\u003C/a>\u003C/li>\r\n\u003Cli id=\"note3\">\u003Cstrong>\u003Ca style=\"color:gray;\" class=\"footnotetextanchor\" href=\"#note3a\" title=\"\">^\u003C/a>\u003C/strong>\u003Ca style=\"color:gray;\" href=\"http://www.hgvs.org/mutnomen/\">http://www.hgvs.org/mutnomen/\u003C/a>\u003C/li>\r\n\u003Cli id=\"note4\">\u003Cstrong>\u003Ca style=\"color:gray;\" class=\"footnotetextanchor\" href=\"#note4a\" title=\"\">^\u003C/a>\u003C/strong>\u003Ca style=\"color:gray;\" href=\"http://www.fruitfly.org/seq_tools/splice.html\">http://www.fruitfly.org/seq_tools/splice.html\u003C/a>\u003C/li>\r\n\u003Cli id=\"note5\">\u003Cstrong>\u003Ca style=\"color:gray;\" class=\"footnotetextanchor\" href=\"#note5a\" title=\"\">^\u003C/a>\u003C/strong>\u003Ca style=\"color:gray;\" href=\"http://www.umd.be/HSF3/\">http://www.umd.be/HSF3/\u003C/a>\u003C/li>\r\n\u003Cli id=\"note6\">\u003Cstrong>\u003Ca style=\"color:gray;\" class=\"footnotetextanchor\" href=\"#note6a\" title=\"\">^\u003C/a>\u003C/strong>\u003Ca style=\"color:gray;\" href=\"http://agvgd.hci.utah.edu/BRCA2_Spur.html\">http://agvgd.hci.utah.edu/BRCA2_Spur.html\u003C/a>\u003C/li>\r\n\u003Cli id=\"note7\">\u003Cstrong>\u003Ca style=\"color:gray;\" class=\"footnotetextanchor\" href=\"#note7a\" title=\"\">^\u003C/a>\u003C/strong>\u003Ca style=\"color:gray;\" href=\"http://agvgd.hci.utah.edu/BRCA2_Spur.html\">http://agvgd.hci.utah.edu/BRCA2_Spur.html\u003C/a>\u003C/li>\r\n\u003Cli id=\"note8\">\u003Cstrong>\u003Ca style=\"color:gray;\" class=\"footnotetextanchor\" href=\"#note8a\" title=\"\">^\u003C/a>\u003C/strong>\u003Ca style=\"color:gray;\" href=\"https://www.ncbi.nlm.nih.gov/clinvar/variation/185651/#clinical-assertions\">https://www.ncbi.nlm.nih.gov/clinvar/variation/185651/#clinical-assertions\u003C/a>\u003C/li>\r\n\u003Cli id=\"note9\">\u003Cstrong>\u003Ca style=\"color:gray;\" class=\"footnotetextanchor\" href=\"#note9a\" title=\"\">^\u003C/a>\u003C/strong>\u003Ca style=\"color:gray;\" href=\"https://enigmaconsortium.org/library/general-documents/enigma-classification-criteria/\">https://enigmaconsortium.org/library/general-documents/enigma-classification-criteria/\u003C/a>\u003C/li>\r\n\u003C/ol>\r\n\u003Ca id=\"h12\" name=\"h12\">\u003C/a>\u003Ch2>References\u003C/h2>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B1\" id=\"B1\">\u003C/a>Acedo, A., Hern&#x00E1;ndez-Moro, C., Curiel-Garc&#x00ED;a,&#x00C1;, D&#x00ED;ez-G&#x00F3;mez, B., and Velasco, E. A. (2015). Functional classification of \u003Ci>BRCA2\u003C/i> DNA variants by splicing assays in a large minigene with 9 exons. \u003Ci>Hum. Mutat.\u003C/i> 36, 210&#x2013;221. doi: 10.1002/humu.22725\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=25382762\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1002/humu.22725\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Functional+classification+of+BRCA2+DNA+variants+by+splicing+assays+in+a+large+minigene+with+9+exons%2E&#x0026;journal=Hum%2E+Mutat%2E&#x0026;author=Acedo+A.&#x0026;author=Hern&#x00E1;ndez-Moro+C.+Curiel-Garc&#x00ED;a&#x0026;author=&#x00C1;+D&#x00ED;ez-G&#x00F3;mez+B.&#x0026;author=and+Velasco+E.+A.&#x0026;publication_year=2015&#x0026;volume=36&#x0026;pages=210-221\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B2\" id=\"B2\">\u003C/a>Acedo, A., Sanz, D. J., Dur&#x00E1;n, M., Infante, M., P&#x00E9;rez-Cabornero, L., Miner, C., et al. (2012). Comprehensive splicing functional analysis of DNA variants of the \u003Ci>BRCA2\u003C/i> gene by hybrid minigenes. \u003Ci>Breast Cancer Res.\u003C/i> 14:R87. doi: 10.1186/bcr3202\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=22632462\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1186/bcr3202\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Comprehensive+splicing+functional+analysis+of+DNA+variants+of+the+BRCA2+gene+by+hybrid+minigenes%2E&#x0026;journal=Breast+Cancer+Res%2E&#x0026;author=Acedo+A.&#x0026;author=Sanz+D.+J.&#x0026;author=Dur&#x00E1;n+M.&#x0026;author=Infante+M.&#x0026;author=P&#x00E9;rez-Cabornero+L.&#x0026;author=Miner+C.&#x0026;publication_year=2012\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B3\" id=\"B3\">\u003C/a>Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., et al. (2010). A method and server for predicting damaging missense mutations. \u003Ci>Nat. Methods\u003C/i> 7, 248&#x2013;249. doi: 10.1038/nmeth0410-248\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=20354512\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/nmeth0410-248\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=A+method+and+server+for+predicting+damaging+missense+mutations%2E&#x0026;journal=Nat%2E+Methods&#x0026;author=Adzhubei+I.+A.&#x0026;author=Schmidt+S.&#x0026;author=Peshkin+L.&#x0026;author=Ramensky+V.+E.&#x0026;author=Gerasimova+A.&#x0026;author=Bork+P.&#x0026;publication_year=2010&#x0026;volume=7&#x0026;pages=248-249\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B4\" id=\"B4\">\u003C/a>Beroud, C., Letovsky, S. I., Braastad, C. D., Caputo, S. M., Beaudoux, O., Bignon, Y. J., et al. (2016). BRCA share: a collection of clinical BRCA gene variants. \u003Ci>Hum. Mutat.\u003C/i> 37, 1318&#x2013;1328. doi: 10.1002/humu.23113\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=27633797\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1002/humu.23113\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=BRCA+share%3A+a+collection+of+clinical+BRCA+gene+variants%2E&#x0026;journal=Hum%2E+Mutat%2E&#x0026;author=Beroud+C.&#x0026;author=Letovsky+S.+I.&#x0026;author=Braastad+C.+D.&#x0026;author=Caputo+S.+M.&#x0026;author=Beaudoux+O.&#x0026;author=Bignon+Y.+J.&#x0026;publication_year=2016&#x0026;volume=37&#x0026;pages=1318-1328\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B5\" id=\"B5\">\u003C/a>Bonnet, C., Krieger, S., Vezain, M., Rousselin, A., Tournier, I., Martins, A., et al. (2008). Screening \u003Ci>BRCA1\u003C/i> and \u003Ci>BRCA2\u003C/i> unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene. \u003Ci>J. Med. Genet.\u003C/i> 45, 438&#x2013;446. doi: 10.1136/jmg.2007.056895\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=18424508\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1136/jmg.2007.056895\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Screening+BRCA1+and+BRCA2+unclassified+variants+for+splicing+mutations+using+reverse+transcription+PCR+on+patient+RNA+and+an+ex+vivo+assay+based+on+a+splicing+reporter+minigene%2E&#x0026;journal=J%2E+Med%2E+Genet%2E&#x0026;author=Bonnet+C.&#x0026;author=Krieger+S.&#x0026;author=Vezain+M.&#x0026;author=Rousselin+A.&#x0026;author=Tournier+I.&#x0026;author=Martins+A.&#x0026;publication_year=2008&#x0026;volume=45&#x0026;pages=438-446\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B6\" id=\"B6\">\u003C/a>Cartegni, L., Wang, J., Zhu, Z., Zhang, M. Q., and Krainer, A. R. (2003). ESEfinder: A web resource to identify exonic splicing enhancers. \u003Ci>Nucleic Acids Res.\u003C/i> 31, 3568&#x2013;3571. doi: 10.1093/nar/gkg616\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=12824367\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/nar/gkg616\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=ESEfinder%3A+A+web+resource+to+identify+exonic+splicing+enhancers%2E&#x0026;journal=Nucleic+Acids+Res%2E&#x0026;author=Cartegni+L.&#x0026;author=Wang+J.&#x0026;author=Zhu+Z.&#x0026;author=Zhang+M.+Q.&#x0026;author=and+Krainer+A.+R.&#x0026;publication_year=2003&#x0026;volume=31&#x0026;pages=3568-3571\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B7\" id=\"B7\">\u003C/a>Colombo, M., Blok, M. J., Whiley, P., Santamari&#x00F1;a, M., Guti&#x00E9;rrez-Enr&#x00ED;quez, S., Romero, A., et al. (2014). Comprehensive annotation of splice junctions supports pervasive alternative splicing at the \u003Ci>BRCA1\u003C/i> locus: a report from the ENIGMA consortium. \u003Ci>Hum. Mol. Genet.\u003C/i> 23, 3666&#x2013;3680. doi: 10.1093/hmg/ddu075\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=24569164\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/hmg/ddu075\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Comprehensive+annotation+of+splice+junctions+supports+pervasive+alternative+splicing+at+the+BRCA1+locus%3A+a+report+from+the+ENIGMA+consortium%2E&#x0026;journal=Hum%2E++Mol%2E+Genet%2E&#x0026;author=Colombo+M.&#x0026;author=Blok+M.++J.&#x0026;author=Whiley+P.&#x0026;author=Santamari&#x00F1;a+M.&#x0026;author=Guti&#x00E9;rrez-Enr&#x00ED;quez+S.&#x0026;author=Romero+A.&#x0026;publication_year=2014&#x0026;volume=23&#x0026;pages=3666-3680\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B8\" id=\"B8\">\u003C/a>de la Hoya, M., Soukarieh, O., L&#x00F3;pez-Perolio, I., Vega, A., Walker, L. C., van Ierland, Y., et al. (2016). Combined genetic and splicing analysis of \u003Ci>BRCA1\u003C/i> c.[594-2A > C; 641A > G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms. \u003Ci>Hum. Mol. Genet.\u003C/i> 25, 2256&#x2013;2268. doi: 10.1093/hmg/ddw094\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=27008870\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/hmg/ddw094\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Combined+genetic+and+splicing+analysis+of+BRCA1+c%2E%5B594-2A+>+C;+641A+>+G%5D+highlights+the+relevance+of+naturally+occurring+in-frame+transcripts+for+developing+disease+gene+variant+classification+algorithms%2E&#x0026;journal=Hum%2E+Mol%2E+Genet%2E&#x0026;author=de+la+Hoya+M.&#x0026;author=Soukarieh+O.&#x0026;author=L&#x00F3;pez-Perolio+I.&#x0026;author=Vega+A.&#x0026;author=Walker+L.++C.&#x0026;author=van+Ierland+Y.&#x0026;publication_year=2016&#x0026;volume=25&#x0026;pages=2256-2268\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B9\" id=\"B9\">\u003C/a>Degrolard-Courcet, E., Sokolowska, J., Padeano, M. M., Guiu, S., Bronner, M., Chery, C., et al. (2014). Development of primary early-onset colorectal cancers due to biallelic mutations of the FANCD1/\u003Ci>BRCA2\u003C/i> gene. \u003Ci>Eur. J. Hum. Genet.\u003C/i> 22, 979&#x2013;987. doi: 10.1038/ejhg.2013.278\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=24301060\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/ejhg.2013.278\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Development+of+primary+early-onset+colorectal++cancers+due+to+biallelic+mutations+of+the+FANCD1%2FBRCA2+gene%2E&#x0026;journal=Eur%2E+J%2E+Hum%2E++Genet%2E&#x0026;author=Degrolard-Courcet+E.&#x0026;author=Sokolowska+J.&#x0026;author=Padeano+M.+M.&#x0026;author=Guiu+S.&#x0026;author=Bronner+M.&#x0026;author=Chery+C.&#x0026;publication_year=2014&#x0026;volume=22&#x0026;pages=979-987\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B10\" id=\"B10\">\u003C/a>Desmet, F.-O., Hamroun, D., Lalande, M., Collod-B&#x00E9;roud, G., Claustres, M., and B&#x00E9;roud, C. (2009). Human Splicing Finder: an online bioinformatics tool to predict splicing signals. \u003Ci>Nucleic Acids Res.\u003C/i> 37:e67. doi: 10.1093/nar/gkp215\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=19339519\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/nar/gkp215\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Human+Splicing+Finder%3A+an+online+bioinformatics+tool+to+predict+splicing+signals%2E&#x0026;journal=Nucleic+Acids+Res%2E&#x0026;author=Desmet+F.-O.&#x0026;author=Hamroun+D.&#x0026;author=Lalande+M.&#x0026;author=Collod-B&#x00E9;roud+G.&#x0026;author=Claustres+M.&#x0026;author=and+B&#x00E9;roud+C.&#x0026;publication_year=2009\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B11\" id=\"B11\">\u003C/a>Douglas, A. G., and Wood, M. J. (2011). RNA splicing: disease and therapy. \u003Ci>Brief Funct. Genomics\u003C/i> 10, 151&#x2013;164. doi: 10.1093/bfgp/elr020\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=21628314\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/bfgp/elr020\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=RNA+splicing%3A+disease+and+therapy%2E&#x0026;journal=Brief+Funct%2E+Genomics&#x0026;author=Douglas+A.+G.&#x0026;author=and+Wood+M.+J.&#x0026;publication_year=2011&#x0026;volume=10&#x0026;pages=151-164\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B12\" id=\"B12\">\u003C/a>Fackenthal, J. D., Yoshimatsu, T., Zhang, B., de Garibay, G. R., Colombo, M., De Vecchi, G., et al. (2016). Naturally occurring \u003Ci>BRCA2\u003C/i> alternative mRNA splicing events in clinically relevant samples. \u003Ci>J. Med. Genet.\u003C/i> 53, 548&#x2013;558. doi: 10.1136/jmedgenet-2015-103570\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=27060066\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1136/jmedgenet-2015-103570\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Naturally+occurring+BRCA2+alternative+mRNA+splicing+events+in+clinically+relevant+samples%2E&#x0026;journal=J%2E+Med%2E+Genet%2E&#x0026;author=Fackenthal+J.+D.&#x0026;author=Yoshimatsu+T.&#x0026;author=Zhang+B.&#x0026;author=de+Garibay+G.+R.&#x0026;author=Colombo+M.&#x0026;author=De+Vecchi+G.&#x0026;publication_year=2016&#x0026;volume=53&#x0026;pages=548-558\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B13\" id=\"B13\">\u003C/a>Fairbrother, W. G., Holste, D., Burge, C. B., and Sharp, P. A. (2004). Single nucleotide polymorphism-based validation of exonic splicing enhancers. \u003Ci>PLoS Biol.\u003C/i> 2:E268. doi: 10.1371/journal.pbio.0020268\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=15340491\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1371/journal.pbio.0020268\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Single+nucleotide+polymorphism-based+validation+of+exonic+splicing+enhancers%2E&#x0026;journal=PLoS+Biol%2E&#x0026;author=Fairbrother+W.+G.&#x0026;author=Holste+D.&#x0026;author=Burge+C.+B.&#x0026;author=and+Sharp+P.+A.&#x0026;publication_year=2004\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B14\" id=\"B14\">\u003C/a>Fairbrother, W. G., Yeh, R.-F., Sharp, P. A., and Burge, C. B. (2002). Predictive identification of exonic splicing enhancers in human genes. \u003Ci>Science\u003C/i> 297, 1007&#x2013;1013. doi: 10.1126/science.1073774\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=12114529\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1126/science.1073774\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Predictive+identification+of+exonic+splicing+enhancers+in+human+genes%2E&#x0026;journal=Science&#x0026;author=Fairbrother+W.++G.&#x0026;author=Yeh+R.-F.&#x0026;author=Sharp+P.++A.&#x0026;author=and+Burge+C.++B.&#x0026;publication_year=2002&#x0026;volume=297&#x0026;pages=1007-1013\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B15\" id=\"B15\">\u003C/a>Fraile-Bethencourt, E., D&#x00ED;ez-G&#x00F3;mez, B., Vel&#x00E1;squez-Zapata, V., Acedo, A., Sanz, D. J., and Velasco, E. A. (2017). Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of \u003Ci>BRCA2\u003C/i> exons 17 and 18. \u003Ci>PLoS Genet.\u003C/i> 13:e1006691. doi: 10.1371/journal.pgen.1006691\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=28339459\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1371/journal.pgen.1006691\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Functional+classification+of+DNA+variants+by+hybrid+minigenes%3A+Identification+of+30+spliceogenic+variants+of+BRCA2+exons+17+and+18%2E&#x0026;journal=PLoS+Genet%2E&#x0026;author=Fraile-Bethencourt+E.&#x0026;author=D&#x00ED;ez-G&#x00F3;mez+B.&#x0026;author=Vel&#x00E1;squez-Zapata+V.&#x0026;author=Acedo+A.&#x0026;author=Sanz+D.++J.&#x0026;author=and+Velasco+E.++A.&#x0026;publication_year=2017\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B16\" id=\"B16\">\u003C/a>Grodeck&#x00E1;, L., Buratti, E., and Freiberger, T. (2017). Mutations of pre-mRNA splicing regulatory elements: Are predictions moving forward to clinical diagnostics? \u003Ci>Int. J. Mol. Sci.\u003C/i> 18:E1668. doi: 10.3390/ijms18081668\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=28758972\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3390/ijms18081668\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Mutations+of+pre-mRNA+splicing+regulatory+elements%3A+Are+predictions+moving+forward+to+clinical+diagnostics%B4&#x0026;journal=Int%2E+J%2E+Mol%2E+Sci%2E&#x0026;author=Grodeck&#x00E1;+L.&#x0026;author=Buratti+E.&#x0026;author=and+Freiberger+T.&#x0026;publication_year=2017\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B17\" id=\"B17\">\u003C/a>Hussain, S., Wilson, J. B., Medhurst, A. L., Hejna, J., Witt, E., Ananth, S., et al. (2004). Direct interaction of FANCD2 with \u003Ci>BRCA2\u003C/i> in DNA damage response pathways. \u003Ci>Hum. Mol. Genet.\u003C/i> 13, 1241&#x2013;1248. doi: 10.1093/hmg/ddh135\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=15115758\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/hmg/ddh135\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Direct+interaction+of+FANCD2+with+BRCA2+in+DNA+damage+response+pathways%2E&#x0026;journal=Hum%2E++Mol%2E++Genet%2E&#x0026;author=Hussain+S.&#x0026;author=Wilson+J.++B.&#x0026;author=Medhurst+A.++L.&#x0026;author=Hejna+J.&#x0026;author=Witt+E.&#x0026;author=Ananth+S.&#x0026;publication_year=2004&#x0026;volume=13&#x0026;pages=1241-1248\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B18\" id=\"B18\">\u003C/a>Infante, M., Dur&#x00E1;n, M., Acedo, A., S&#x00E1;nchez-Tapia, E. M., D&#x00ED;ez-G&#x00F3;mez, B., Barroso, A., et al. (2013). The highly prevalent \u003Ci>BRCA2\u003C/i> mutation c.2808_2811del (3036delACAA) is located in a mutational hotspot and has multiple origins. \u003Ci>Carcinogenesis\u003C/i> 34, 2505&#x2013;2511. doi: 10.1093/carcin/bgt272\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=23929434\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/carcin/bgt272\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=The+highly+prevalent+BRCA2+mutation++c%2E2808%5F2811del+%283036delACAA%29+is+located+in+a+mutational+hotspot+and+has+multiple+origins%2E&#x0026;journal=Carcinogenesis&#x0026;author=Infante+M.&#x0026;author=Dur&#x00E1;n+M.&#x0026;author=Acedo+A.&#x0026;author=S&#x00E1;nchez-Tapia+E.+M.&#x0026;author=D&#x00ED;ez-G&#x00F3;mez+B.&#x0026;author=Barroso+A.&#x0026;publication_year=2013&#x0026;volume=34&#x0026;pages=2505-2511\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B19\" id=\"B19\">\u003C/a>Lara, B., Mart&#x00ED;nez, M. T., Blanco, I., Hern&#x00E1;ndez-Moro, C., Velasco, E. A., Ferrarotti, I., et al. (2014). Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid. \u003Ci>Respir. Res.\u003C/i> 15:125. doi: 10.1186/s12931-014-0125-y\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=25287719\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1186/s12931-014-0125-y\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Severe+alpha-1+antitrypsin+deficiency+in+composite+heterozygotes+inheriting+a+new+splicing+mutation+QOMadrid%2E&#x0026;journal=Respir%2E++Res%2E&#x0026;author=Lara+B.&#x0026;author=Mart&#x00ED;nez+M.+T.&#x0026;author=Blanco+I.&#x0026;author=Hern&#x00E1;ndez-Moro+C.&#x0026;author=Velasco+E.+A.&#x0026;author=Ferrarotti+I.&#x0026;publication_year=2014\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B20\" id=\"B20\">\u003C/a>Levy-Lahad, E., Catane, R., Eisenberg, S., Kaufman, B., Hornreich, G., Lishinsky, E., et al. (1997). Founder \u003Ci>BRCA1\u003C/i> and \u003Ci>BRCA2\u003C/i> mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. \u003Ci>Am. J. Hum. Genet.\u003C/i> 60, 1059&#x2013;1067.\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=9150153\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Founder+BRCA1+and+BRCA2+mutations+in+Ashkenazi+Jews+in+Israel%3A+frequency+and+differential+penetrance+in+ovarian+cancer+and+in+breast-ovarian+cancer+families%2E&#x0026;journal=Am%2E++J%2E++Hum%2E++Genet%2E&#x0026;author=Levy-Lahad+E.&#x0026;author=Catane+R.&#x0026;author=Eisenberg+S.&#x0026;author=Kaufman+B.&#x0026;author=Hornreich+G.&#x0026;author=Lishinsky+E.&#x0026;publication_year=1997&#x0026;volume=60&#x0026;pages=1059-1067\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B21\" id=\"B21\">\u003C/a>Li, J., Zou, C., Bai, Y., Wazer, D. E., Band, V., and Gao, Q. (2006). DSS1 is required for the stability of \u003Ci>BRCA2\u003C/i>. \u003Ci>Oncogene\u003C/i> 25, 1186&#x2013;1194. doi: 10.1038/sj.onc.1209153\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=16205630\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/sj.onc.1209153\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=DSS1+is+required+for+the+stability+of+BRCA2%2E&#x0026;journal=Oncogene&#x0026;author=Li+J.&#x0026;author=Zou+C.&#x0026;author=Bai+Y.&#x0026;author=Wazer+D.++E.&#x0026;author=Band+V.&#x0026;author=and+Gao+Q.&#x0026;publication_year=2006&#x0026;volume=25&#x0026;pages=1186-1194\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B22\" id=\"B22\">\u003C/a>L&#x00F3;pez-Bigas, N., Audit, B., Ouzounis, C., Parra, G., and Guig&#x00F3;, R. (2005). Are splicing mutations the most frequent cause of hereditary disease? \u003Ci>FEBS Lett.\u003C/i> 579, 1900&#x2013;1903. doi: 10.1016/j.febslet.2005.02.047\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=15792793\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.febslet.2005.02.047\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Are+splicing+mutations+the+most+frequent+cause+of+hereditary+disease%B4&#x0026;journal=FEBS+Lett%2E&#x0026;author=L&#x00F3;pez-Bigas+N.&#x0026;author=Audit+B.&#x0026;author=Ouzounis+C.&#x0026;author=Parra+G.&#x0026;author=and+Guig&#x00F3;+R.&#x0026;publication_year=2005&#x0026;volume=579&#x0026;pages=1900-1903\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B23\" id=\"B23\">\u003C/a>Marston, N. J., Richards, W. J., Hughes, D., Bertwistle, D., Marshall, C. J., and Ashworth, A. (1999). Interaction between the product of the breast cancer susceptibility gene \u003Ci>BRCA2\u003C/i> and DSS1, a protein functionally conserved from yeast to mammals. \u003Ci>Mol. Cell. Biol.\u003C/i> 19, 4633&#x2013;4642. doi: 10.1128/MCB.19.7.4633\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=10373512\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1128/MCB.19.7.4633\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Interaction+between+the+product+of+the+breast+cancer+susceptibility+gene+BRCA2+and+DSS1%2C+a+protein+functionally+conserved+from+yeast+to+mammals%2E&#x0026;journal=Mol%2E+Cell%2E+Biol%2E&#x0026;author=Marston+N.+J.&#x0026;author=Richards+W.+J.&#x0026;author=Hughes+D.&#x0026;author=Bertwistle+D.&#x0026;author=Marshall+C.+J.&#x0026;author=and+Ashworth+A.&#x0026;publication_year=1999&#x0026;volume=19&#x0026;pages=4633-4642\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B24\" id=\"B24\">\u003C/a>Musolino, A., Naldi, N., Michiara, M., Bella, M. A., Zanelli, P., Bortesi, B., et al. (2005). A breast cancer patient from Italy with germline mutations in both the \u003Ci>BRCA1\u003C/i> and \u003Ci>BRCA2\u003C/i> genes. \u003Ci>Breast Cancer Res. Treat.\u003C/i> 91, 203&#x2013;205. doi: 10.1007/s10549-004-7704-4\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=15868448\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s10549-004-7704-4\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=A+breast+cancer+patient+from+Italy+with+germline+mutations+in+both+the+BRCA1+and+BRCA2+genes%2E&#x0026;journal=Breast+Cancer+Res%2E+Treat%2E&#x0026;author=Musolino+A.&#x0026;author=Naldi+N.&#x0026;author=Michiara+M.&#x0026;author=Bella+M.+A.&#x0026;author=Zanelli+P.&#x0026;author=Bortesi+B.&#x0026;publication_year=2005&#x0026;volume=91&#x0026;pages=203-205\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B25\" id=\"B25\">\u003C/a>Nielsen, F. C., van Overeem Hansen, T., and S&#x00F8;rensen, C. S. (2016). Hereditary breast and ovarian cancer: new genes in confined pathways. \u003Ci>Nat. Rev. Cancer\u003C/i> 16, 599&#x2013;612. doi: 10.1038/nrc.2016.72\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=27515922\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/nrc.2016.72\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Hereditary+breast+and+ovarian+cancer%3A+new+genes+in+confined+pathways%2E&#x0026;journal=Nat%2E++Rev%2E+Cancer&#x0026;author=Nielsen+F.++C.&#x0026;author=van+Overeem+Hansen+T.&#x0026;author=and+S&#x00F8;rensen+C.++S.&#x0026;publication_year=2016&#x0026;volume=16&#x0026;pages=599-612\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B26\" id=\"B26\">\u003C/a>Petrucelli, N., Daly, M. B., and Feldman, G. L. (2013). \u003Ci>BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer.\u003C/i> Seattle, WA: University of Washington.\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=BRCA1+and+BRCA2+Hereditary+Breast+and+Ovarian+Cancer%2E&#x0026;author=Petrucelli+N.&#x0026;author=Daly+M.+B.&#x0026;author=and+Feldman+G.+L.&#x0026;publication_year=2013\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B27\" id=\"B27\">\u003C/a>Pettigrew, C. A., Wayte, N., Wronski, A., Lovelock, P. K., Spurdle, A. B., and Brown, M. A. (2008). Colocalisation of predicted exonic splicing enhancers in \u003Ci>BRCA2\u003C/i> with reported sequence variants. \u003Ci>Breast Cancer Res. Treat.\u003C/i> 110, 227&#x2013;234. doi: 10.1007/s10549-007-9714-5\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=17899372\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s10549-007-9714-5\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Colocalisation+of+predicted+exonic+splicing+enhancers+in+BRCA2+with+reported+sequence+variants%2E&#x0026;journal=Breast+Cancer+Res%2E+Treat%2E&#x0026;author=Pettigrew+C.+A.&#x0026;author=Wayte+N.&#x0026;author=Wronski+A.&#x0026;author=Lovelock+P.+K.&#x0026;author=Spurdle+A.+B.&#x0026;author=and+Brown+M.+A.&#x0026;publication_year=2008&#x0026;volume=110&#x0026;pages=227-234\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B28\" id=\"B28\">\u003C/a>Reese, M. G., Eeckman, F. H., Kulp, D., and Haussler, D. (1997). Improved splice site detection in Genie. \u003Ci>J. Comput. Biol.\u003C/i> 4, 311&#x2013;323. doi: 10.1089/cmb.1997.4.311\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=9278062\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1089/cmb.1997.4.311\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Improved+splice+site+detection+in+Genie%2E&#x0026;journal=J%2E+Comput%2E+Biol%2E&#x0026;author=Reese+M.++G.&#x0026;author=Eeckman+F.++H.&#x0026;author=Kulp+D.&#x0026;author=and+Haussler+D.&#x0026;publication_year=1997&#x0026;volume=4&#x0026;pages=311-323\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B29\" id=\"B29\">\u003C/a>Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., et al. (2015). Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. \u003Ci>Genet. Med.\u003C/i> 17, 405&#x2013;423. doi: 10.1038/gim.2015.30\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=25741868\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/gim.2015.30\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Standards+and+guidelines+for+the+interpretation+of+sequence+variants%3A+a+joint+consensus+recommendation+of+the+American+college+of+medical+genetics+and+genomics+and+the+association+for+molecular+pathology%2E&#x0026;journal=Genet%2E+Med%2E&#x0026;author=Richards+S.&#x0026;author=Aziz+N.&#x0026;author=Bale+S.&#x0026;author=Bick+D.&#x0026;author=Das+S.&#x0026;author=Gastier-Foster+J.&#x0026;publication_year=2015&#x0026;volume=17&#x0026;pages=405-423\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B30\" id=\"B30\">\u003C/a>Ricks, T. K., Chiu, H.-J., Ison, G., Kim, G., McKee, A. E., Kluetz, P., et al. (2015). Successes and challenges of PARP inhibitors in cancer therapy. \u003Ci>Front. Oncol.\u003C/i> 5:222. doi: 10.3389/fonc.2015.00222\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=26528434\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fonc.2015.00222\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Successes+and+challenges+of+PARP+inhibitors+in+cancer+therapy%2E&#x0026;journal=Front%2E++Oncol%2E&#x0026;author=Ricks+T.+K.&#x0026;author=Chiu+H.-J.&#x0026;author=Ison+G.&#x0026;author=Kim+G.&#x0026;author=McKee+A.+E.&#x0026;author=Kluetz+P.&#x0026;publication_year=2015\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B31\" id=\"B31\">\u003C/a>Roy, R., Chun, J., and Powell, S. N. (2012). \u003Ci>BRCA1\u003C/i> and \u003Ci>BRCA2\u003C/i>: different roles in a common pathway of genome protection. \u003Ci>Nat. Rev. Cancer\u003C/i> 12, 68&#x2013;78. doi: 10.1038/nrc3181\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=22193408\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/nrc3181\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=BRCA1+and+BRCA2%3A+different+roles+in+a+common+pathway+of+genome+protection%2E&#x0026;journal=Nat%2E+Rev%2E+Cancer&#x0026;author=Roy+R.&#x0026;author=Chun+J.&#x0026;author=and+Powell+S.+N.&#x0026;publication_year=2012&#x0026;volume=12&#x0026;pages=68-78\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B32\" id=\"B32\">\u003C/a>Sanz, D. J., Acedo, A., Infante, M., Dur&#x00E1;n, M., P&#x00E9;rez-Cabornero, L., Esteban-Carde&#x00F1;osa, E., et al. (2010). A high proportion of DNA variants of \u003Ci>BRCA1\u003C/i> and \u003Ci>BRCA2\u003C/i> is associated with aberrant splicing in breast/ovarian cancer patients. \u003Ci>Clin. Cancer Res.\u003C/i> 16, 1957&#x2013;1967. doi: 10.1158/1078-0432.CCR-09-2564\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=20215541\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1158/1078-0432.CCR-09-2564\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=A+high+proportion+of+DNA+variants+of+BRCA1+and+BRCA2+is+associated+with+aberrant+splicing+in+breast%2Fovarian+cancer+patients%2E&#x0026;journal=Clin%2E++Cancer+Res%2E&#x0026;author=Sanz+D.++J.&#x0026;author=Acedo+A.&#x0026;author=Infante+M.&#x0026;author=Dur&#x00E1;n+M.&#x0026;author=P&#x00E9;rez-Cabornero+L.&#x0026;author=Esteban-Carde&#x00F1;osa+E.&#x0026;publication_year=2010&#x0026;volume=16&#x0026;pages=1957-1967\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B33\" id=\"B33\">\u003C/a>Sironi, M., Menozzi, G., Riva, L., Cagliani, R., Comi, G. P., Bresolin, N., et al. (2004). Silencer elements as possible inhibitors of pseudoexon splicing. \u003Ci>Nucleic Acids Res.\u003C/i> 32, 1783&#x2013;1791. doi: 10.1093/nar/gkh341\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=15034146\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/nar/gkh341\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Silencer+elements+as+possible+inhibitors+of+pseudoexon+splicing%2E&#x0026;journal=Nucleic+Acids+Res%2E&#x0026;author=Sironi+M.&#x0026;author=Menozzi+G.&#x0026;author=Riva+L.&#x0026;author=Cagliani+R.&#x0026;author=Comi+G.+P.&#x0026;author=Bresolin+N.&#x0026;publication_year=2004&#x0026;volume=32&#x0026;pages=1783-1791\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B34\" id=\"B34\">\u003C/a>Slavin, T. P., Niell-Swiller, M., Solomon, I., Nehoray, B., Rybak, C., Blazer, K. R., et al. (2015). Clinical application of multigene panels: challenges of next-generation counseling and cancer risk management. \u003Ci>Front. Oncol.\u003C/i> 5:208. doi: 10.3389/fonc.2015.00208\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=26484312\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fonc.2015.00208\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Clinical+application+of+multigene+panels%3A+challenges+of+next-generation+counseling+and+cancer+risk+management%2E&#x0026;journal=Front%2E+Oncol%2E&#x0026;author=Slavin+T.+P.&#x0026;author=Niell-Swiller+M.&#x0026;author=Solomon+I.&#x0026;author=Nehoray+B.&#x0026;author=Rybak+C.&#x0026;author=Blazer+K.+R.&#x0026;publication_year=2015\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B35\" id=\"B35\">\u003C/a>Soemedi, R., Cygan, K. J., Rhine, C. L., Glidden, D. T., Taggart, A. J., Lin, C.-L., et al. (2017). The effects of structure on pre-mRNA processing and stability. \u003Ci>Methods\u003C/i> 125, 36&#x2013;44. doi: 10.1016/j.ymeth.2017.06.001\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=28595983\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.ymeth.2017.06.001\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=The+effects+of+structure+on+pre-mRNA+processing+and+stability%2E&#x0026;journal=Methods&#x0026;author=Soemedi+R.&#x0026;author=Cygan+K.+J.&#x0026;author=Rhine+C.+L.&#x0026;author=Glidden+D.+T.&#x0026;author=Taggart+A.+J.&#x0026;author=Lin+C.-L.&#x0026;publication_year=2017&#x0026;volume=125&#x0026;pages=36-44\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B36\" id=\"B36\">\u003C/a>Villate, O., Ibarluzea, N., Fraile-bethencourt, E., and Valenzuela, A. (2018). Functional analyses of a novel splice variant in the CHD7 gene, found by next generation sequencing, confirm its pathogenicity in a Spanish patient and diagnose him with CHARGE syndrome. 9, 26&#x2013;31. doi: 10.3389/fgene.2018.00007\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.3389/fgene.2018.00007\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;author=Villate+O.&#x0026;author=Ibarluzea+N.&#x0026;author=Fraile-bethencourt+E.&#x0026;author=and+Valenzuela+A.&#x0026;publication_year=2018&#x0026;volume=9&#x0026;pages=26-31\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B37\" id=\"B37\">\u003C/a>Wang, G.-S., and Cooper, T. A. (2007). Splicing in disease: disruption of the splicing code and the decoding machinery. \u003Ci>Nat. Rev. Genet.\u003C/i> 8, 749&#x2013;761. doi: 10.1038/nrg2164\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=17726481\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/nrg2164\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Splicing+in+disease%3A+disruption+of+the+splicing+code+and+the+decoding+machinery%2E&#x0026;journal=Nat%2E+Rev%2E+Genet%2E&#x0026;author=Wang+G.-S.&#x0026;author=and+Cooper+T.+A.&#x0026;publication_year=2007&#x0026;volume=8&#x0026;pages=749-761\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B38\" id=\"B38\">\u003C/a>Wang, Z., Rolish, M. E., Yeo, G., Tung, V., Mawson, M., and Burge, C. B. (2004). Systematic identification and analysis of exonic splicing silencers. \u003Ci>Cell\u003C/i> 119, 831&#x2013;845. doi: 10.1016/j.cell.2004.11.010\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=15607979\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.cell.2004.11.010\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Systematic+identification+and+analysis+of+exonic+splicing+silencers%2E&#x0026;journal=Cell&#x0026;author=Wang+Z.&#x0026;author=Rolish+M.+E.&#x0026;author=Yeo+G.&#x0026;author=Tung+V.&#x0026;author=Mawson+M.&#x0026;author=and+Burge+C.+B.&#x0026;publication_year=2004&#x0026;volume=119&#x0026;pages=831-845\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B39\" id=\"B39\">\u003C/a>Whiley, P. J., Guidugli, L., Walker, L. C., Healey, S., Thompson, B. A., Lakhani, S. R., et al. (2011). Splicing and multifactorial analysis of intronic \u003Ci>BRCA1\u003C/i> and \u003Ci>BRCA2\u003C/i> sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundary. \u003Ci>Hum. Mutat.\u003C/i> 32, 678&#x2013;687. doi: 10.1002/humu.21495\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=21394826\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1002/humu.21495\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Splicing+and+multifactorial+analysis+of+intronic+BRCA1+and+BRCA2+sequence+variants+identifies+clinically+significant+splicing+aberrations+up+to+12+nucleotides+from+the+intron%2Fexon+boundary%2E&#x0026;journal=Hum%2E+Mutat%2E&#x0026;author=Whiley+P.+J.&#x0026;author=Guidugli+L.&#x0026;author=Walker+L.+C.&#x0026;author=Healey+S.&#x0026;author=Thompson+B.+A.&#x0026;author=Lakhani+S.+R.&#x0026;publication_year=2011&#x0026;volume=32&#x0026;pages=678-687\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B40\" id=\"B40\">\u003C/a>Will, C. L., and L&#x00FC;hrmann, R. (2011). Spliceosome structure and function. \u003Ci>Cold Spring Harb. Perspect. Biol.\u003C/i> 3:a003707. doi: 10.1101/cshperspect.a003707\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=21441581\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1101/cshperspect.a003707\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Spliceosome+structure+and+function%2E&#x0026;journal=Cold+Spring+Harb%2E+Perspect%2E+Biol%2E&#x0026;author=Will+C.+L.&#x0026;author=and+L&#x00FC;hrmann+R.&#x0026;publication_year=2011\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B41\" id=\"B41\">\u003C/a>Yeo, G., and Burge, C. B. (2004). Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. \u003Ci>J. Comput. Biol.\u003C/i> 11, 377&#x2013;394. doi: 10.1089/1066527041410418\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=15285897\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1089/1066527041410418\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Maximum+entropy+modeling+of+short+sequence+motifs+with+applications+to+RNA+splicing+signals%2E&#x0026;journal=J%2E+Comput%2E+Biol%2E&#x0026;author=Yeo+G.&#x0026;author=and+Burge+C.++B.&#x0026;publication_year=2004&#x0026;volume=11&#x0026;pages=377-394\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B42\" id=\"B42\">\u003C/a>Zhang, M. (1998). Statistical features of human exons and their flanking regions. \u003Ci>Hum. Mol. Genet.\u003C/i> 7, 919&#x2013;932. doi: 10.1093/hmg/7.5.919\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1093/hmg/7.5.919\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Statistical+features+of+human+exons+and+their+flanking+regions%2E&#x0026;journal=Hum%2E+Mol%2E+Genet%2E&#x0026;author=Zhang+M.&#x0026;publication_year=1998&#x0026;volume=7&#x0026;pages=919-932\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B43\" id=\"B43\">\u003C/a>Zhang, X. H., and Chasin, L. A. (2004). Computational definition of sequence motifs governing constitutive exon splicing. \u003Ci>Genes Dev.\u003C/i> 18, 1241&#x2013;1250. doi: 10.1101/gad.1195304\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x0026;Cmd=ShowDetailView&#x0026;TermToSearch=15145827\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1101/gad.1195304\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Computational+definition+of+sequence+motifs+governing+constitutive+exon+splicing%2E&#x0026;journal=Genes+Dev%2E&#x0026;author=Zhang+X.+H.&#x0026;author=and+Chasin+L.+A.&#x0026;publication_year=2004&#x0026;volume=18&#x0026;pages=1241-1250\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003C/div>\r\n\u003Cdiv class=\"thinLineM20\">\u003C/div>\r\n\u003Cdiv class=\"AbstractSummary\">\r\n\u003Cp>\u003Cspan>Keywords\u003C/span>: breast cancer, BRCA2, DNA variants, splicing, hybrid minigenes\u003C/p>\r\n\u003Cp>\u003Cspan>Citation:\u003C/span> Fraile-Bethencourt E, Valenzuela-Palomo A, D&#x00ED;ez-G&#x00F3;mez B, Acedo A and Velasco EA (2018) Identification of Eight Spliceogenic Variants in BRCA2 Exon 16 by Minigene Assays. \u003Ci>Front. Genet.\u003C/i> 9:188. doi: 10.3389/fgene.2018.00188\u003C/p>\r\n\u003Cp id=\"timestamps\">\r\n\u003Cspan>Received:\u003C/span> 16 March 2018; \u003Cspan>Accepted:\u003C/span> 08 May 2018;\u003Cbr>\u003Cspan>Published:\u003C/span> 24 May 2018.\u003C/p>\r\n\u003Cdiv>\r\n\u003Cp>Edited by:\u003C/p>\r\n\u003Ca href=\"http://loop.frontiersin.org/people/489555/overview\">Paolo Peterlongo\u003C/a>, IFOM &#x2013; The FIRC Institute of Molecular Oncology, Italy\u003C/div>\r\n\u003Cdiv>\r\n\u003Cp>Reviewed by:\u003C/p>\r\n\u003Ca href=\"http://loop.frontiersin.org/people/302927/overview\">Logan Walker\u003C/a>, University of Otago, New Zealand\u003Cbr>\r\n\u003Ca href=\"http://loop.frontiersin.org/people/53480/overview\">John Frederick Pearson\u003C/a>, University of Otago, New Zealand\u003C/div>\r\n\u003Cp>\u003Cspan>Copyright\u003C/span> &#x00A9; 2018 Fraile-Bethencourt, Valenzuela-Palomo, D&#x00ED;ez -G&#x00F3;mez, Acedo and Velasco. This is an open-access article distributed under the terms of the \u003Ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/4.0/\" target=\"_blank\">Creative Commons Attribution License (CC BY)\u003C/a>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.\u003C/p>\r\n\u003Cp>\u003Cspan>*Correspondence:\u003C/span> Eladio A. Velasco, \u003Ca id=\"encmail\">ZWF2ZWxzYW1AaWJnbS51dmEuZXM=\u003C/a>\u003C/p>\r\n\u003Cp>\u003Cspan>\u003Csup>&#x2020;\u003C/sup>Present address:\u003C/span> Alberto Acedo, AC-Gen Reading Life SL, Valladolid, Spain\u003C/p>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003C/div>","\u003Cul class=\"flyoutJournal\">\r\n\u003Cli>\u003Ca href=\"#h1\">Abstract\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h2\">Introduction\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h3\">Materials and Methods\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h4\">Results\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h5\">Discussion\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h6\">Author Contributions\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h7\">Funding\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h8\">Conflict of Interest Statement\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h9\">Acknowledgments\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h10\">Supplementary Material\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h11\">Footnotes\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h12\">References\u003C/a>\u003C/li>\r\n\u003C/ul>\r\n",[632,637,643,646,652],{"name":633,"fileServerPackageEntryId":19,"fileServerId":634,"fileServerVersionNumber":374,"type":635},"EPUB.epub","340287/epub",{"code":636,"name":636},"EPUB",{"name":638,"fileServerPackageEntryId":639,"fileServerId":640,"fileServerVersionNumber":374,"type":641},"fgene-09-00188.pdf","fgene-09-00188/fgene-09-00188.pdf","340287/pubmed-zip",{"code":642,"name":642},"PDF",{"name":638,"fileServerPackageEntryId":19,"fileServerId":644,"fileServerVersionNumber":374,"type":645},"340287/publishers-proof/pdf",{"code":642,"name":642},{"name":647,"fileServerPackageEntryId":648,"fileServerId":640,"fileServerVersionNumber":374,"type":649},"fgene-09-00188.xml","fgene-09-00188/fgene-09-00188.xml",{"code":650,"name":651},"NLM_XML","XML",{"name":653,"fileServerPackageEntryId":19,"fileServerId":654,"fileServerVersionNumber":374,"type":655},"Provisional PDF.pdf","340287/provisional-pdf",{"code":642,"name":642},"v3",{"title":658,"link":659,"meta":663,"script":767},"Frontiers | Identification of Eight Spliceogenic Variants in BRCA2 Exon 16 by Minigene Assays",[660],{"rel":661,"href":662},"canonical","https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/full",[664,667,670,672,675,679,682,686,689,692,695,697,699,701,703,705,708,711,713,716,719,721,724,727,730,733,736,740,744,747,749,752,754,757,759,762,764],{"hid":665,"property":665,"name":665,"content":666},"description","Genetic testing of BRCA1 and BRCA2 identifies a large number of variants of uncertain clinical significance (VUS) whose functional and clinical interpretatio...",{"hid":668,"property":668,"name":669,"content":658},"og:title","title",{"hid":671,"property":671,"name":665,"content":666},"og:description",{"hid":673,"name":673,"content":674},"keywords","breast cancer,BRCA2,DNA variants,Splicing,hybrid minigenes",{"hid":676,"property":676,"name":677,"content":678},"og:site_name","site_name","Frontiers",{"hid":680,"property":680,"name":367,"content":681},"og:image","https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/340287/fgene-09-00188-HTML/image_m/fgene-09-00188-g001.jpg",{"hid":683,"property":683,"name":684,"content":685},"og:type","type","article",{"hid":687,"property":687,"name":688,"content":662},"og:url","url",{"hid":690,"name":690,"content":691},"twitter:card","summary_large_image",{"hid":693,"name":693,"content":694},"citation_volume","9",{"hid":696,"name":696,"content":116},"citation_journal_title",{"hid":698,"name":698,"content":678},"citation_publisher",{"hid":700,"name":700,"content":610},"citation_journal_abbrev",{"hid":702,"name":702,"content":611},"citation_issn",{"hid":704,"name":704,"content":518},"citation_doi",{"hid":706,"name":706,"content":707},"citation_firstpage","340287",{"hid":709,"name":709,"content":710},"citation_language","English",{"hid":712,"name":712,"content":519},"citation_title",{"hid":714,"name":714,"content":715},"citation_keywords","breast cancer; BRCA2; DNA variants; Splicing; hybrid minigenes",{"hid":717,"name":717,"content":718},"citation_abstract","Genetic testing of BRCA1 and BRCA2 identifies a large number of variants of uncertain clinical significance (VUS) whose functional and clinical interpretations pose a challenge for genetic counselling.  Interestingly, a relevant fraction of DNA variants can disrupt the splicing process in cancer susceptibility genes.  We have tested more than 200 variants throughout 19 BRCA2 exons mostly by minigene assays, 54% of which displayed aberrant splicing, thus confirming the utility of this assay to check genetic variants in the absence of patient RNA. Our goal was to investigate BRCA2 exon 16 with a view to characterizing spliceogenic variants recorded at the mutational databases. Seventy-two different BIC and UMD variants were analyzed with NNSplice and Human Splicing Finder, 12 of which were selected because they were predicted to disrupt essential splice motifs: canonical splice sites (ss; 8 variants) and ESE/ESS (4 variants). These 12 candidate variants were introduced into the BRCA2 minigene with 7 exons (14 to 20) by site-directed mutagenesis and then transfected into MCF-7 cells. Seven variants (6 intronic and 1 missense) induced complete abnormal splicing patterns: c.7618-2A>T, c.7618-2A>G, c.7618-1G>C, c.7618-1G>A, c.7805G>C, c.7805+1G>A and c.7805+3A>C, as well as a partial anomalous outcome by c.7802A>G. They generated at least 10 different transcripts: 16p44 (alternative 3ss 44-nt downstream; acceptor variants), 16 (exon 16-skipping; donor variants), 16p55 (alternative 3ss 55-nt downstream), 16q4 (alternative 5ss 4-nt upstream), 16q100 (alternative 5ss 4-nt upstream), 16q20 (alternative 5ss 20-nt downstream) as well as minor (16p93 and 16,17p69) and uncharacterized transcripts of 893 and 954 nucleotides. Isoforms 16p44, 16, 16p55, 16q4, 16q100 and16q20 introduced premature termination codons which presumably inactivate BRCA2. According to the guidelines the American College of Medical Genetics and Genomics (ACMG) these eight variants could be classified as pathogenic or likely pathogenic whereas the Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) rules suggested seven class 4 and one class 3 variants. In conclusion, our study highlights the relevance of splicing functional assays by hybrid minigenes for the clinical classification of genetic variations. Hence, we provide new data about spliceogenic variants of BRCA2 exon 16 that are directly correlated with breast cancer susceptibility.",{"hid":720,"name":720,"content":533},"citation_article_type",{"hid":722,"name":722,"content":723},"citation_pdf_url","https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/pdf",{"hid":725,"name":725,"content":726},"citation_xml_url","https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00188/xml",{"hid":728,"name":728,"content":729},"citation_fulltext_world_readable","yes",{"hid":731,"name":731,"content":732},"citation_online_date","2018/05/08",{"hid":734,"name":734,"content":735},"citation_publication_date","2018/05/24",{"hid":737,"name":738,"content":739},"citation_author_0","citation_author","Fraile-Bethencourt, Eugenia ",{"hid":741,"name":742,"content":743},"citation_author_institution_0","citation_author_institution","Splicing and Genetic Susceptibility to Cancer, Instituto de Biologa y Gentica Molecular, Consejo Superior de Investigaciones Cientficas, Universidad de Valladolid, Spain",{"hid":745,"name":738,"content":746},"citation_author_1","Valenzuela-Palomo, Alberto ",{"hid":748,"name":742,"content":743},"citation_author_institution_1",{"hid":750,"name":738,"content":751},"citation_author_2","Dez-Gmez, Beatriz ",{"hid":753,"name":742,"content":743},"citation_author_institution_2",{"hid":755,"name":738,"content":756},"citation_author_3","Acedo, Alberto ",{"hid":758,"name":742,"content":743},"citation_author_institution_3",{"hid":760,"name":738,"content":761},"citation_author_4","Velasco, Eladio A. ",{"hid":763,"name":742,"content":743},"citation_author_institution_4",{"hid":765,"name":765,"content":766},"dc.identifier","doi:10.3389/fgene.2018.00188",[768,771,773,775,777],{"src":769,"body":13,"type":770,"async":13},"https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6","text/javascript",{"src":772,"body":13,"type":770,"async":13},"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML",{"src":774,"body":13,"type":770,"async":13},"https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js",{"src":776,"body":13,"type":770,"async":13},"https://api.altmetric.com/v1/doi/10.3389/fgene.2018.00188?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15",{"src":778,"body":13,"type":770,"async":13},"https://crossmark-cdn.crossref.org/widget/v2.0/widget.js",{"articleHubSlug":19,"articleHubPage":780,"articleHubArticlesList":781,"canJournalHasArticleHub":359,"articleDoiList":782},{},[],[],{"title":19,"image":-1,"breadcrumbs":784,"linksCollection":785,"metricsCollection":787},[],{"total":371,"items":786},[],{"total":371,"items":788},[]]</script>
<script>window.__NUXT__={};window.__NUXT__.config={public:{isDevMode:false,appName:"article-pages-2024",baseUrl:"https://www.frontiersin.org",domain:"frontiersin.org",loopUrl:"https://loop.frontiersin.org",ssMainDomain:"frontiersin.org",contentfulUrl:"https://graphql.contentful.com/content/v1/spaces",spaceId:1,spaceName:"Frontiers",liveSpaceId:1,tenantLogoUrl:"",frontiersGraphUrl:"https://apollo-federation-gateway.frontiersin.org",registrationApiUrl:"https://onboarding-ui.frontiersin.org",emailDigestApiUrl:"https://api-email-digest.frontiersin.org",journalFilesApiUrl:"https://files-journal-api.frontiersin.org",publicPagesFilesUrl:"https://public-pages-files-2025.frontiersin.org",searchApiUrl:"https://search-api.frontiersin.org",productionForumApiUrl:"https://production-forum-api-v2.frontiersin.org",gtmServerUrl:"https://tag-manager.frontiersin.org",gtmId:"GTM-M322FV2",gtmAuth:"owVbWxfaJr21yQv1fe1cAQ",gtmPreview:"env-1",figsharePluginUrl:"https://widgets.figshare.com/static/figshare.js",figshareApiUrl:"https://api.figshare.com/v2/collections/search",figshareTimeout:3000,crossmarkPublishedDate:"2015/08/24",googleRecaptchaSiteKey:"6LdG3i0UAAAAAOC4qUh35ubHgJotEHp_STXHgr_v",googleRecaptchaKeyName:"FrontiersRecaptchaV2",faviconSize16:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png",faviconSize32:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png",faviconSize180:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_180-tenantFavicon-Frontiers.png",faviconSize192:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_192-tenantFavicon-Frontiers.png",faviconSize512:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_512-tenantFavicon-Frontiers.png",socialMediaImg:"https://brand.frontiersin.org/m/1c8bcb536c789e11/Guidelines-Frontiers_Logo_1200x628_1-91to1.png",linkedArticleCopyText:"'{\"articleTypeCopyText\":[{\"articleTypeId\":0,\"originalArticleCopyText\":\"Part of this article's content has been mentioned in:\",\"linkedArticleCopyText\":\"This article mentions parts of:\"},{\"articleTypeId\":122,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an erratum on:\"},{\"articleTypeId\":129,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an addendum to:\"},{\"articleTypeId\":128,\"originalArticleCopyText\":\"A correction has been applied to this article in:\",\"linkedArticleCopyText\":\"This article is a correction to:\"},{\"articleTypeId\":134,\"originalArticleCopyText\":\"A retraction of this article was approved in:\",\"linkedArticleCopyText\":\"This article is a retraction of:\"},{\"articleTypeId\":29,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"},{\"articleTypeId\":30,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"}],\"articleIdCopyText\":[]}'\n",acceptedArticleExcludedJournalIds:"'[2766,979]'\n",articleTypeConfigurableLabel:"\u003C\u003Carticle-type:uppercase>> article",settingsFeaturesSwitchers:"'{\"displayTitlePillLabels\":true,\"displayRelatedArticlesBox\":true,\"showEditors\":true,\"showReviewers\":true,\"showLoopImpactLink\":true,\"enableFigshare\":false}'\n",journalsWithArticleHub:"'{\"strings\":[\"science\"]}'\n",terminologySettings:"'{\"terms\":[{\"sequenceNumber\":1,\"key\":\"frontiers\",\"tenantTerm\":\"Frontiers\",\"frontiersDefaultTerm\":\"Frontiers\",\"category\":\"Customer\"},{\"sequenceNumber\":2,\"key\":\"submission_system\",\"tenantTerm\":\"submission system\",\"frontiersDefaultTerm\":\"submission system\",\"category\":\"Product\"},{\"sequenceNumber\":3,\"key\":\"public_pages\",\"tenantTerm\":\"public pages\",\"frontiersDefaultTerm\":\"public pages\",\"category\":\"Product\"},{\"sequenceNumber\":4,\"key\":\"my_frontiers\",\"tenantTerm\":\"my frontiers\",\"frontiersDefaultTerm\":\"my frontiers\",\"category\":\"Product\"},{\"sequenceNumber\":5,\"key\":\"digital_editorial_office\",\"tenantTerm\":\"digital editorial office\",\"frontiersDefaultTerm\":\"digital editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":6,\"key\":\"deo\",\"tenantTerm\":\"DEO\",\"frontiersDefaultTerm\":\"DEO\",\"category\":\"Product\"},{\"sequenceNumber\":7,\"key\":\"digital_editorial_office_for_chiefs\",\"tenantTerm\":\"digital editorial office for chiefs\",\"frontiersDefaultTerm\":\"digital editorial office for chiefs\",\"category\":\"Product\"},{\"sequenceNumber\":8,\"key\":\"digital_editorial_office_for_eof\",\"tenantTerm\":\"digital editorial office for eof\",\"frontiersDefaultTerm\":\"digital editorial office for eof\",\"category\":\"Product\"},{\"sequenceNumber\":9,\"key\":\"editorial_office\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":10,\"key\":\"eof\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"Product\"},{\"sequenceNumber\":11,\"key\":\"research_topic_management\",\"tenantTerm\":\"research topic management\",\"frontiersDefaultTerm\":\"research topic management\",\"category\":\"Product\"},{\"sequenceNumber\":12,\"key\":\"review_forum\",\"tenantTerm\":\"review forum\",\"frontiersDefaultTerm\":\"review forum\",\"category\":\"Product\"},{\"sequenceNumber\":13,\"key\":\"accounting_office\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"Product\"},{\"sequenceNumber\":14,\"key\":\"aof\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"Product\"},{\"sequenceNumber\":15,\"key\":\"publishing_office\",\"tenantTerm\":\"publishing office\",\"frontiersDefaultTerm\":\"publishing office\",\"category\":\"Product\"},{\"sequenceNumber\":16,\"key\":\"production_office\",\"tenantTerm\":\"production office forum\",\"frontiersDefaultTerm\":\"production office forum\",\"category\":\"Product\"},{\"sequenceNumber\":17,\"key\":\"pof\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"Product\"},{\"sequenceNumber\":18,\"key\":\"book_office_forum\",\"tenantTerm\":\"book office forum\",\"frontiersDefaultTerm\":\"book office forum\",\"category\":\"Product\"},{\"sequenceNumber\":19,\"key\":\"bof\",\"tenantTerm\":\"BOF\",\"frontiersDefaultTerm\":\"BOF\",\"category\":\"Product\"},{\"sequenceNumber\":20,\"key\":\"aira\",\"tenantTerm\":\"AIRA\",\"frontiersDefaultTerm\":\"AIRA\",\"category\":\"Product\"},{\"sequenceNumber\":21,\"key\":\"editorial_board_management\",\"tenantTerm\":\"editorial board management\",\"frontiersDefaultTerm\":\"editorial board management\",\"category\":\"Product\"},{\"sequenceNumber\":22,\"key\":\"ebm\",\"tenantTerm\":\"EBM\",\"frontiersDefaultTerm\":\"EBM\",\"category\":\"Product\"},{\"sequenceNumber\":23,\"key\":\"domain\",\"tenantTerm\":\"domain\",\"frontiersDefaultTerm\":\"domain\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":24,\"key\":\"journal\",\"tenantTerm\":\"journal\",\"frontiersDefaultTerm\":\"journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":25,\"key\":\"section\",\"tenantTerm\":\"section\",\"frontiersDefaultTerm\":\"section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":26,\"key\":\"domains\",\"tenantTerm\":\"domains\",\"frontiersDefaultTerm\":\"domains\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":27,\"key\":\"specialty_section\",\"tenantTerm\":\"specialty section\",\"frontiersDefaultTerm\":\"specialty section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":28,\"key\":\"specialty_journal\",\"tenantTerm\":\"specialty journal\",\"frontiersDefaultTerm\":\"specialty journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":29,\"key\":\"journals\",\"tenantTerm\":\"journals\",\"frontiersDefaultTerm\":\"journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":30,\"key\":\"sections\",\"tenantTerm\":\"sections\",\"frontiersDefaultTerm\":\"sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":31,\"key\":\"specialty_sections\",\"tenantTerm\":\"specialty sections\",\"frontiersDefaultTerm\":\"specialty sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":32,\"key\":\"specialty_journals\",\"tenantTerm\":\"specialty journals\",\"frontiersDefaultTerm\":\"specialty journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":33,\"key\":\"manuscript\",\"tenantTerm\":\"manuscript\",\"frontiersDefaultTerm\":\"manuscript\",\"category\":\"Core\"},{\"sequenceNumber\":34,\"key\":\"manuscripts\",\"tenantTerm\":\"manuscripts\",\"frontiersDefaultTerm\":\"manuscripts\",\"category\":\"Core\"},{\"sequenceNumber\":35,\"key\":\"article\",\"tenantTerm\":\"article\",\"frontiersDefaultTerm\":\"article\",\"category\":\"Core\"},{\"sequenceNumber\":36,\"key\":\"articles\",\"tenantTerm\":\"articles\",\"frontiersDefaultTerm\":\"articles\",\"category\":\"Core\"},{\"sequenceNumber\":37,\"key\":\"article_type\",\"tenantTerm\":\"article type\",\"frontiersDefaultTerm\":\"article type\",\"category\":\"Core\"},{\"sequenceNumber\":38,\"key\":\"article_types\",\"tenantTerm\":\"article types\",\"frontiersDefaultTerm\":\"article types\",\"category\":\"Core\"},{\"sequenceNumber\":39,\"key\":\"author\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":40,\"key\":\"authors\",\"tenantTerm\":\"authors\",\"frontiersDefaultTerm\":\"authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":41,\"key\":\"authoring\",\"tenantTerm\":\"authoring\",\"frontiersDefaultTerm\":\"authoring\",\"category\":\"Core\"},{\"sequenceNumber\":42,\"key\":\"authored\",\"tenantTerm\":\"authored\",\"frontiersDefaultTerm\":\"authored\",\"category\":\"Core\"},{\"sequenceNumber\":43,\"key\":\"accept\",\"tenantTerm\":\"accept\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":44,\"key\":\"accepted\",\"tenantTerm\":\"accepted\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":45,\"key\":\"assistant_field_chief_editor\",\"tenantTerm\":\"Assistant Field Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editor\",\"description\":\"An editorial role on a Field Journal that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":46,\"key\":\"assistant_specialty_chief_editor\",\"tenantTerm\":\"Assistant Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":47,\"key\":\"assistant_specialty_chief_editors\",\"tenantTerm\":\"Assistant Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":48,\"key\":\"associate_editor\",\"tenantTerm\":\"Associate Editor\",\"frontiersDefaultTerm\":\"Associate Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":49,\"key\":\"specialty_chief_editor\",\"tenantTerm\":\"Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":50,\"key\":\"specialty_chief_editors\",\"tenantTerm\":\"Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":51,\"key\":\"chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":52,\"key\":\"chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":53,\"key\":\"call_for_participation\",\"tenantTerm\":\"call for participation\",\"frontiersDefaultTerm\":\"call for participation\",\"category\":\"Process\"},{\"sequenceNumber\":54,\"key\":\"citation\",\"tenantTerm\":\"citation\",\"frontiersDefaultTerm\":\"citation\",\"category\":\"Misc.\"},{\"sequenceNumber\":55,\"key\":\"citations\",\"tenantTerm\":\"citations\",\"frontiersDefaultTerm\":\"citations\",\"category\":\"Misc.\"},{\"sequenceNumber\":56,\"key\":\"contributor\",\"tenantTerm\":\"contributor\",\"frontiersDefaultTerm\":\"contributor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":57,\"key\":\"contributors\",\"tenantTerm\":\"contributors\",\"frontiersDefaultTerm\":\"contributors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":58,\"key\":\"corresponding_author\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":59,\"key\":\"corresponding_authors\",\"tenantTerm\":\"corresponding authors\",\"frontiersDefaultTerm\":\"corresponding authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":60,\"key\":\"decline\",\"tenantTerm\":\"decline\",\"frontiersDefaultTerm\":\"decline\",\"category\":\"Process\"},{\"sequenceNumber\":61,\"key\":\"declined\",\"tenantTerm\":\"declined\",\"frontiersDefaultTerm\":\"declined\",\"category\":\"Process\"},{\"sequenceNumber\":62,\"key\":\"reject\",\"tenantTerm\":\"reject\",\"frontiersDefaultTerm\":\"reject\",\"category\":\"Process\"},{\"sequenceNumber\":63,\"key\":\"rejected\",\"tenantTerm\":\"rejected\",\"frontiersDefaultTerm\":\"rejected\",\"category\":\"Process\"},{\"sequenceNumber\":64,\"key\":\"publish\",\"tenantTerm\":\"publish\",\"frontiersDefaultTerm\":\"publish\",\"category\":\"Core\"},{\"sequenceNumber\":65,\"key\":\"published\",\"tenantTerm\":\"published\",\"frontiersDefaultTerm\":\"published\",\"category\":\"Core\"},{\"sequenceNumber\":66,\"key\":\"publication\",\"tenantTerm\":\"publication\",\"frontiersDefaultTerm\":\"publication\",\"category\":\"Core\"},{\"sequenceNumber\":67,\"key\":\"peer_review\",\"tenantTerm\":\"peer review\",\"frontiersDefaultTerm\":\"peer review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":68,\"key\":\"peer_reviewed\",\"tenantTerm\":\"peer reviewed\",\"frontiersDefaultTerm\":\"peer reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":69,\"key\":\"initial_validation\",\"tenantTerm\":\"initial validation\",\"frontiersDefaultTerm\":\"initial validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":70,\"key\":\"editorial_assignment\",\"tenantTerm\":\"editorial assignment\",\"frontiersDefaultTerm\":\"editorial assignment\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":71,\"key\":\"independent_review\",\"tenantTerm\":\"independent review\",\"frontiersDefaultTerm\":\"independent review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":72,\"key\":\"interactive_review\",\"tenantTerm\":\"interactive review\",\"frontiersDefaultTerm\":\"interactive review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":73,\"key\":\"review\",\"tenantTerm\":\"review\",\"frontiersDefaultTerm\":\"review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":74,\"key\":\"reviewing\",\"tenantTerm\":\"reviewing\",\"frontiersDefaultTerm\":\"reviewing\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":75,\"key\":\"reviewer\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":76,\"key\":\"reviewers\",\"tenantTerm\":\"reviewers\",\"frontiersDefaultTerm\":\"reviewers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":77,\"key\":\"review_finalized\",\"tenantTerm\":\"review finalized\",\"frontiersDefaultTerm\":\"review finalized\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":78,\"key\":\"final_decision\",\"tenantTerm\":\"final decision\",\"frontiersDefaultTerm\":\"final decision\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":79,\"key\":\"final_validation\",\"tenantTerm\":\"final validation\",\"frontiersDefaultTerm\":\"final validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":80,\"key\":\"ae_accept_manuscript\",\"tenantTerm\":\"recommend to accept manuscript\",\"frontiersDefaultTerm\":\"accept manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":81,\"key\":\"fee\",\"tenantTerm\":\"fee\",\"frontiersDefaultTerm\":\"fee\",\"category\":\"Accounting\"},{\"sequenceNumber\":82,\"key\":\"fees\",\"tenantTerm\":\"fees\",\"frontiersDefaultTerm\":\"fees\",\"category\":\"Accounting\"},{\"sequenceNumber\":83,\"key\":\"guest_associate_editor\",\"tenantTerm\":\"Guest Associate Editor\",\"frontiersDefaultTerm\":\"Guest Associate Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":84,\"key\":\"guest_associate_editors\",\"tenantTerm\":\"Guest Associate Editors\",\"frontiersDefaultTerm\":\"Guest Associate Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":85,\"key\":\"in_review\",\"tenantTerm\":\"in review\",\"frontiersDefaultTerm\":\"in review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":86,\"key\":\"institutional_member\",\"tenantTerm\":\"institutional partner\",\"frontiersDefaultTerm\":\"institutional partner\",\"category\":\"Accounting\"},{\"sequenceNumber\":87,\"key\":\"institutional_membership\",\"tenantTerm\":\"institutional partnership\",\"frontiersDefaultTerm\":\"institutional partnership\",\"category\":\"Accounting\"},{\"sequenceNumber\":88,\"key\":\"article_processing_charge\",\"tenantTerm\":\"article processing charge\",\"frontiersDefaultTerm\":\"article processing charge\",\"category\":\"Accounting\"},{\"sequenceNumber\":89,\"key\":\"article_processing_charges\",\"tenantTerm\":\"article processing charges\",\"frontiersDefaultTerm\":\"article processing charges\",\"category\":\"Accounting\"},{\"sequenceNumber\":90,\"key\":\"apcs\",\"tenantTerm\":\"APCs\",\"frontiersDefaultTerm\":\"APCs\",\"category\":\"Accounting\"},{\"sequenceNumber\":91,\"key\":\"apc\",\"tenantTerm\":\"APC\",\"frontiersDefaultTerm\":\"APC\",\"category\":\"Accounting\"},{\"sequenceNumber\":92,\"key\":\"received\",\"tenantTerm\":\"received\",\"frontiersDefaultTerm\":\"received\",\"description\":\"Date manuscript was received on.\",\"category\":\"Core\"},{\"sequenceNumber\":93,\"key\":\"transferred\",\"tenantTerm\":\"transferred\",\"frontiersDefaultTerm\":\"transferred\",\"category\":\"Core\"},{\"sequenceNumber\":94,\"key\":\"transfer\",\"tenantTerm\":\"transfer\",\"frontiersDefaultTerm\":\"transfer\",\"category\":\"Core\"},{\"sequenceNumber\":95,\"key\":\"research_topic\",\"tenantTerm\":\"research topic\",\"frontiersDefaultTerm\":\"research topic\",\"category\":\"Core\"},{\"sequenceNumber\":96,\"key\":\"research_topics\",\"tenantTerm\":\"research topics\",\"frontiersDefaultTerm\":\"research topics\",\"category\":\"Core\"},{\"sequenceNumber\":97,\"key\":\"topic_editor\",\"tenantTerm\":\"Topic Editor\",\"frontiersDefaultTerm\":\"Topic Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":98,\"key\":\"review_editor\",\"tenantTerm\":\"Community Reviewer\",\"frontiersDefaultTerm\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":99,\"key\":\"title\",\"tenantTerm\":\"title\",\"frontiersDefaultTerm\":\"title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":100,\"key\":\"running_title\",\"tenantTerm\":\"running title\",\"frontiersDefaultTerm\":\"running title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":101,\"key\":\"submit\",\"tenantTerm\":\"submit\",\"frontiersDefaultTerm\":\"submit\",\"category\":\"Process\"},{\"sequenceNumber\":102,\"key\":\"submitted\",\"tenantTerm\":\"submitted\",\"frontiersDefaultTerm\":\"submitted\",\"category\":\"Process\"},{\"sequenceNumber\":103,\"key\":\"submitting\",\"tenantTerm\":\"submitting\",\"frontiersDefaultTerm\":\"submitting\",\"category\":\"Process\"},{\"sequenceNumber\":104,\"key\":\"t_e\",\"tenantTerm\":\"TE\",\"frontiersDefaultTerm\":\"TE\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":105,\"key\":\"topic\",\"tenantTerm\":\"topic\",\"frontiersDefaultTerm\":\"topic\",\"category\":\"Process\"},{\"sequenceNumber\":106,\"key\":\"topic_summary\",\"tenantTerm\":\"topic summary\",\"frontiersDefaultTerm\":\"topic summary\",\"category\":\"Process\"},{\"sequenceNumber\":107,\"key\":\"figure\",\"tenantTerm\":\"figure\",\"frontiersDefaultTerm\":\"figure\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":108,\"key\":\"figures\",\"tenantTerm\":\"figures\",\"frontiersDefaultTerm\":\"figures\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":109,\"key\":\"editorial_file\",\"tenantTerm\":\"editorial file\",\"frontiersDefaultTerm\":\"editorial file\",\"category\":\"Core\"},{\"sequenceNumber\":110,\"key\":\"editorial_files\",\"tenantTerm\":\"editorial files\",\"frontiersDefaultTerm\":\"editorial files\",\"category\":\"Core\"},{\"sequenceNumber\":111,\"key\":\"e_book\",\"tenantTerm\":\"e-book\",\"frontiersDefaultTerm\":\"e-book\",\"category\":\"Core\"},{\"sequenceNumber\":112,\"key\":\"organization\",\"tenantTerm\":\"organization\",\"frontiersDefaultTerm\":\"organization\",\"category\":\"Core\"},{\"sequenceNumber\":113,\"key\":\"institution\",\"tenantTerm\":\"institution\",\"frontiersDefaultTerm\":\"institution\",\"category\":\"Core\"},{\"sequenceNumber\":114,\"key\":\"reference\",\"tenantTerm\":\"reference\",\"frontiersDefaultTerm\":\"reference\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":115,\"key\":\"references\",\"tenantTerm\":\"references\",\"frontiersDefaultTerm\":\"references\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":116,\"key\":\"sce\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"description\":\"Abbreviation for Specialty Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":117,\"key\":\"submission\",\"tenantTerm\":\"submission\",\"frontiersDefaultTerm\":\"submission\",\"category\":\"Process\"},{\"sequenceNumber\":118,\"key\":\"submissions\",\"tenantTerm\":\"submissions\",\"frontiersDefaultTerm\":\"submissions\",\"category\":\"Process\"},{\"sequenceNumber\":119,\"key\":\"editing\",\"tenantTerm\":\"editing\",\"frontiersDefaultTerm\":\"editing\",\"category\":\"Process\"},{\"sequenceNumber\":120,\"key\":\"in_preparation\",\"tenantTerm\":\"in preparation\",\"frontiersDefaultTerm\":\"in preparation\",\"category\":\"Process\"},{\"sequenceNumber\":121,\"key\":\"country_region\",\"tenantTerm\":\"country/region\",\"frontiersDefaultTerm\":\"country/region\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":122,\"key\":\"countries_regions\",\"tenantTerm\":\"countries/regions\",\"frontiersDefaultTerm\":\"countries/regions\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":123,\"key\":\"specialty\",\"tenantTerm\":\"specialty\",\"frontiersDefaultTerm\":\"specialty\",\"category\":\"Core\"},{\"sequenceNumber\":124,\"key\":\"specialties\",\"tenantTerm\":\"specialties\",\"frontiersDefaultTerm\":\"specialties\",\"category\":\"Core\"},{\"sequenceNumber\":125,\"key\":\"associate_editors\",\"tenantTerm\":\"Associate Editors\",\"frontiersDefaultTerm\":\"Associate Editors\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":126,\"key\":\"reviewed\",\"tenantTerm\":\"reviewed\",\"frontiersDefaultTerm\":\"reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":127,\"key\":\"institutional_members\",\"tenantTerm\":\"institutional partners\",\"frontiersDefaultTerm\":\"institutional partners\",\"category\":\"Accounting\"},{\"sequenceNumber\":128,\"key\":\"institutional_memberships\",\"tenantTerm\":\"institutional partnerships\",\"frontiersDefaultTerm\":\"institutional partnerships\",\"category\":\"Accounting\"},{\"sequenceNumber\":129,\"key\":\"assistant_field_chief_editors\",\"tenantTerm\":\"Assistant Field Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":130,\"key\":\"publications\",\"tenantTerm\":\"publications\",\"frontiersDefaultTerm\":\"publications\",\"category\":\"Process\"},{\"sequenceNumber\":131,\"key\":\"ae_accepted\",\"tenantTerm\":\"recommended acceptance\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":132,\"key\":\"field_journal\",\"tenantTerm\":\"field journal\",\"frontiersDefaultTerm\":\"field journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":133,\"key\":\"field_journals\",\"tenantTerm\":\"field journals\",\"frontiersDefaultTerm\":\"field journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":134,\"key\":\"program_manager\",\"tenantTerm\":\"program manager\",\"frontiersDefaultTerm\":\"program manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":135,\"key\":\"journal_manager\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":136,\"key\":\"journal_specialist\",\"tenantTerm\":\"journal specialist\",\"frontiersDefaultTerm\":\"journal specialist\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":137,\"key\":\"program_managers\",\"tenantTerm\":\"program managers\",\"frontiersDefaultTerm\":\"program managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":138,\"key\":\"journal_managers\",\"tenantTerm\":\"journal managers\",\"frontiersDefaultTerm\":\"journal managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":139,\"key\":\"journal_specialists\",\"tenantTerm\":\"journal specialists\",\"frontiersDefaultTerm\":\"journal specialists\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":140,\"key\":\"cover_letter\",\"tenantTerm\":\"manuscript contribution to the field\",\"frontiersDefaultTerm\":\"manuscript contribution to the field\",\"category\":\"Process\"},{\"sequenceNumber\":141,\"key\":\"ae_accepted_manuscript\",\"tenantTerm\":\"recommended to accept manuscript\",\"frontiersDefaultTerm\":\"accepted manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":142,\"key\":\"recommend_for_rejection\",\"tenantTerm\":\"recommend for rejection\",\"frontiersDefaultTerm\":\"recommend for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":143,\"key\":\"recommended_for_rejection\",\"tenantTerm\":\"recommended for rejection\",\"frontiersDefaultTerm\":\"recommended for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":144,\"key\":\"ae\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"description\":\"Associate Editor - board member\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":145,\"key\":\"re\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"description\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":146,\"key\":\"rev\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"description\":\"Reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":147,\"key\":\"aut\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"description\":\"Author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":148,\"key\":\"coraut\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"description\":\"Corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":149,\"key\":\"saut\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"description\":\"Submitting author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":150,\"key\":\"coaut\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"description\":\"co-author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":151,\"key\":\"tsof\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"description\":\"Typesetter\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":152,\"key\":\"typesetting_office\",\"tenantTerm\":\"typesetting office\",\"frontiersDefaultTerm\":\"typesetting office\",\"category\":\"Product\"},{\"sequenceNumber\":153,\"key\":\"config\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"description\":\"Configuration office role\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":154,\"key\":\"jm\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"description\":\"Journal Manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":155,\"key\":\"rte\",\"tenantTerm\":\"RTE\",\"frontiersDefaultTerm\":\"RTE\",\"description\":\"Research topic editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":156,\"key\":\"organizations\",\"tenantTerm\":\"organizations\",\"frontiersDefaultTerm\":\"organizations\",\"category\":\"Core\"},{\"sequenceNumber\":157,\"key\":\"publishing\",\"tenantTerm\":\"publishing\",\"frontiersDefaultTerm\":\"publishing\",\"category\":\"Core\"},{\"sequenceNumber\":158,\"key\":\"acceptance\",\"tenantTerm\":\"acceptance\",\"frontiersDefaultTerm\":\"acceptance\",\"category\":\"Process\"},{\"sequenceNumber\":159,\"key\":\"preferred_associate_editor\",\"tenantTerm\":\"preferred associate editor\",\"frontiersDefaultTerm\":\"preferred associate editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":160,\"key\":\"topic_editors\",\"tenantTerm\":\"Topic Editors\",\"frontiersDefaultTerm\":\"Topic Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":161,\"key\":\"institutions\",\"tenantTerm\":\"institutions\",\"frontiersDefaultTerm\":\"institutions\",\"category\":\"Core\"},{\"sequenceNumber\":162,\"key\":\"author(s)\",\"tenantTerm\":\"author(s)\",\"frontiersDefaultTerm\":\"author(s)\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":163,\"key\":\"figure(s)\",\"tenantTerm\":\"figure(s)\",\"frontiersDefaultTerm\":\"figure(s)\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":164,\"key\":\"co-authors\",\"tenantTerm\":\"co-authors\",\"frontiersDefaultTerm\":\"co-authors\",\"description\":\"co-authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":165,\"key\":\"editorial_board_members\",\"tenantTerm\":\"editorial board members\",\"frontiersDefaultTerm\":\"editorial board members\",\"description\":\"editorial board members\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":166,\"key\":\"editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"editorial board\",\"category\":\"Product\"},{\"sequenceNumber\":167,\"key\":\"co-authorship\",\"tenantTerm\":\"co-authorship\",\"frontiersDefaultTerm\":\"co-authorship\",\"description\":\"co-authorship\",\"category\":\"Misc.\"},{\"sequenceNumber\":168,\"key\":\"role_id_1\",\"tenantTerm\":\"registration office\",\"frontiersDefaultTerm\":\"registration office\",\"category\":\"User Role\"},{\"sequenceNumber\":169,\"key\":\"role_id_2\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"User Role\"},{\"sequenceNumber\":170,\"key\":\"role_id_7\",\"tenantTerm\":\"field chief editor\",\"frontiersDefaultTerm\":\"field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":171,\"key\":\"role_id_8\",\"tenantTerm\":\"assistant field chief editor\",\"frontiersDefaultTerm\":\"assistant field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":172,\"key\":\"role_id_9\",\"tenantTerm\":\"specialty chief editor\",\"frontiersDefaultTerm\":\"specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":173,\"key\":\"role_id_10\",\"tenantTerm\":\"assistant specialty chief editor\",\"frontiersDefaultTerm\":\"assistant specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":174,\"key\":\"role_id_11\",\"tenantTerm\":\"associate editor\",\"frontiersDefaultTerm\":\"associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":175,\"key\":\"role_id_12\",\"tenantTerm\":\"guest associate editor\",\"frontiersDefaultTerm\":\"guest associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":176,\"key\":\"role_id_13\",\"tenantTerm\":\"review editor\",\"frontiersDefaultTerm\":\"review editor\",\"category\":\"User Role\"},{\"sequenceNumber\":177,\"key\":\"role_id_14\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":178,\"key\":\"role_id_15\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"User Role\"},{\"sequenceNumber\":179,\"key\":\"role_id_16\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"User Role\"},{\"sequenceNumber\":180,\"key\":\"role_id_17\",\"tenantTerm\":\"submitting author\",\"frontiersDefaultTerm\":\"submitting author\",\"category\":\"User Role\"},{\"sequenceNumber\":181,\"key\":\"role_id_18\",\"tenantTerm\":\"co-author\",\"frontiersDefaultTerm\":\"co-author\",\"category\":\"User Role\"},{\"sequenceNumber\":182,\"key\":\"role_id_20\",\"tenantTerm\":\"production office\",\"frontiersDefaultTerm\":\"production office\",\"category\":\"User Role\"},{\"sequenceNumber\":183,\"key\":\"role_id_22\",\"tenantTerm\":\"typesetting office (typesetter)\",\"frontiersDefaultTerm\":\"typesetting office (typesetter)\",\"category\":\"User Role\"},{\"sequenceNumber\":184,\"key\":\"role_id_24\",\"tenantTerm\":\"registered user\",\"frontiersDefaultTerm\":\"registered user\",\"category\":\"User Role\"},{\"sequenceNumber\":185,\"key\":\"role_id_35\",\"tenantTerm\":\"job office\",\"frontiersDefaultTerm\":\"job office\",\"category\":\"User Role\"},{\"sequenceNumber\":186,\"key\":\"role_id_41\",\"tenantTerm\":\"special event administrator\",\"frontiersDefaultTerm\":\"special event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":187,\"key\":\"role_id_42\",\"tenantTerm\":\"special event reviewer\",\"frontiersDefaultTerm\":\"special event reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":188,\"key\":\"role_id_43\",\"tenantTerm\":\"submit abstract\",\"frontiersDefaultTerm\":\"submit abstract\",\"category\":\"User Role\"},{\"sequenceNumber\":189,\"key\":\"role_id_52\",\"tenantTerm\":\"events office\",\"frontiersDefaultTerm\":\"events office\",\"category\":\"User Role\"},{\"sequenceNumber\":190,\"key\":\"role_id_53\",\"tenantTerm\":\"event administrator\",\"frontiersDefaultTerm\":\"event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":191,\"key\":\"role_id_89\",\"tenantTerm\":\"content management office\",\"frontiersDefaultTerm\":\"content management office\",\"category\":\"User Role\"},{\"sequenceNumber\":192,\"key\":\"role_id_98\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"User Role\"},{\"sequenceNumber\":193,\"key\":\"role_id_99\",\"tenantTerm\":\"projects\",\"frontiersDefaultTerm\":\"projects\",\"category\":\"User Role\"},{\"sequenceNumber\":194,\"key\":\"role_id_103\",\"tenantTerm\":\"configuration office\",\"frontiersDefaultTerm\":\"configuration office\",\"category\":\"User Role\"},{\"sequenceNumber\":195,\"key\":\"role_id_104\",\"tenantTerm\":\"beta user\",\"frontiersDefaultTerm\":\"beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":196,\"key\":\"role_id_106\",\"tenantTerm\":\"wfconf\",\"frontiersDefaultTerm\":\"wfconf\",\"category\":\"User Role\"},{\"sequenceNumber\":197,\"key\":\"role_id_107\",\"tenantTerm\":\"rt management beta user\",\"frontiersDefaultTerm\":\"rt management beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":198,\"key\":\"role_id_108\",\"tenantTerm\":\"deo beta user\",\"frontiersDefaultTerm\":\"deo beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":199,\"key\":\"role_id_109\",\"tenantTerm\":\"search beta user\",\"frontiersDefaultTerm\":\"search beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":200,\"key\":\"role_id_110\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"User Role\"},{\"sequenceNumber\":201,\"key\":\"role_id_111\",\"tenantTerm\":\"myfrontiers beta user\",\"frontiersDefaultTerm\":\"myfrontiers beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":202,\"key\":\"role_id_21\",\"tenantTerm\":\"copy editor\",\"frontiersDefaultTerm\":\"copy editor\",\"category\":\"User Role\"},{\"sequenceNumber\":203,\"key\":\"role_id_1_abr\",\"tenantTerm\":\"ROF\",\"frontiersDefaultTerm\":\"ROF\",\"category\":\"User Role\"},{\"sequenceNumber\":204,\"key\":\"role_id_2_abr\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"User Role\"},{\"sequenceNumber\":205,\"key\":\"role_id_7_abr\",\"tenantTerm\":\"FCE\",\"frontiersDefaultTerm\":\"FCE\",\"category\":\"User Role\"},{\"sequenceNumber\":206,\"key\":\"role_id_8_abr\",\"tenantTerm\":\"AFCE\",\"frontiersDefaultTerm\":\"AFCE\",\"category\":\"User Role\"},{\"sequenceNumber\":207,\"key\":\"role_id_9_abr\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"category\":\"User Role\"},{\"sequenceNumber\":208,\"key\":\"role_id_10_abr\",\"tenantTerm\":\"ASCE\",\"frontiersDefaultTerm\":\"ASCE\",\"category\":\"User Role\"},{\"sequenceNumber\":209,\"key\":\"role_id_11_abr\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"category\":\"User Role\"},{\"sequenceNumber\":210,\"key\":\"role_id_12_abr\",\"tenantTerm\":\"GAE\",\"frontiersDefaultTerm\":\"GAE\",\"category\":\"User Role\"},{\"sequenceNumber\":211,\"key\":\"role_id_13_abr\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"category\":\"User Role\"},{\"sequenceNumber\":212,\"key\":\"role_id_14_abr\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"category\":\"User Role\"},{\"sequenceNumber\":213,\"key\":\"role_id_15_abr\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":214,\"key\":\"role_id_16_abr\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":215,\"key\":\"role_id_17_abr\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":216,\"key\":\"role_id_18_abr\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":217,\"key\":\"role_id_20_abr\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"User Role\"},{\"sequenceNumber\":218,\"key\":\"role_id_22_abr\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"category\":\"User Role\"},{\"sequenceNumber\":219,\"key\":\"role_id_24_abr\",\"tenantTerm\":\"RU\",\"frontiersDefaultTerm\":\"RU\",\"category\":\"User Role\"},{\"sequenceNumber\":220,\"key\":\"role_id_35_abr\",\"tenantTerm\":\"JOF\",\"frontiersDefaultTerm\":\"JOF\",\"category\":\"User Role\"},{\"sequenceNumber\":221,\"key\":\"role_id_41_abr\",\"tenantTerm\":\"SE-ADM\",\"frontiersDefaultTerm\":\"SE-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":222,\"key\":\"role_id_42_abr\",\"tenantTerm\":\"SE-REV\",\"frontiersDefaultTerm\":\"SE-REV\",\"category\":\"User Role\"},{\"sequenceNumber\":223,\"key\":\"role_id_43_abr\",\"tenantTerm\":\"SE-AUT\",\"frontiersDefaultTerm\":\"SE-AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":224,\"key\":\"role_id_52_abr\",\"tenantTerm\":\"EVOF\",\"frontiersDefaultTerm\":\"EVOF\",\"category\":\"User Role\"},{\"sequenceNumber\":225,\"key\":\"role_id_53_abr\",\"tenantTerm\":\"EV-ADM\",\"frontiersDefaultTerm\":\"EV-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":226,\"key\":\"role_id_89_abr\",\"tenantTerm\":\"COMOF\",\"frontiersDefaultTerm\":\"COMOF\",\"category\":\"User Role\"},{\"sequenceNumber\":227,\"key\":\"role_id_98_abr\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"User Role\"},{\"sequenceNumber\":228,\"key\":\"role_id_99_abr\",\"tenantTerm\":\"Projects\",\"frontiersDefaultTerm\":\"Projects\",\"category\":\"User Role\"},{\"sequenceNumber\":229,\"key\":\"role_id_103_abr\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"category\":\"User Role\"},{\"sequenceNumber\":230,\"key\":\"role_id_104_abr\",\"tenantTerm\":\"BETA\",\"frontiersDefaultTerm\":\"BETA\",\"category\":\"User Role\"},{\"sequenceNumber\":231,\"key\":\"role_id_106_abr\",\"tenantTerm\":\"WFCONF\",\"frontiersDefaultTerm\":\"WFCONF\",\"category\":\"User Role\"},{\"sequenceNumber\":232,\"key\":\"role_id_107_abr\",\"tenantTerm\":\"RTBETA\",\"frontiersDefaultTerm\":\"RTBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":233,\"key\":\"role_id_108_abr\",\"tenantTerm\":\"DEOBETA\",\"frontiersDefaultTerm\":\"DEOBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":234,\"key\":\"role_id_109_abr\",\"tenantTerm\":\"SEARCHBETA\",\"frontiersDefaultTerm\":\"SEARCHBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":235,\"key\":\"role_id_110_abr\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"category\":\"User Role\"},{\"sequenceNumber\":236,\"key\":\"role_id_111_abr\",\"tenantTerm\":\"MFBETA\",\"frontiersDefaultTerm\":\"MFBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":237,\"key\":\"role_id_21_abr\",\"tenantTerm\":\"COPED\",\"frontiersDefaultTerm\":\"COPED\",\"category\":\"User Role\"},{\"sequenceNumber\":238,\"key\":\"reviewer_editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"This is the label for the review editorial board\",\"category\":\"Label\"},{\"sequenceNumber\":239,\"key\":\"field_chief_editor\",\"tenantTerm\":\"Field Chief Editor\",\"frontiersDefaultTerm\":\"Field Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":240,\"key\":\"field_chief_editors\",\"tenantTerm\":\"Field Chief Editors\",\"frontiersDefaultTerm\":\"Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":241,\"key\":\"editor\",\"tenantTerm\":\"editor\",\"frontiersDefaultTerm\":\"editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":242,\"key\":\"editors\",\"tenantTerm\":\"editors\",\"frontiersDefaultTerm\":\"editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":243,\"key\":\"board\",\"tenantTerm\":\"board\",\"frontiersDefaultTerm\":\"board\",\"category\":\"Label\"},{\"sequenceNumber\":244,\"key\":\"boards\",\"tenantTerm\":\"boards\",\"frontiersDefaultTerm\":\"boards\",\"category\":\"Label\"},{\"sequenceNumber\":245,\"key\":\"article_collection\",\"tenantTerm\":\"article collection\",\"frontiersDefaultTerm\":\"article collection\",\"category\":\"Label\"},{\"sequenceNumber\":246,\"key\":\"article_collections\",\"tenantTerm\":\"article collections\",\"frontiersDefaultTerm\":\"article collections\",\"category\":\"Label\"},{\"sequenceNumber\":247,\"key\":\"handling_editor\",\"tenantTerm\":\"handling editor\",\"frontiersDefaultTerm\":\"associate editor\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":248,\"key\":\"handling_editors\",\"tenantTerm\":\"handling editors\",\"frontiersDefaultTerm\":\"associate editors\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":249,\"key\":\"ae_accept\",\"tenantTerm\":\"recommend acceptance\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":250,\"key\":\"rtm\",\"tenantTerm\":\"RTM\",\"frontiersDefaultTerm\":\"RTM\",\"category\":\"Product\"},{\"sequenceNumber\":251,\"key\":\"frontiers_media_sa\",\"tenantTerm\":\"Frontiers Media S.A\",\"frontiersDefaultTerm\":\"Frontiers Media S.A\",\"category\":\"Customer\"},{\"sequenceNumber\":252,\"key\":\"review_editors\",\"tenantTerm\":\"Community Reviewers\",\"frontiersDefaultTerm\":\"Review Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":253,\"key\":\"journal_card_chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":254,\"key\":\"journal_card_chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":255,\"key\":\"call_for_papers\",\"tenantTerm\":\"Call for papers\",\"frontiersDefaultTerm\":\"Call for papers\",\"category\":\"Label\"},{\"sequenceNumber\":256,\"key\":\"calls_for_papers\",\"tenantTerm\":\"Calls for papers\",\"frontiersDefaultTerm\":\"Calls for papers\",\"category\":\"Label\"},{\"sequenceNumber\":257,\"key\":\"supervising_editor\",\"tenantTerm\":\"Supervising Editor\",\"frontiersDefaultTerm\":\"Supervising Editor\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editor\"},{\"sequenceNumber\":258,\"key\":\"supervising_editors\",\"tenantTerm\":\"Supervising Editors\",\"frontiersDefaultTerm\":\"Supervising Editors\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editors\"},{\"sequenceNumber\":259,\"key\":\"reviewer_endorse\",\"tenantTerm\":\"endorse\",\"frontiersDefaultTerm\":\"endorse\",\"category\":\"Label\"},{\"sequenceNumber\":260,\"key\":\"reviewer_endorsed\",\"tenantTerm\":\"endorsed\",\"frontiersDefaultTerm\":\"endorsed\",\"category\":\"Label\"},{\"sequenceNumber\":261,\"key\":\"reviewer_endorse_publication\",\"tenantTerm\":\"endorse publication\",\"frontiersDefaultTerm\":\"endorse publication\",\"category\":\"Label\"},{\"sequenceNumber\":262,\"key\":\"reviewer_endorsed_publication\",\"tenantTerm\":\"endorsed publication\",\"frontiersDefaultTerm\":\"endorsed publication\",\"category\":\"Label\"},{\"sequenceNumber\":263,\"key\":\"editor_role\",\"tenantTerm\":\"editor role\",\"frontiersDefaultTerm\":\"Editor Role\",\"category\":\"Label\"},{\"sequenceNumber\":264,\"key\":\"editor_roles\",\"tenantTerm\":\"editor roles\",\"frontiersDefaultTerm\":\"Editor Roles\",\"category\":\"Label\"},{\"sequenceNumber\":265,\"key\":\"editorial_role\",\"tenantTerm\":\"editorial role\",\"frontiersDefaultTerm\":\"Editorial Role\",\"category\":\"Label\"},{\"sequenceNumber\":266,\"key\":\"editorial_roles\",\"tenantTerm\":\"editorial roles\",\"frontiersDefaultTerm\":\"Editorial Roles\",\"category\":\"Label\"},{\"sequenceNumber\":267,\"key\":\"call_for_paper\",\"tenantTerm\":\"Call for paper\",\"frontiersDefaultTerm\":\"Call for paper\",\"category\":\"Label\"},{\"sequenceNumber\":268,\"key\":\"research_topic_abstract\",\"tenantTerm\":\"manuscript summary\",\"frontiersDefaultTerm\":\"manuscript summary\",\"category\":\"Process\"},{\"sequenceNumber\":269,\"key\":\"research_topic_abstracts\",\"tenantTerm\":\"manuscript summaries\",\"frontiersDefaultTerm\":\"manuscript summaries\",\"category\":\"Process\"},{\"sequenceNumber\":270,\"key\":\"submissions_team_manager\",\"tenantTerm\":\"Journal Manager\",\"frontiersDefaultTerm\":\"Content Manager\",\"category\":\"Process\"},{\"sequenceNumber\":271,\"key\":\"submissions_team\",\"tenantTerm\":\"Journal Team\",\"frontiersDefaultTerm\":\"Content Team\",\"category\":\"Process\"},{\"sequenceNumber\":272,\"key\":\"topic_coordinator\",\"tenantTerm\":\"topic coordinator\",\"frontiersDefaultTerm\":\"topic coordinator\",\"category\":\"Process\"},{\"sequenceNumber\":273,\"key\":\"topic_coordinators\",\"tenantTerm\":\"topic coordinators\",\"frontiersDefaultTerm\":\"topic coordinators\",\"category\":\"Process\"},{\"sequenceNumber\":274,\"key\":\"frontiers_journal_team\",\"tenantTerm\":\"frontiers journal team\",\"frontiersDefaultTerm\":\"frontiers journal team\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":275,\"key\":\"research_topic_ic_submission\",\"tenantTerm\":\"RT:IC Submission\",\"frontiersDefaultTerm\":\"RT:IC Submission\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":276,\"key\":\"research_topic_ic_submission_participant\",\"tenantTerm\":\"RT:IC Submission participant\",\"frontiersDefaultTerm\":\"RT:IC Submission participant\",\"category\":\"Label (Role)\"}]}'\n",impactGtmId:"GTM-NJF2ML9B",impactGtmAuth:"fYo-7NoDm9w37QgFMs03SA",impactGtmPreview:"env-1",impactGoogleMapsApiKey:"AIzaSyCTEhX2EU8PWfi86GW9FI00FTcyKk6Ifr8",qualtricsV4ToV3:"'{\"enabled\":true,\"interceptId\":\"SI_er0E2ze69Oz8Yn4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsUmux:"'{\"enabled\":false,\"interceptId\":\"SI_89fPHY3eTxQBwtU\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsContinuousBrand:"'{\"enabled\":true,\"interceptId\":\"SI_9ZuT94UT81FcRh4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",defaultArticleTemplate:"v3"},app:{baseURL:"/",buildId:"ed555f16-85f7-4f41-8f2f-451827c59120",buildAssetsDir:"ap-2024/_nuxt",cdnURL:""}}</script>
<script src="https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6" type="text/javascript" async></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML" type="text/javascript" async></script>
<script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js" type="text/javascript" async></script>
<script src="https://api.altmetric.com/v1/doi/10.3389/fgene.2018.00188?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15" type="text/javascript" async></script>
<script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript" async></script></body></html>